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RESUMEN 
Salmonella es un patógeno alimentario de gran relevancia clínica 
capaz de adherirse a superficies y formar comunidades bacterianas 
embebidas en una matriz que ellas mismas producen denominadas 
biofilms. Esta matriz confiere a las bacterias protección frente a agentes 
externos, aumentando su tolerancia frente a condiciones ambientales 
adversas, agentes antimicrobianos o el sistema inmune del hospedador. 
Existe una vía de señalización, mediada por el dinucleótido cíclico, c-di-
GMP, que controla en muchas especies bacterianas la síntesis de diversos 
componentes de la matriz del biofilm, de manera que concentraciones 
elevadas de este nucleótido activan la producción de la matriz y por lo tanto 
del biofilm. La formación de biofilms en explotaciones agropecuarias y 
lugares donde se procesan alimentos es una fuente potencial de 
contaminación y de transmisión de este patógeno. Diversas medidas de 
higiene y seguimiento han sido implementadas por las autoridades para el 
control de esta bacteria; sin embargo alrededor de 93 millones de personas 
en todo el mundo sufren salmonelosis cada año. Por ello, la búsqueda de 
medidas alternativas de control, basadas en la vacunación animal, así 
como el estudio de los mecanismos de patogenicidad y formación de biofilm 
de Salmonella han sido el objeto de este trabajo. 
La primera parte de esta tesis se ha dedicado a la evaluación de una 
cepa atenuada de Salmonella para su posible uso como cepa vacunal. En 
primer lugar, se analizó la implicación del sistema de señalización mediado 
por c-di-GMP en la virulencia de Salmonella mediante la comparación, en 
diversos modelos de infección en ratón, de la virulencia de una cepa salvaje 
y de una cepa mutante múltiple en todos los genes  responsables de la 
síntesis de c-di-GMP, y por lo tanto incapaz de sintetizar c-di-GMP. Este 
mutante presentó una atenuación moderada, indicando que el sistema de 
señalización del c-di-GMP es necesario durante la infección. La mutación 
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adicional, en este mutante, del gen rpoS dio lugar a una cepa, denominada 
ΔXIII, muy atenuada y capaz de inducir una respuesta inmune protectora 
frente a un desafío con una cepa virulenta de S. Typhimurium. Además, 
esta cepa vacunal presenta una serie de características que indican que no 
sería capaz de sobrevivir en el ambiente y que, por otra parte, permitirían la 
diferenciación de animales vacunados y no vacunados. Por todo ello, se 
propone el uso de la cepa ΔXIII como una cepa vacunal viva y atenuada 
para la protección frente a Salmonella de los animales implicados en la 
transmisión de esta bacteria.    
Posteriormente y recogido en el capítulo dos, hemos estudiado la 
implicación del receptor eucariota del c-di-GMP, denominado STING 
(STimulator of INterferon Genes), durante la infección por Salmonella. 
Recientemente se ha descrito que STING es una proteína de la célula 
huésped capaz de unir c-di-GMP y generar una respuesta inmune a través 
de la producción de interferón. Sin embargo se desconoce si en el caso de 
Salmonella, tal y como ocurre en otras bacterias, esta producción de IFN 
puede suponer una estrategia de la bacteria para modular la respuesta 
inmune del hospedador, o por el contrario la activación de STING 
representa un mecanismo del huésped de protección frente a la infección. 
Para llevar a cabo este estudio, hemos utilizado una cepa salvaje y el 
mutante múltiple incapaz de sintetizar c-di-GMP y hemos realizado 
infecciones in vitro e in vivo utilizando ratones salvajes y mutantes en 
STING. Nuestros resultados indican que la infección de macrófagos con 
Salmonella da lugar a la producción de IFN-β mediada por STING, 
independientemente de la presencia de c-di-GMP. Por otra parte, tanto la 
cepa salvaje de Salmonella como el mutante en c-di-GMP son capaces de 
infectar de igual manera ratones salvajes y deficientes en STING, lo cual 
demuestra que ni el reconocimiento del c-di-GMP a través de STING ni 
cualquier otro mecanismo de activación de STING juegan un papel 
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relevante en el resultado de la infección por Salmonella.  
Por último, en el capítulo tres, hemos estudiado las razones por las 
cuales Salmonella no presenta en su genoma los genes necesarios para la 
síntesis  del exopolisacárido PGA (poly-β-1,6-N-acetyl-D-glucosamine). La 
matriz del biofilm de Salmonella está formada fundamentalmente por el 
exopolisacárido celulosa; sin embargo otras enterobacterias como 
Escherichia coli además de sintetizar celulosa, recurren también al 
exopolisacarido PGA para la formación del biofilm. Teniendo en cuenta que 
Salmonella y E. coli se encuentran filogenéticamente muy relacionadas 
pero sus ciclos de vida son muy diferentes, nos planteamos que tal vez la 
ausencia de PGA supuso un evento evolutivo de diversificación entre estas 
especies. El análisis filogenético comparativo de genomas de 
enterobacterias sugiere que Salmonella perdió los genes implicados en la 
síntesis de PGA después de la diversificación de los géneros Salmonella y 
Citrobacter y antes de la diversificación de las distintas especies de 
Salmonella. Mediante la expresión heteróloga del polisacárido PGA de 
Escherichia coli en Salmonella hemos podido determinar que al igual que 
ocurre en E. coli, la síntesis de PGA es dependiente de c-di-GMP. Hemos 
observado que la producción de PGA da lugar a la formación de un biofilm 
muy diferente a nivel estructural de la celulosa que no proporciona una 
ventaja adicional para la supervivencia de la bacteria frente a diferentes 
estreses ambientales. Por otra parte, la producción de PGA resulta muy 
perjudicial para la supervivencia de Salmonella dentro del huésped, ya que 
aumenta la sensibilidad a las sales biliares y especies reactivas de oxigeno, 
comprometiendo su capacidad de supervivencia en macrófagos y la 
colonización de órganos incluyendo la vesícula biliar. Por lo tanto, nuestros 
resultados indican que el PGA es un factor antivirulencia en Salmonella, 
cuya pérdida supuso una estrategia evolutiva necesaria para garantizar la 
colonización y supervivencia en el huésped. 
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SUMMARY 
Salmonella is a foodborne pathogen of clinical relevance able to 
adhere to surfaces and form biofilms that are defined as bacterial 
communities embedded in a self-produced matrix. This matrix confers upon 
bacteria protection against external agents, increasing their resistance to 
adverse environmental conditions, antimicrobial agents and the host 
immune system. There is a signaling pathway mediated by the cyclic 
dinucleotide c-di-GMP, which controls, in many bacterial species, the 
synthesis of various components of the biofilm matrix, so that high 
concentrations of this nucleotide activate matrix production and biofilm 
formation. Biofilm formation in farms and food processing sites is a potential 
source of contamination and transmission of this pathogen. In spite of 
hygiene and control measures implemented by the authorities for the control 
of this bacterium, around 93 million people suffer from salmonellosis every 
year, worldwide. Therefore, the search for alternative control measures, 
based on animal vaccination, as well as the study of Salmonella 
pathogenicity mechanisms and the biofilm formation process have been the 
subject of this work. 
The first part of this thesis has been focused on the evaluation of a 
Salmonella strain as a putative vaccine candidate. First, the implication of 
the c-di-GMP-mediated signaling system in Salmonella virulence was 
analyzed by comparing the virulence of a wild-type strain with that of a 
multiple mutant strain in all the genes responsible for c-di-GMP synthesis, 
and therefore unable to synthesize c-di-GMP. This mutant showed a slight 
but significant attenuation in virulence, indicating that the c-di-GMP 
signaling system is required during infection. An additional deletion in this 
mutant of the rpoS gene resulted in a highly attenuated strain, named ΔXIII, 
capable of inducing a protective immune response against a challenge with 
a virulent S. Typhimurium strain. In addition, this vaccine strain showed 
Summary 
10 
several features that indicate that it would not be able to survive in the 
environment and that, on the other hand, would allow the differentiation 
between vaccinated and unvaccinated animals. Therefore, we propose the 
use of ΔXIII strain as a live and attenuated vaccine against Salmonella for 
the protection of animals involved in the transmission of this pathogen. 
Then, chapter two is dedicated to analyze the involvement of the c-di-
GMP eukaryotic receptor STING (STimulator of INterferon Genes) in 
Salmonella infection. It has recently been described that STING is a host 
cell protein capable of binding c-di-GMP and generating an immune 
response through the production of interferon. However, it is not known 
whether, in the case of Salmonella, stimulation of IFN production might be a 
bacterial strategy to modulate the host immune response, as it happens with 
other bacteria, or on the contrary, STING activation represents a host 
mechanism for protection against infection. To carry out this study, we used 
a wild type strain and the multiple mutant unable to synthesize c-di-GMP to 
perform in vitro and in vivo infections, using wild type and STING deficient 
mice. Our results indicate that macrophages infection with Salmonella 
results in the production of IFN-β mediated by STING, regardless of the 
presence of c-di-GMP. On the other hand, both the wild-type and the c-di-
GMP mutant strains are equally able to infect wild-type and STING deficient 
mice, showing that neither recognition of c-di-GMP via STING nor a different 
mechanism of STING activation play a relevant role in the outcome of a 
Salmonella infection. 
Finally, in chapter three, we have studied the reasons why 
Salmonella does not harbor the genes necessary for the synthesis of the 
PGA (poly-β-1,6-N-acetyl-D-glucosamine) exopolysaccharide. The 
Salmonella biofilm matrix is mainly formed by cellulose. However, other 
bacteria from the Enterobacteriaceae family such as Escherichia coli, 
synthesize not only cellulose, but also PGA for biofilm formation. Taking into 
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account that Salmonella and E. coli are phylogenetically very related and 
that their life cycles are very different, we considered that perhaps, absence 
of PGA in Salmonella was an evolutionary event of diversification amongst 
these species. Comparative phylogenetic analyses of Enterobacteriaceae 
genomes suggest that Salmonella lost the genes involved in PGA synthesis 
after the diversification of the Salmonella and Citrobacter clades and 
previous to the diversification of the currently sequenced Salmonella strains. 
Heterologous expression of the Escherichia coli PGA polysaccharide in 
Salmonella allowed us to determine that, as it happens in E. coli, PGA 
synthesis is dependent on c-di-GMP. PGA production in Salmonella leads to 
the formation of a biofilm that is very different at a structural level from the 
biofilm formed by cellulose and that does not provide any additional 
advantage for bacterial survival against different environmental stresses. On 
the other hand, PGA production is very detrimental to Salmonella survival 
inside the host, since it increases the sensitivity to bile salts and reactive 
oxygen species, compromising Salmonella survival inside macrophages and 
also organ colonization, including that of the gallbladder. Therefore, our 
results indicate that PGA is an antivirulence factor in Salmonella, whose 
loss may have been an evolutionary strategy to guarantee colonization and 
survival inside the host. 
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INTRODUCTION 
The genus Salmonella  
Taxonomy of the genus Salmonella  
The genus Salmonella belongs to the Enterobacteriaceae family. This 
genus contains flagellated, non-sporulated, facultative anaerobic, gram-
negative bacilli. Based on DNA-DNA hybridization assays, the genus has 
been divided into two species, S. enterica and S. bongori (Reeves et al., 
1989; Euzeby, 1999; Shelobolina et al., 2004; Tindall, 2005). Salmonella 
enterica is further divided into six subspecies named as:  
 
S. enterica subsp. enterica (I) 
S. enterica subsp. salamae (II) 
S. enterica subsp. arizonae (IIIa) 
S. enterica subsp. diarizonae (IIIb) 
S. enterica subsp. houtenae (IV) 
S. enterica subsp. indica (VI) 
 
These subspecies include more than 2500 different serovars that are 
classified based on the serologic identification of O (somatic) and H 
(flagellar) antigens and are listed in a document called the Kauffmann–
White scheme (Grimont and François-Xavier, 2007). Whereas S. bongori 
and S. enterica subspecies II–IV and VI are isolated predominantly from 
poikilothermic vertebrate species, the host range of S. enterica subspecies I 
serovars includes homeothermic animals (i.e., mammals and birds). 
Importantly, approximately 99% of human clinical isolates belong to S. 
enterica subspecies I, and the vast majority of the 1,531 serovars of this 
subspecies are associated with gastroenteritis in immunocompetent 
individuals (Brenner et al., 2000). From a clinical perspective, Salmonella 
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serovars are usually classified into two broad groups. Nontyphoidal 
Salmonella (NTS) serovars are considered to be generalist in terms of host 
range and have a low human invasiveness index, typically causing self-
limiting enterocolitis in immunocompetent hosts. On the other hand, 
typhoidal serovars that encompass S. enterica serovars Typhi and 
Paratyphi, are human specific pathogens that cause enteric fever, a 
systemic illness due to dissemination to the lymph nodes, liver and spleen 
through the lymphatic system.  
In this thesis, we have mainly worked with S. enterica subsp. enterica 
ser Enteritidis, which is hereafter abbreviated as S. Enteritidis.  
 
Epidemiology 
The primary habitat of Salmonella is the intestinal tract of humans and 
other animals (mammals, reptiles, birds and even insects), though it can 
also survive for long periods of time outside the host withstanding a variety 
of stresses associated with environmental fluctuations (Winfield and 
Groisman, 2003). This adaptability allows Salmonella to transit from the 
environment to the host during its life cycle (Winfield and Groisman, 2003). 
Salmonella is one of the most common etiologic agents of foodborne 
diarrhoea and enteric fever in the world, mainly in non-developed countries. 
In humans, Salmonella infection usually results from the ingestion of water 
and food contaminated products, such as undercooked beef, pork, chicken, 
seafood or eggs (Pang et al., 1995), although there is also evidence of 
Salmonella infections following the consumption of fresh fruits or vegetables 
that have been contaminated by infected fertilizers (Tauxe, 1997) and even 
of transmission between reptilian pets and their owners (Cain et al., 2009). 
In the European Union (EU), a total of 88,715 clinical cases of 
salmonellosis were reported in 2014. The European Food Safety Authority 
(EFSA) has estimated that the overall economic burden of human 
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salmonellosis could be as high as 3 billion euros a year 
(http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2015.4329/epdf). In 
Europe, the two most commonly detected serovars in the year 2014 were S. 
Typhimurium and S. Enteritidis, two ubiquitous serovars whose lack of 
specificity in host adaptation permits them to colonize a wide variety of 
organisms (Uzzau et al., 2000), representing 44.4% and 17.4%, 
respectively, of all reported serovars in confirmed human cases. The 
reporting of human S. Enteritidis cases increased, whereas S. Typhimurium 
and other common serovars cases decreased in 2014 compared with 2103. 
As in previous years, Salmonella was most frequently detected in poultry 
meat, and less often in pig or bovine meat. The most important source of 
food-borne Salmonella outbreaks was, however, still eggs and egg 
products.  
In 2003, the European Union (EU) set up an extended control 
programme for zoonoses, considering Salmonella as a priority (Regulation 
(EC) Nº 2160/2003 of the European Parliament and of the Council of 17 
November 2003 on the control of Salmonella and other specified food-borne 
zoonotic agents), (http://eur-lex.europa.eu/legal-
content/ES/TXT/?uri=CELEX:32003R2160). The purpose of this regulation 
was to ensure that proper and effective measures were taken to detect and 
control Salmonella and other zoonotic agents at all relevant stages of 
production, processing and distribution, particularly at the level of primary 
production, including in feed. The final aim of these interventions was 
reducing Salmonella prevalence and consequently the risk of reaching the 
human food chain. Enhanced Salmonella control programmes in poultry 
were implemented in all EU Member States. Targets were set for the 
reduction of Salmonella in poultry flocks (e.g. laying hens, broilers, turkeys) 
and pigs. Restrictions were also imposed on the trade of products from 
infected flocks.  
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Salmonellosis in Spain, as throughout the EU, is one of the main food-
borne zoonosis. In 2014, 6.643 human cases were reported in Spain, and 
as in other countries of the EU the main focus of contamination was egg 
consumption. Several control programs have been approved to control 
Salmonella incidence in poultry farms in order to avoid foodstuff 
contamination. Since January the 1rst, 2009, eggs cannot be used for direct 
human consumption as table eggs unless they originate from a commercial 
flock of laying hens subjected to a national Salmonella control programme. 
Also, fresh eggs from flocks found positive for S. Typhimurium or S. 
Enteritidis must be heat treated before consumption (Regulation (EC) Nº 
1237/200723). According to Regulation (EC) Nº 2160/2003 and Regulation 
(EC) No 200/2010.2, control programmes for breeding flocks aim to meet a 
reduction target of 1% or less of positive flocks for the following serovars; S. 
Enteritidis, S. Typhimurium, S. Infantis, S. Virchow and S. Hadar. In 2014, 
the percentage of positive breeding flocks of these serovars in the 
framework of this normative was 0,5% in Spain, and the total amount of 
Salmonella incidence was 4,31% (Table 1). While these control programs 
have been successful for reducing Salmonella incidence in poultry farms, 
the amount of human cases is still high, suggesting that additional control 
programs (to reduce Salmonellosis human cases) are needed. 
In the case of pigs, although related infections due to pig meat 
consumption are fewer than in the case of poultry derived products, the 
incidence of Salmonella in european pig farms is still very high. At the 
moment, control programmes aimed at reducing Salmonella contamination 
of pig derived products and prevalence in farms are not mandatory, and 
thus, spanish data regarding Salmonella in pigs from bacteriological 
monitoring programmes are unavailable in the 2014 EFSA report. Although 
there is still not a national control programme established in Spain, a 
number of studies have been performed through the last decade that show 
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the high Salmonella prevalence in finishing herds. 
High Salmonella incidence is due, amongst other factors, to the 
increased consumption of processed food, which implies a consequent risk 
of cold chain rupture during food transport, and also to the high-productivity-
focused model of animal breeding in which antibiotics are extensively used 
leading to the spread of antibiotic resistance (Shakespeare et al., 2005) 
(Parry, 2004) (González-Zorn and Escudero, 2012). This scenario demands 
the search of new strategies to reduce contamination incidence based on 
measures related to feeding practices, vaccination and generic measures of 
hygiene and biosecurity.  
 
Table 1. Salmonella prevalence in Spanish farms 
Breeding flocks of Gallus gallus 4,31 % 
Laying hen flocks of Gallus gallus 7,67 % 
Broiler flocks of Gallus gallus 3,63 % 
Breeding turkeys flocks 9,38 % 
Flattering turkeys flocks 17,5 % 
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Pathogenesis 
Salmonella disease manifestation depends on both, host susceptibility 
and the S. enterica serovar. In humans, serovars Typhi and Paratyphi cause 
enteric fever that manifests one to 2 weeks following bacterial inoculation, 
while non-typhoidal Salmonella serovars such as S. Typhimurium and S. 
Enteritidis cause a localized gastroenteritis which results in diarrhoea, 
nausea, vomiting, intestinal cramping and fever within 12 to 72 hours after 
infection (Coburn et al., 2006). 
Salmonella infection starts with the ingestion of bacteria, usually 
through contaminated food. Following ingestion, Salmonella is able to resist 
the acidic environment in the stomach and the bactericidal effect of 
compounds such as bile salts, especially in the initial part of the small 
intestine. In this location, Salmonella reaches its main target, the gut 
associated lymphoid tissue of the ileum, in particular the M cells foci of the 
Peyer´s patches. Virulence genes of the TTSS-1 (type three secretion 
system) encoded in the Salmonella pathogenicity island I allow bacteria 
internalization in these M cells and also in enterocytes and goblet cells via a 
process called macropinocytosis (a form of endocytosis of large particles 
such as bacteria) (Francis et al., 1993; Ginocchio et al., 1994). Acting as a 
molecular syringe, the TTSS-1 injects proteins termed effectors into host 
cells (Fu and Galán, 1998). Four TTSS-1 effectors, named SipA, SopB, 
SopD and SopE2 act in concert to trigger alterations in the actin 
cytoskeleton of host cells, thereby promoting intestinal inflammation (Zhang 
et al., 2002; Raffatellu et al., 2004). Bacterial translocation across the 
intestinal epithelium occurs through the uptake by M cells as well as 
dendritic cells gaining access to the host circulation. Besides, numerous 
evidences indicate that Salmonella is able to disrupt tight junctions between 
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epithelial cells allowing paracellular transit into the gastrointestinal tissue 
(Boyle et al., 2006).(Fig.1 and Fig.2) 
An important factor in Salmonella pathogenesis is the ability to survive 
inside cells. Upon bacterial internalization or uptake, Salmonella resides in a 
unique membrane-bound compartment, different from the phagosome or 
lysosome, named SCV (salmonella containing vacuole). In this stage, the 
second type three secretion system (TTSS-2) codified in the SPI-2 inhibits 
the fusion with lysosomes and host oxidase killing (Raffatellu et al., 2004; 
Thiennimitr et al., 2012). 
Once the epithelial barrier is breached, the innate immune cells 
stimulate the pattern recognition receptors (PRRs). Bacterial LPS, curli 
fimbriae, lipopeptide and flagellin (the monomeric subunit of the bacterial 
flagellar apparatus) are important PAMPs (pathogen-associated molecular 
patterns) recognized by host cells. The activation of Toll-like receptor 4 
(TLR4) in response to Salmonella LPS causes a high inflammatory 
response in macrophages. Flagellin is recognized by TLR5 in epithelial cells 
and is a potent inducer of IL-8 (Gewirtz et al., 2000; Vazquez-Torres et al., 
2004; Zeng, 2005). TLR2 in concert with TLR1 or TLR6 recognizes triacyl or 
diacyl bacterial lipopeptide. Curli fimbriae is the main PAMP detected by 
TLR1/TLR2 on intact bacterial cells (Tükel et al., 2010).  
In addition to the recognition of PAMPS from extracellular bacteria, the 
presence of intracellular Salmonella also leads to changes in the expression 
of host genes encoding for cytokines, cell surface receptors, or 
transcriptional activators. Upon phagocytosis of Salmonella, macrophages 
and dendritic cells activate a proinflammatory response, characterized by IL-
12, IFN-γ and TNF-α production in mice. IFN-γ production is necessary to 
control bacterial replication, and is triggered by IL-12 produced by antigen-
presenting cells (APCs). On the other hand, TNF-α enhances microbicidal 
activity synergistically with IFN-γ and triggers the production of nitric oxide. 
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The immune response against intracellular Salmonella has been shown to 
be very relevant for resistance against infection (Thiennimitr et al., 2012) 
(Coburn et al., 2006) (Eckmann and Kagnoff, 2001). 
In the case of enterocolitis, upon colonization of the intestine, bacteria 
localize to the apical epithelium, induce invasion associated virulence 
factors and elicit significant inflammatory changes including 
polymorphonuclear cells (PMNs) and monocyte infiltration, inflammation of 
the lamina propia, epithelial necrosis, edema and fluid secretion (Fig. 1). 
Enterocolitis is more severe in the caudal ileum, the cecum and the proximal 
colon (Finlay et al., 1989). 
In the case of typhoid fever, bacteria disseminate via the mononuclear 
phagocyte system and form granulomatous foci in the liver and spleen 
known as typhoid nodules predominantly within macrophages, dendritic 
cells and PMNs (Coburn et al., 2006; Wallis and Galyov, 2000; Raffatellu et 
al., 2008). Spread to the gall bladder or urinary bladder can eventually also 
occur leading to chronic carriage, which is important for human-to-human 
spread of the disease (Gonzalez-Escobedo and Gunn, 2013) (Fig. 2). In the 
murine infection model, which is commonly accepted to study Salmonella 
pathogenesis due to its low cost and ease of use, S. Enteritidis and S. 
Typhimurium develop a systemic disease that resembles the enteric fever 
caused by S. Typhi in humans (Tsolis et al., 2011). 
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Fig. 1. Schematic representation of Salmonella-caused enterocolitis. A) Salmonella adheres to the intestinal epithelium and initiates the secretion of effector 
proteins from the TTSS-1 into the cell cytoplasm provoking its internalization in intestinal cells. Once inside the cell, Salmonella is housed in the SCV (Salmonella 
containing vacuole), where TTSS-2 effector proteins allow it to survive, replicate and finally migrate to the enterocyte basal wall. In response to bacterial infection, 
enterocytes produce IL-8 causing neutrophils recruitment to the lamina propia. These neutrophils alongside resident macrophages, phagocytose bacteria located in the 
lamina propia. B) Within macrophages, bacteria induce cellular death, fact that leads to IL1-β secretion and therefore to an increased inflammatory process. As 
inflammation progresses, PMNs migrate to the intestinal lumen across the epithelium while proteases and other inflammatory mediators favor the secretion of fluids, 
setting a diarrheal process. 
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Fig. 2. Schematic representation of systemic dissemination of Salmonella in 
the murine model. The two mechanisms normally used by Salmonella to traverse the 
intestinal epithelium include the invasion of M cells (A) and pathogen capture by dendritic 
cells (C). However, Salmonella is also capable to penetrate enterocytes (B). Within 
dendritic cells, the enteropathogen reaches mesenteric nodules, where bacteria are 
transferred to macrophages and migrate to the spleen and liver via the lymph nodes. In 
target organs, Salmonella reside and replicate within macrophages. 
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Salmonella vaccines 
Considering the worldwide incidence of Salmonella described above, a 
major objective for the prevention of Salmonella infections is to develop 
efficient vaccines (Mastroeni et al., 2000). Currently available vaccines 
against salmonellosis can be divided into three major classes. 
 
Whole-cell killed vaccines 
These vaccines contain Salmonella cells inactivated with different 
procedures such as heat, phenol, acetone or formaldehyde treatment. 
These vaccines ensure a lower epidemiological risk than live vaccines and 
have the potential for inducing high humoral antibody titres. However, in 
contrast to live vaccines, an important weakness of inactivated vaccines is 
the lack of cell-mediated immunity induction, which is required for protection 
against the intracellular lifestyle of Salmonella (Harrison et al., 1997).  
 
Subunit vaccines 
Instead of the entire microbe, subunit vaccines include only selected 
antigens that best stimulate the immune system. In some cases, these 
vaccines include specific parts of the antigen that antibodies or T cells 
recognize and bind to. Because subunit vaccines only contain the essential 
antigens and not all other molecules that make up the microbe, chances of 
adverse reactions to the vaccine are low.  
An example of a subunit vaccine is the vaccine for S. Typhi registered 
as Typhim Vi. This vaccine is based on the immunogenicity that induces the 
capsule (Vi) that surrounds the bacteria and is unique to this serovar  
(Guzman et al., 2006). Other subunit vaccines such as the ones based on 
detoxified LPS, cell extracts, porins, O-polysaccharide and O-conjugates 
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have been tested in experimental models and have shown lower efficiency 
(Mastroeni, 2003).  
 
Live attenuated vaccines 
Live attenuated vaccines contain a version of the living microbe that has 
been weakened in the lab so it cannot cause disease. Because an 
attenuated vaccine is the closest thing to a natural infection, the 
administration route usually coincides with the natural infection route of 
Salmonella. These vaccines elicit strong cellular and antibody responses 
and often confer lifelong immunity with only one or two doses. Despite their 
advantages, attenuated vaccines also have some downsides. The 
possibility, though remote, exists that an attenuated microbe in the vaccine 
could revert to a virulent form and cause disease. Also, live vaccines cannot 
be administered to immunocompromised people who have damaged or 
weakened immune systems. There are several vaccines based on live 
attenuated Salmonella strains approved for vaccination of humans or farm 
animals. These vaccines have been generally obtained by serial passages 
in the laboratory or through random mutagenesis, so the exact biological 
nature of the attenuation remains unknown. Nowadays, the availability of 
complete genome sequences together with new tools for genome 
modification and for identification of virulence genes expressed in vivo 
allows the design and generation of Salmonella mutants with very precise 
modifications to cause attenuation that can serve as potential vaccine 
candidates. Common strategies for attenuation of Salmonella are based on 
auxotrophies raised by mutations of genes involved in the synthesis of 
purines (purA, purE mutants) (Williams, 1956) or aromatic compounds 
synthesis (aro genes) (Callaghan et al., 1990). Also, genes that are directly 
involved in the infection process, for example virulence genes encoded in 
pathogenity islands and the virulence plasmid, have been proposed for 
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attenuation purposes (Bohez et al., 2008; Matulova et al., 2012). Another 
common strategy is the mutation of global regulators like PhoPQ, or RpoS. 
The first one is a two-component system which regulates the expression of 
at least 40 virulence genes (Miller et al., 1989). Some of these are involved 
in intramacrophage survival (Fields et al., 1986) and resistance to host 
antimicrobial peptides (Groisman et al., 1992; Beuzon et al., 2001). RpoS is 
a global transcriptional regulator activated in response to different 
environmental conditions and represents the master regulator of the general 
stress response, playing a central role in the survival of bacteria under 
starvation or stress conditions, such as oxidative stress, DNA damage, and 
low pH, which Salmonella likely encounters during intracellular growth in 
host macrophages (Fang et al., 1992) (Dong and Schellhorn, 2010). This 
global regulator plays a critical role in Salmonella virulence. For example, 
curli production (csgBAC), which is important for host colonization, is 
positively regulated by RpoS (Olsen et al., 1993). RpoS also activates the 
expression of the plasmid-borne spvR and spvABCD genes, which are 
required for intracellular growth and systemic infection in mice and humans 
(Fang et al., 1992). 
A summary of the Salmonella vaccines available for chicken, pigs and 
humans is presented in Table 2. 
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Table 2. Commercial vaccines for chicken, pigs and human protection against Salmonella 
Vaccine Name  Vaccine type 
Animal in which 
the vaccine 
confers protection 
Serotype of the 
vaccine strain 
Attenuation  
mechanism 
Serotype against 
which the vaccine 
confers protection 
Company 
NOBILIS® SG 9R 
CEVA® SG 9R 
Live 
attenuated 
Chicken S. Gallinarium Undetermined S. Gallinarium 
MSD Animal 
Health 
CEVA 
NOBILIS® 
SALMOVAC440 
Live 
attenuated 
Chicken S. Enteritidis Undetermined  
S. Enteritidis 
S. Typhimurium 
IDT Biologika 
NOBILIS® 
SALENVAC 
Inactivated Chicken 
S. Enteritidis 
S. Typhimurium 
Undetermined 
S. Enteritidis 
S. Typhimurium 
MSD Animal 
Health 
NOBILIS® 
SALENVAC T 
Inactivated Chicken 
S. Enteritidis 
S. Typhimurium 
Undetermined. Addition of new 
inmunogens from S. enterica 
PT14 and S. Typhimurium 
DT104 strains to Salenvac 
vaccine.  
S. Enteritidis 
S. Typhimurium 
S. Heilderberg 
S. Agona 
MSD Animal 
Health 
SALMUNE® 
Live 
attenuated 
Chicken S. Typhimurium 
Undetermined. Chromosome 
chemically mutated 
S. Enteritidis 
S. Typhimurium 
S. Hadar 
S. Kentucky 
S. Heilderberg 
CEVA  
Layermune ®SE Inactivated Chicken S. Enteritidis Undetermined S. Enteritidis CEVA  
AviPro® Salmonella 
VacE 
Live 
attenuated 
Chicken S. Enteritidis 
Mutant in essential enzymes 
and metabolic compartments 
due to a spontaneous 
mutation. Metabolic Drift 
Mutation (MDM). 
S. Enteritidis Lohmann 
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Vaccine Name  Vaccine type 
Animal in which 
the vaccine 
confers protection 
Serotype of the 
vaccine strain 
Attenuation  
mechanism 
Serotype against 
which the vaccine 
confers protection 
Company 
AviPro® Salmonella 
VacT 
Live 
attenuated 
Chicken S. Typhimurium 
Mutant in essential enzymes 
and metabolic compartments 
due to a spontaneous 
mutation. Metabolic Drift 
Mutation (MDM). 
S. Typhimurium Lohmann 
AviPro® Salmonella 
DUO 
Live 
attenuated 
Chicken 
S. Enteritidis 
S. Typhimurium 
Mixture of AviPro® VacE 
Salmonella and 
AviPro®Salmonella VacT  
vaccines.  
S. Enteritidis 
S. Typhimurium 
Lohmann 
Enterisol SC-54 
Live 
attenuated 
Pigs S. Typhimurium  Undetermined S. Typhimurium BIVI 
Enterisol Salmonella 
T/C 
Live 
attenuated 
Pigs 
S. Cholerasuis 
S. Typhimurium 
Undetermined 
S. Cholerasuis 
S. Typhimurium 
BIVI 
SalmoPorc SCS 
Live 
attenuated 
Pigs S. Cholerasuis Undetermined S. Cholerasuis IDT Biologika 
SalmoPorc STM 
Live 
attenuated 
Pigs S. Typhimurium Undetermined S. Typhimurium IDT Biologika 
Vivotif 
Live 
attenuated 
Human S. Typhi 
Mutant in genes responsible 
for the production of Vi antigen 
and other undetermined genes.  
S. Typhi PaxVax 
Typhim Vi Subunit Human S. Typhi Capsular polysaccharide Vi S. Typhi 
Sanofi 
Pasteur MSD 
Peda-typhTM Conjugated Human S. Typhi 
Capsular polysaccharide Vi 
conjugated with Tetanus toxoid 
protein 
S. Typhi and 
Clostridium tetani 
BioMed 
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Bacterial Biofilms 
Definition and overview 
Biofilms are nowadays regarded as the major reservoirs of bacteria 
and other microbes in the environment. In the seventeenth century, Van 
Leeuwenhoek examined the “animalcules” in the plaque of his own teeth, 
but it was not until 1978 that the general theory of biofilm predominance 
was promulgated. In this year, J. William Costerton defined a biofilm as 
“bacteria covered by a glycocalyx of fibers that adhere to surfaces and to 
other cells” (Costerton et al., 1978). Thirty-eight years later, the biofilm 
concept has evolved and is currently defined as aggregates of 
microorganisms that are attached to each other and/or to a surface, in 
which cells are embedded in a self-produced matrix of extracellular 
polymeric substance (EPS) (Flemming et al., 2016) . 
Biofilms are one of the most widely distributed and successful models 
of life on Earth. They comprise complex systems with high cell densities, 
ranging from 108 to 1011 cells g -1 wet weigh, and typically include different 
bacterial species (Morgan-Sagastume et al., 2008). Microbial communities 
can contain hundreds of strains and species, and we are only beginning to 
understand how and why different genotypes arrange themselves in space. 
Biofilm-dwelling cells influence each other’s evolutionary fitness through 
social phenotypes. Many of these phenotypes are simple forms of 
cooperation that benefit neighboring cells through the secretion of 
molecules such as digestive enzymes, nutrient chelators, wetting agents, 
structural polymers and signaling molecules (Zelezniak et al., 2015). Owing 
to this cooperative and collective behaviour, bacteria within the biofilm have 
substantial advantages compared with solitary cells, including an increased 
resilience against external threats and a higher efficiency in digesting 
complex nutrients.  
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However, social interactions can also be competitive and cells within a 
microbial community should not be assumed to work harmoniously together. 
Competition for limited space and resources is very common, and many 
social phenotypes are dedicated to kill other strains and species. For 
instance, antibiotic secretion or injection of toxins into adjacent cells are 
mechanisms used by some species to avoid the growth of neighbor cells 
(Nadell et al., 2016).  
 
Harmful and beneficial biofilms  
Biofilm formation has substantial implications in fields ranging from 
industrial processes to health-related subjects like medicine or dentistry. In 
some cases, this bacterial way of life results in beneficial effects. For 
example, bacterial biofilms are used to degrade toxic compounds such as 
petrol derivatives, heavy metals and soil bioremediation (Bums and Stach, 
2002; Vu et al., 2009; Meliani, 2014) or to improve waste water clean up 
(Smith et al., 2015). In other cases, biofilms act as efficient biocontrol 
agents through the formation of microbial aggregates in the plant 
rhizosphere (Rudrappa et al., 2008) and the subsequent increase in the 
productivity of important leguminous plants (Espinosa-Urgel, 2004). In 
healthcare, an attractive proposal concerning beneficial biofilms is to 
administer probiotics capable of forming biofilms, thus preventing 
colonization of pathogenic bacteria on the tooth surface, in the vagina and 
digestive tract (Vuotto et al., 2014). 
However, more often, biofilm formation is associated with great 
detrimental effects on industrial processes like oil drilling, paper production 
and food processing (Shi and Zhu, 2009; Van Houdt and Michiels, 2010). 
Also, biofilm formation on the surface of catheters, medical devices or host 
tissues correlates with deep-rooted chronic infections and resistance to both 
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phagocytosis and antimicrobial agents (Donlan, 2011; Donlan and 
Costerton, 2002).  
 
Biofilm formation 
The transition from a planktonic to a biofilm lifestyle occurs in response 
to environmental changes and involves multiple regulatory networks, 
necessary to translate environmental cues to the cellular machinery. In a 
first step, motile or non-motile bacteria attach irreversibly to a surface. Upon 
attachment, bacteria divide and daughter cells extend around the surface 
creating a colony. At this stage, bacteria initiate the synthesis of the 
extracellular matrix that surrounds the cells during biofilm growth. Finally, 
some bacteria are released from the biofilm community and the cycle starts 
again (Fig. 3).  
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Fig. 3. Stages in the biofilm formation process. Biofilms develop via initial attachment, which depends on transport of the bacteria to a surface 
that is a passive process in the case of nonmotile bacteria such as staphylococci (yellow), and active in the case of motile bacteria such as Salmonella 
(pink). Initial attachment to biotic and abiotic surfaces depends on bacterial surface structures, like pili or adhesines. Subsequent steps do not differ in 
principle for motile or nonmotile bacteria. They involve proliferation, embedding in an extracellular matrix, and maturation. Finally, cells can eventually 
detach from the biofilm and re-enter a planktonic mode. These planktonic cells can then repeat the cycle, infecting new surface. 
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Bacterial living inside biofilms 
The biofilm lifestyle is clearly distinct from that of free-living bacterial 
cells. Biofilm communities confer unique properties on bacteria since “group 
behavior” facilitates survival in adverse environmental conditions. Biofilms 
confer resistance to many external unfavorable environmental changes and 
to the host immune system, increase tolerance to antimicrobials and also 
promote the establishment of physical and social interactions that favor 
gene exchange (Flemming et al., 2016). 
A major element responsible for the increased protection to 
unfavorable conditions within the biofilm is the extracellular matrix that acts 
as a potent shield against extracellular aggressions whilst it allows water, 
nutrients and oxygen circulation through microscopic channels (Flemming et 
al., 2016).  
 
The biofilm extracellular matrix 
The composition of the biofilm extracellular matrix is complex and 
variable, even within the same bacterial species when environmental 
conditions are altered. However, one common principle is that the matrix 
scaffold is built of exopolysaccharides and/or proteins, which eventually can 
be interwoven with extracellular genomic DNA. The reasons underlying the 
election of a polysaccharide or protein-based biofilm matrix are not well 
understood. In the next section we will focus on the exopolysacharidic 
biofilm matrix. 
Despite the diversity of exopolysaccharides that bacteria are able to 
produce, there are two exopolysaccharides that different bacterial species 
have chosen for building the biofilm matrix; these are cellulose and poly-N-
acetylglucosamine (PNAG/PGA) (Table 3). Interestingly, some bacteria, 
including E. coli, Burkholderia cepanocepacia or Klebsiella pneumoniae, 
have the capacity to produce both of them. It is assumed that each 
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exopolysaccharide is produced in a different environmental condition likely 
because it bestows different properties to the surrounded bacteria. 
However, this hypothesis has never been tested. This situation does not 
occur only with cellulose and PNAG/PGA exopolysaccharides. 
Pseudomonas aeruginosa can produce at least three types of 
polysaccharides, namely alginate, Psl and Pel and again, evidences 
suggest that the synthesis of these exopolysaccharides is tightly regulated 
and that they are produced under specific conditions. The finding that 
bacteria make use of different exopolysaccharides, depending on the 
environmental conditions, to build the biofilm matrix together with the fact 
that many genetically unrelated bacteria coincide in the same 
exopolysaccharide for this purpose strongly suggest that biofilm matrix 
exopolysaccharides have evolved in bacteria through strong selecting 
factors that are still not well understood.  
A detailed description of the two most abundant exopolysaccharides 
used by pathogenic bacteria to build the biofilm matrix is summarized below.  
Cellulose 
Cellulose is one of the most abundant organic polymers in nature and 
the capacity to synthesize cellulose is widespread in bacteria (Table 3). 
Cellulose comprises only one type of sugar (glucose), which are linked 
together through β-1,4 linkages linearly. Bunches of β-1,4 glucan chains are 
assembled into microfibrils in the same direction, and then crystallized into 
cellulose  fibers (Koyama et al., 1997). In E. coli and Salmonella, the 
synthesis of this polysaccharide is regulated by two divergently operons 
bcsABZC and bcsEFG (Solano et al., 2002). Due to the high interest on 
bacterial cellulose for biotechnological purposes, an enormous amount of 
studies has been devoted to investigate the properties of bacterial cellulose 
itself. However, only few studies have been focused on how cellulose is 
actually produced in bacteria. As a consequence, the exact role of each of 
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the proteins in the cellulose synthase machinery still remains poorly 
characterized. BcsA is an integral inner membrane protein with multiple 
transmembrane domains (Kumar and Turner, 2015) and a cytoplasmic 
family 2-glycosil-transferase domain. This protein catalyzes cellulose 
polymerization and facilitates translocation of the newly formed polymer 
across the inner membrane. In addition, it contains a PilZ domain in the C-
terminal domain implicated in cyclic di-GMP (c-di-GMP) binding. Binding of 
the dinucleotide c-di-GMP to BcsA allosterically activates cellulose 
synthesis. BcsB is a periplasmic protein attached to BcsA through a single 
terminal TM helix and contains two carbohydrate binding domains (CBD1 
and CBD2) that chaperone the synthesized glucan chain through the 
periplasm (Morgan et al., 2013; Morgan et al., 2016). The BcsA/BcsB 
complex has been shown to be sufficient for cellulose biosynthesis in vitro 
(Omadjelaa et al., 2013). On the other hand, BcsC is a periplasmic protein 
that consists of an N-terminal α-helical part formed by several 
tetratricopeptide repeat (TPR) domains and a C-terminal part that is 
structurally similar to the β-barrels of outer membrane proteins. The TPR-
containing N-terminal part of BcsC is believed to interact with peptidoglycan 
and other BCS components, while its C-terminal β-barrel domain is likely 
located in the outer membrane, forming a channel that guides the nascent 
glucan out of the cell (Whitney and Howell, 2013). Finally, BcsZ is a 
periplasmic protein, with endo β-1,4 glucanase activity and has been 
suggested to be required for degradation of cellulose chains in the 
periplasm and/or cleavage of nascent cellulose chains to allow microfibrill 
formation outside the cytoplasm (Römling and Galperin, 2015). The function 
of BcsE, BcsF, and BcsG proteins encoded in the second operon remains 
unknown, though a recent study has revealed that BcsE also binds c-di-
GMP through a novel domain denominated GIL (GGDEF I site like), being 
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this binding essential for maximum cellulose production in Salmonella (Xin 
Fang et al., 2014).  
The membrane-integrated bacterial cellulose synthase contains the 
inner membrane components BcsA and BcsB as well as the outer 
membrane protein BcsC. Bacterial cellulose synthase polymerizes glucose 
via β-1,4 glycosidic linkages in a multi-step process which requires the 
presence of a divalent cation, usually magnesium, and c-di-GMP. First, 
upon stimulation by c-di-GMP, the synthase binds its substrate UDP-Glc 
(donor) at an intracellular glycosyltransferase domain. Second, the donor 
glucose is transferred to the 4´hydroxyl group at the non-reducing end of the 
growing polysaccharide chain (acceptor), thereby extending the polymer 
and forming UDP as a second reaction product. Third, following glycosilic 
transfer, the elongated polymer has to be translocated by one glucose unit 
into a transmembrane (TM) channel so that the newly added glucose unit 
occupies the acceptor site and UDP must be replaced with UDP-Glc for 
another round of catalysis (Fig. 4) (Morgan et al., 2014).  
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Fig. 4. Proposed model for cellulose synthesis and translocation (Morgan et al., 
2013) After glycosyl transfer, the newly added Glc could rotate around the acetal linkage 
into the plane of the polymer. The rotation direction would be determined by steric 
interactions and formation of the β-1,4 glucan characteristic intramolecular O3-H-O5 
hydrogen bond. The glucan might translocate into the channel during this relaxation. This 
process would be repeated with a second UDP-Glc but the rotation direction after glycosyl 
transfer would be in the opposite direction owing to steric constraints. Alternatively, the 
glucan might not translocate into the channel until UDP is replaced by UDP-Glc. Trp 383 
and Cys 318 mark the entrance to the transmembrane channel (only shown in the right 
panel). 
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The outstanding crystallographic work with Rodobacter sphaeroides 
BcsA-BcsB complex developed by (Morgan et al., 2014) has confirmed a 
theoretical mechanistic model on the allosteric activation of cellulose 
synthesis by c-di-GMP (Benach et al., 2007; Ko et al., 2010; Fujiwara et al., 
2013; Omadjelaa et al., 2013). BcsA contains eight transmembrane (TM) 
helices and a cytosolic glycosyltransferase (GT) domain between TM 
helices four and five. The GT domain contains seven β-barrel surrounded by 
seven α-helix and linked to the transmembrane region via three amphipathic 
interface (IF) helices (IF1-3). It is important to note that IF3 forms a loop with 
TM7 called the gating loop. Between the TM3-8 domains, BcsA also forms a 
polysaccharide channel across the membrane, thereby allowing the 
coupling of cellulose synthesis and translocation. Finally, BcsA contains a 
PilZ domain within its C-terminal intracellular extension, which comprises an 
RRxxxR motif in a flexible linker region followed by a β-barrel that contains a 
DxSxxG motif, both responsible of c-di-GMP binding. In the presence of c-
di-GMP, one molecule of the dimer binds to the DxSxxG β-barrel motif and 
the other molecule to the RRxxxR TM8- β-barrel motif, being both arginine 
(Arg580) and (Arg584) implicated in c-di-GMP interaction. In the absence of 
c-di-GMP, Arg580 of the PilZ domain contacts Thr511 of the gating loop, 
which is located in front of the GT domain entry, blocking the catalytic site of 
the enzyme. Also a saline bridge between Arg580 and Glu371 stabilizes the 
autoinhibited state of the enzyme. In the presence of c-di-GMP, a 
conformational change of the molecule occurs. Arg580 rotates 180º to bind 
c-di-GMP and breaks its interaction with the gating loop and Glu371. 
Besides, the gating loop is stabilized by hydrophobic interactions with the 
amphipatic helix (IF) and forms the TM channel entry, leaving the UDP-Glc 
binding site available.  
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PIA-PNAG or PGA (poly N-acetyl-glucosamine) 
This polysaccharide is a β-1,6-linked N-acetyl–D-glucosamine 
homopolymer that was firstly described in the gram-positive bacteria 
Staphylococcus epidermis (Heilmann et al., 1996). Initially, it was named as 
PIA (polysaccharide intercellular adhesin) (Heilmann et al., 1996). Later on 
and based on its composition the group of J. Pier named it as PNAG 
(McKenney et al., 1998; Maira-Litran et al., 2002). Because there is no 
agreement in the area with respect to this polysaccharide name, it will 
hereafter be denominated PIA/PNAG. 
The genes involved in PIA/PNAG synthesis are encoded in the 
icaADBC operon (Cramton et al., 1999). IcaAD form a complex responsible 
for the synthesis and export of the polysaccharide. IcaC functions by adding 
succinyl groups to the growing polymer using its O-succinyltransferase 
activity and, on the other hand, IcaB is an N-deacetylase that is specific to 
PIA-PNAG (Atkin et al., 2014). An exopolysaccharide of identical 
composition to PIA-PNAG has been identified by the group of T. Romeo 
(Wang et al., 2004) in E. coli. This exopolysaccharide was named PGA and 
according to the presence of orthologous genes in many different bacteria, it 
is also produced by many different gram negative bacteria (Table 3). In E. 
coli the synthesis of the PGA polysaccharide is driven by the proteins 
encoded in the pgaABCD operon (Wang et al., 2004). While PgaC and 
PgaD are implicated in its synthesis, PgaA and PgaB are responsible for 
poly-GlcNA export (Itoh et al., 2008). PgaC is the equivalent to IcaA, with a 
cytoplasmatic GT-2 domain that is 43% identical at the aminoacid level. 
PgaC is located in the inner membrane and polymerizes poly-GlcNAc from 
activated UDP-GlcNAc precursor being the catalytic domain exposed to the 
cytoplasm. PgaD is a small protein that forms a complex with PgaC to 
regulate polysaccharide synthesis. PgaA is an outer membrane porin that 
serves to translocate growing poly-GlcNAc chains to the cell surface (Itoh et 
Introduction 
41 
al., 2008). PgaB is a putative outer membrane lipoprotein that deacetylates 
about 3% of the GlcNAc residues during poly-GlcNAc export and shares the 
same function with IcaB (Wang et al., 2004; Itoh et al., 2008; Atkin et al., 
2014).  
In the case of PGA synthesis, protein complex structures and 
regulation mechanisms are not as well defined as in the case of the 
cellulose polysaccharide. Similarly to the regulation of cellulose synthesis in 
gram negative bacteria, PGA synthesis is allosterically regulated by c-di-
GMP in E. coli (Steiner et al., 2013) (Fig. 5). The work of (Steiner et al., 
2013) has allowed a better understanding of the regulation of PGA 
synthesis by this dinucleotide. As stated before, in E. coli, poly-GlcNa is 
synthetized and secreted by the envelope-spanning PGA machinery, which 
is encoded in the pgaABCD operon (Wang et al., 2004). PgaC is a 
processive β-glycosyltransferase (GT) of the GT-2 family that is located in 
the inner membrane and polymerizes poly-GlcNAc from activated UDP-
GlcNAc precursor (Wang et al., 2004; Itoh et al., 2008). The catalytic 
domain of the GT-2 family is exposed to the cytoplasm with sugar transfer 
through the cytoplasmic membrane being independent of an undecaprenyl 
phosphate lipid carrier. In the presence of c-di-GMP, PgaC forms a stable 
complex with PgaD and binds c-di-GMP to activate polysaccharide 
synthesis. When the level of c-di-GMP decreases, PgaD is not bound to c-
di-GMP and the protein adopts a conformation that is more prone to 
degradation by proteases (Steiner et al., 2013). Using error prone PCR 
mutagenesis the authors found and isolated specific mutations (N75D, 
K76E) in PgaD and (V277L) in PgaC that mimic a c-di-GMP bound state 
that activates the PgaCD GT complex. They also studied the involvement of 
PgaC conserved arginines in c-di-GMP binding and found that Arg222 is 
implicated in c-di-GMP binding and complex formation with PgaD. However, 
future crystallographic studies may help to resolve the exact structure of 
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these proteins and the residues implicated in poly-GlcNa synthesis and c-di-
GMP regulation. 
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Fig. 5. Schematic representation of PGA and cellulose exopolysaccharides synthesis machineries. The components for A) cellulose 
synthesis machinery and B) PGA synthesis machinery are shown. Color-code is used according to a similar predicted function as follows: 
glycosiltransferase, yellow; porin, orange; exopolysaccharide-modifying enzyme, green; proteins that couple glycosiltransferase activity, blue. In each 
system, the polysaccharide indicated is polymerized and transported across the inner membrane by its respective synthase. For both polysaccharides 
the process also requires c-di-GMP, shown in pink. Once in the periplasm, polysaccharide-modifying enzymes act on each polysaccharide before they 
are exported across the outer membrane by the porin protein. IM, inner membrane; OM, outer membrane; PP, periplasmic space; UDP-Glc, UDP 
glucose; UDP-GlcNAc, UDP N-acetylglucosamine. 
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Table 3. Summary of the most common bacterial polysaccharides.  
Bacteria Polysaccharide Type of pathogen Reservoir Gram stain Reference 
Salmonella spp 
Cellulose/ 
Colanic acid 
Facultative intracellular 
human pathogen 
Environment. 
Human and animal 
intestine 
Negative 
(Solano et al., 2002) 
(Zogaj et al., 2001) 
Citrobacter spp Cellulose 
Facultative intracellular 
human pathogen 
Environment. 
Human and animal 
intestine 
Negative (Zogaj et al., 2003) 
Burkholderia spp Cellulose/PGA 
Facultative intracellular 
human pathogen 
Environment (soil) Negative 
(Yakandawala et al., 
2011) 
(Römling and Galperin, 
2015) 
Escherichia spp 
Cellulose/PGA/Colanic 
acid 
Commensal and extracellular 
human pathogen 
Environment. 
Human and animal 
intestine 
Negative 
(Zogaj et al., 2001) 
(Wang et al., 2004) 
Acinetobacter 
baumanii 
PGA 
Facultative intracellular 
human pathogen 
Environment. Human 
skin and respiratory 
tract 
Negative (Choi et al., 2009) 
Bordetella pertussis PGA Human pathogen Humans Negative (Parise et al., 2007) 
Actinobacillus PGA 
Facultative intracellular 
human pathogen 
Humans and animals Negative (Kaplan et al., 2004) 
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Bacteria Polysaccharide Type of pathogen Reservoir Gram stain Reference 
Yersinia spp PGA 
Facultative intracellular 
human pathogen 
Fleas and rodents Negative (Bobrov et al., 2008) 
Vibrio cholerae 
 
VPS 
Extracellular human 
pathogen 
Environment Negative 
(Yildiz and Schoolnik, 
1999) 
Klebsiella 
pneumoniae 
Cellulose/PGA 
Facultative intracellular 
human pathogen 
Environment  
Nosocomial infections 
Negative 
(Römling, 2002) 
(Zogaj et al., 2003) 
(Kuang-Ming Chen et al., 
2014) 
Pseudomona 
aureginosa 
Psl/Pel/Alginate 
Extracellular human 
pathogen 
Environment . 
Nosocomial infections. 
Negative (Franklin et al., 2011) 
Pseudomona putida 
Pea/Peb/Alginate/ 
Cellulose 
Plant symbiont Environment Negative (Nilsson et al., 2011) 
Chromobacterium 
violaceum  
Cellulose/PGA Human pathogen Environment Negative 
(Recouvreux et al., 2008) 
(Becker et al., 2009) 
Enterobacter 
amnigenus GH-1 
Cellulose Human pathogen 
Environment. 
Human intestine 
Negative 
(Hungund and Gupta, 
2010) 
Pseudomonas 
syringae 
Cellulose Plant pathogen Environment Negative 
(Prada-Ramírez et al., 
2016) 
Pseudomonas 
fluorescens 
Cellulose Plant symbiont Environment Negative (Spiers et al., 2003) 
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Bacteria Polysaccharide Type of pathogen Reservoir Gram stain Reference 
Rhizobium 
leguminosarum 
Cellulose Plant symbiont Environment Negative (Laus et al., 2005) 
Erwinia 
chrysanthemi 
Cellulose Plant pathogen Environment Negative (Römling, 2002) 
Dickeya dadantii Cellulose Plant pathogen Environment Negative (Jahn et al., 2011) 
Xhantomonas 
campestris 
Xhantan Plant pathogen Environment Negative (Harding et al., 1993) 
Vibrio fischeri Cellulose Symbiont marine animals Environment Negative 
(Bassis and Visick, 
2010) 
Agrobacterium 
tumefaciens 
Cellulose/curdlan/acidi
c succinoglycan/ 
cyclic-β-1,2-D-glucan 
Plant pathogen Environment Negative (Matthysse et al., 1981) 
Komagataeibacter 
xylinus 
Cellulose  Environment: soil Negative (Ross et al., 1987) 
Rodobacter 
sphaeroides 
Cellulose  Aquatic environment Negative (Morgan et al., 2013) 
Sinorhizobium 
meliloti 
(1à3)(1à4)- β- 
glucan 
Plant symbiont Environment Negative 
(Pérez-Mendoza et al., 
2015) 
Mycobacterium 
tuberculosis 
Cellulose 
Facultative intracellular 
human pathogen 
Human, respiratory tract Positive (Trivedi et al., 2016) 
Introduction 
47 
 
 
 
Bacteria Polysaccharide Type of pathogen Reservoir Gram stain Reference 
Sarcina ventriculi Cellulose Human pathogen  
Environment. 
Animal and human 
stomach 
Positive 
(Canale-Parola et al., 
1961) 
Stapylococcus spp PGA 
Extracellular human 
pathogen 
Human nose, groin, 
axillae skin… 
Positive (Heilmann et al., 1996) 
Bacillus subtillis PGA 
Extracellular human 
pathogen 
Soil, commensal gut. Positive (Roux et al., 2015) 
Lysteria 
monocytogenes 
ManNAc-Gal EPS 
Facultative intracellular 
human pathogen 
Environment Positive (Köseoğlu et al., 2015) 
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The Salmonella biofilm 
Salmonella transition involving the environment-host-environment 
cycle depends enormously on the capacity to form biofilms. Salmonella is 
able to form biofilms on crops, soil, aquatic systems and on the surface of 
several materials like glass, polymer or steel (Woodward et al., 2000; Hood 
and Zottola, 1997). In farms, Salmonella can form biofilms in waterways, 
feeders, animal faeces or even on egg surfaces (Vestby et al., 2009; Brandl 
et al., 2011; Brandl et al., 2013; Patel et al., 2013; Pande et al., 2016). In 
food-processing environments, conventional cleaning and sanitation 
procedures usually fail to eradicate Salmonella biofilms (Vestby et al., 2009; 
Shi and Zhu, 2009; Van Houdt and Michiels, 2010) that turn contaminated 
surfaces and equipment into a source of food contamination.  
During human infection, S. Typhi can form biofilms in the gallbladder 
and produce chronic infections. In these patients (3-5% of infected people), 
S. Typhi is released through bacterial shedding in feces and urine. These 
infections can persist for long periods of time because the infected 
individuals, despite being highly contagious, are typically asymptomatic.  
Taking into account the impact that Salmonella biofilms have on 
human health and industry, the study of the composition and regulation of 
the biofilm is of great interest.  
 
Salmonella biofilm formation: components and regulation  
The Salmonella biofilm exhibits different macroscopic phenotypes that 
vary according to the media and growth conditions used in the laboratory. 
When Salmonella is grown in rich media at room temperature without 
shaking, it produces a macroscopic pellicle on the interphase between the 
liquid and the air (Fig 6A). In contrast, when it is grown in a minimal defined 
media (ATM) at 37 °C under shaking conditions, a ring of bacteria adhered 
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to the surface of the tube is formed (Fig. 6B) (Solano et al., 1998). On solid 
rich media, supplemented with the congo red dye, Salmonella colonies 
show a red dry and rough morphotype known as the rdar (red, dry and 
rough) phenotype (Romling, et al., 1998) (Fig. 6C). 
 
 
 
Fig. 6. Different phenotypes displayed by a biofilm positive S. Enteritidis strain. A) 
Pellicle developed at the air-liquid interphase by a standing culture grown in LB after 72 hours of 
incubation at room temperature. B) Ring of bacterial cells adhered to the surface of a glass tube after 
4 hours of incubation in ATM under vigorous shaking conditions. C) rdar morphotype on congo red 
agar plates after 48 hours of incubation at 28ºC.  
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 The Salmonella biofilm extracellular matrix is essentially composed of 
three components: cellulose, curli fibers and the BapA protein. Cellulose 
has been described in a previous section of this introduction. Curli fibers are 
protein appendages formed by repetitions of a protein unit (CsgA) and play 
an important role in the initial adhesion to surfaces or host tissues. Curli 
fibers possess a cross β-sheet quaternary structure that is characteristic of 
amyloids in general and makes these proteins resistant to proteolytic 
digestion (Hufnagel et al., 2013). They were initially described in S. 
Typhimurium as thin aggregative fimbriae and are encoded by the csg gene 
cluster that consist of csgBAC and csgDEFG genes (Romling et al., 1998). 
Although all these genes are essential for fiber synthesis, the exact role of 
some of them in curli biogenesis remains unknown. On the other hand, 
BapA is the second largest protein of the S. Typhimurium genome. It can be 
included in a group of surface proteins that exhibit homology with Bap of 
Staphylococcus aureus (Biofilm-associated protein) and that promote 
adhesion to biotic and/or abiotic surfaces (Latasa et al., 2006). One 
common aspect about Bap proteins is their large size mainly due to the 
presence of a core domain formed by a variable number of tandem repeats. 
Region B of BapA (aa 159–3003) contains 28 tandem imperfect repeats of 
86–106 amino acids. Each repeat of BapA shows on average a 29% of 
identity with a C-repeat of Bap. According to protein domain prediction 
programs (ProDom structural genomics), region B of BapA also exhibits 
homology with a large repetitive RTX inner membrane family of exoproteins 
involved in adhesion and virulence processes (Latasa et al., 2005).  
The presence of these three components is necessary for a robust 
biofilm formation. Mutants deficient in any of these compounds are unable 
to form a biofilm though overexpression of curli fibers can compensate for 
BapA absence (Latasa et al., 2005). Salmonella phenotypes under biofilm 
forming conditions of individual, double and triple mutants in these three 
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components implicated in biofilm formation are shown in Fig. 7.  
The synthesis of all three elements, cellulose, curli and BapA is 
controlled by the LuxR type regulator CsgD. Thus, CsgD is the master 
transcriptional regulator of Salmonella biofilm assembly, acting as a positive 
regulator of the csgBAC operon to promote the transcription of the curli 
structural components CsgA and CsgB and also of the bapA gene (Romling 
et al., 2000; Latasa et al., 2005). CsgD also promotes cellulose production 
by transcriptionally activating adrA, a gene encoding a diguanilate cyclase 
that produces the amount of c-di-GMP necessary to allosterically activate 
BcsA (Romling et al., 2000) (Fig. 8).  
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Fig. 7. Phenotypes displayed by single, double and triple mutants in genes encoding extracellular matrix components of the biofilm formed by 
Salmonella. The upper pannel shows the biofilm phenotype displayed after growth in LB media, for 72 hours at room temperature. A floating pellicle at the air–broth 
interface that totally blocks the surface of the culture is characteristic of a Salmonella biofilm. A pellicle of fragile appearance at the air–broth interface, which is easily 
disrupted by shaking, is indicative of cellulose absence. A lack of curli fimbriae and/or BapA leads to a complete non-biofilm forming phenotype. The bottom pannel 
shows the morphoype exhibited after incubation on congo red agar plates for 48 hours at 28ºC. A rdar (red, dry and rough) morphotype is characteristic of a Salmonella 
biofilm forming strain. Absence of cellulose gives rise to a bdar (brown, dry and rough) morphotype, whilst a curli fimbriae mutant shows a pdar (pink, dry and rough) 
morphotype. Absence of both cellulose and curli fimbriae leads to a saw (smooth and white) morphotype. BapA does not influence the Salmonella phenotype shown on 
congo red agar plates. ΔbcsA, cellulose mutant; ΔcsgBAC, curli mutant; ΔbapA, BapA mutant. 
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Fig. 8. Current model of the regulatory network controlling the expression of 
extracellular matrix components required for biofilm formation in Salmonella. CsgD is the 
Salmonella biofilm master regulator and its expression is controlled by the transcriptional global 
regulators RpoS and MlrA. CsgD positively regulates curli fimbriae synthesis, encoded in two 
divergently operons (represented in orange colour) and also activates cellulose production through 
the expression of AdrA, a member of the GGDEF protein family, which synthetizes c-di-GMP. C-di-
GMP binding to the BcsA PilZ domain results in cellulose production. Genes encoding proteins 
needed for cellulose production are transcribed in two operons, bcsABZC and bcsEFG (shown in 
blue). The expression of the large secreted protein BapA is also regulated by CsgD, although the 
mode by which CsgD activates bapABCD operon (shown in green) transcription remains unknown. 
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The c-di-GMP signal transduction system 
Discovery of c-di-GMP and system overview 
A key factor that determines the evolutionary success of a bacterium is 
the capacity to sense environmental factors and to respond accordingly. 
Thus, all bacteria have evolved signal transduction mechanisms to establish 
“functional connectiveness” between environmental cues and cellular 
physiology. In the case of bacteria, two-component systems (TCSs) are the 
primary means of the sensorial machinery. A second signal transduction 
mechanism in bacteria involves the molecule 3',5'-cyclic diguanosine 
monophosphate (c-di-GMP) (Jenal and Malone, 2006; Cotter and Stibitz, 
2007; Pesavento and Hengge, 2009; Schirmer and Jenal, 2009; Mills et al., 
2011; Romling et al., 2013; Hengge et al., 2015; Tamayo et al., 2007; 
Povolotsky and Hengge, 2012; Hengge, 2013). Bacterial c-di-GMP was 
discovered in 1987 by the group of Moshe Benziman and coworkers, who 
reported c-di-GMP as an allosteric activator for cellulose synthase in 
Gluconacetobacer xylinum (Ross et al., 1987). Ten years later, the same 
group identified the proteins implicated in c-di-GMP synthesis and 
degradation. They found that proteins that contain a GGDEF domain have 
diguanylate cyclase (DGC) activity and are able to synthesize c-di-GMP 
whereas proteins containing an EAL domain are c-di-GMP specific 
phosphodiesterases (PDEs) that degrade c-di-GMP (Tal et al., 1998). Later 
on, a second domain involved in c-di-GMP degradation termed HD-GYP 
was described (Ryan et al., 2006).   
Genome sequencing has revealed the presence of genes encoding 
proteins containing domains associated with c-di-GMP signalling in most 
bacterial species. Pfam database (http://pfam.xfam.org) reveals the 
existence of more than 28.000 GGDEF proteins spread among 1.813 
species and more than 17.000 EAL proteins in 1.591 bacterial species. 
Experimental evidence for c-di-GMP signalling pathways has been obtained 
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in the major phylogenetic branches, including Proteobacteria, Spirochetes, 
Cyanobacteria, Deinococcus-Thermus, Thermotogae, Actinobacteria and 
Firmicutes. Synthesis of c-di-GMP is not restricted to prokaryotic cells, and 
the amoeba Dictyostelium discoideum uses c-di-GMP in the cell 
differentiation process (Zhi-hui Chen and Schaap, 2012). 
The number of proteins dedicated to c-di-GMP-mediated signalling is 
highly variable amongst bacteria. For example, the genome of Escherichia 
coli K-12 encodes 19 proteins with a GGDEF domain and 17 with an EAL 
domain, whereas Bacillus subtilis has four and three, respectively, and even 
the tiny genome of Rickettsia prowazekii encodes one of each. The bacteria 
with the largest number of these type of proteins is Vibrio vulnificus, that 
encodes 66 proteins with a GGDEF domain and 33 with an EAL domain 
(Galperin et al., 2001; Galperin, 2004; Romling, 2005). 
An interesting characteristic of GGDEF/EAL proteins is that most of 
them have a multimodular architecture. The GGDEF and EAL domains are 
often located C-terminally from multiple sensory and signal transduction 
domains. Common sensory domains found in proteins containing GGDEF 
and EAL domains include those termed GAF, PAS, HAMP, REC, BLUF, 
Lux-R like, MASE1, MASE 2 and HAMP (Galperin, 2005). These domains 
have been linked to the sensing of small molecules, redox potential, light, 
voltage, oxygen, nutrients, osmolarity, antibiotics, homoserine lactones, and 
a number of other signals. Based on this modular architecture, it has been 
proposed that GGDEF/EAL proteins are members of a new signal 
transduction system that uses c-di-GMP as a secondary messenger. Thus, 
different GGDEF proteins will sense different stimulus and in response to 
this signal will modify the levels of c-di-GMP which will subsequently affect 
different biological process such as the biosynthesis of adhesins and 
exopolysaccharides (Lee et al., 2007; Wolfe and Visick, 2008), motility 
(Girgis et al., 2007; Wolfe and Visick, 2008), long-term survival and 
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response to environmental stresses (Klebensberger et al., 2007; Sabirova et 
al., 2008), synthesis of secondary metabolites (Fineran et al., 2007),  
regulated proteolysis and cell cycle progression (Duerig et al., 2009) and 
virulence (Tamayo et al., 2008; Lai et al., 2009).  
 
Synthesis and degradation of c-di-GMP by GGDEF, EAL and HD-
GYP domain proteins 
Diguanylate cyclases (DGCs) 
DGC proteins form homodimers, where each GGDEF domain binds 
one molecule of GTP in an antiparallel position to form 3´-5´phophodiester 
linkages. These proteins contain two relevant enzymatic sites named A and 
I sites. The A site is the catalytic site of the protein (GGDEF) in which the 
two first residues are responsible for GTP binding, the third residue plays an 
important role in catalysis and the glutamic residue is involved in Mg2+ and 
Mn2+ ions binding. The I site (RxxD) is located five amino acids upstream of 
the GGDEF motif. When c-di-GMP binds to the I-site of a DGC, c-di-GMP 
synthesis is allosterically inhibited. This mechanism avoids GTP excessive 
consumption and elevated c-di-GMP accumulation (Ralf Paul et al., 2007; 
Schirmer and Jenal, 2009).  
 
Phosphodiesterases 
Proteins with phosphodiesterase activity are characterized by 
containing the EAL or HD-GYP motifs. EAL proteins hydrolyze the c-di-GMP 
molecule to 5´-pGpG, that is later degraded to two GTP molecules by the 
oligoribonuclease Orn (Schmidt et al., 2005; Ryan et al., 2006; Christen, 
2005; Tamayo et al., 2005; Cohen et al., 2015; Orr et al., 2015). This 
process requires the presence of Mg2+ and Mn2+ and is inhibited by Ca2+ 
and Zn2+ (Rao et al., 2008). The HD-GYP proteins however, directly break 
the c-di-GMP into two GTP molecules (Ryan et al., 2006). 
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One intriguing characteristic of GGDEF and EAL domains is that they 
are often found in the same polypeptide chain as part of multidomain 
proteins. This organization is puzzling because it is difficult to understand 
why the same protein contains two domains with opposite enzymatic 
activities. Theoretically, two possibilities exist that may explain this apparent 
contradiction. One scenario is that while both domains are enzymatically 
active, they are differentially regulated by environmental and/or intracellular 
signals so that at any given point one activity is prevalent. The second 
possibility is that one of the two domains is enzymatically inactive and it has 
evolved to carry out new functions. One of these functions may involve bind- 
ing (but not processing) to the substrate and participation in protein-protein 
or protein-RNA interactions (Christen, 2005; Ferreira et al., 2008; Romling 
et al., 2013; Kuchma et al., 2007).  
 
Cellular effectors of c-di-GMP 
Although there is breadth of knowledge about c-di-GMP-metabolizing 
enzymes, we know relatively little about c-di-GMP receptors and targets 
regulated by c-di-GMP. This is so because enzymes involved in c-di-GMP 
synthesis and breakdown are readily identifiable due to the characteristic 
GGDEF, EAL, and HD-GYP domains. In contrast, identifying proteins that 
function as c-di-GMP receptors/effectors is more challenging because c-di-
GMP binds to diverse classes of proteins and other molecules, many of 
which have no sequence or structural similarity to each other. At present, 
there are thousands of proteins known to be involved in the synthesis and 
degradation of c-di-GMP, but only few dozens of receptors have been 
identified, which are summarized in Table 4.   
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Table 4. C-di-GMP bacterial receptors 
Cellular receptor Binding motif Examples References 
PilZ domain 
proteins 
(Q/E) RRxxxR 
(DZxxG) 
YcgR, BcsA, 
MrKH, MapZ, 
PlzA 
(Amikam and Galperin, 2006; 
Ryjenkov et al., 2006; Pratt et 
al., 2007; Freedman et al., 
2010; Wilksch et al., 2011; 
Linghui Xu et al., 2016) 
Enzymatically 
inactive GGDEF 
proteins with an 
intact I site  
RxxD PelD, PopA, (Lee et al., 2007; Duerig et al., 
2009; Newell et al., 2012) 
Enzymatically 
inactive EAL 
proteins  
QxxxxxR 
LapD, FimX, 
FilP 
(Qi et al., 2011; Newell et al., 
2012; Yang et al., 2014) 
Transcriptional 
regulators 
Unknown 
FleQ, VpsT, 
Clp, 
Bcam1349, 
EspI/Nla24, 
BldD, BrlR 
(Hickman and Harwood, 2008; 
Leduc and Roberts, 2009; 
Krasteva et al., 2010; Tao et 
al., 2010; Fazli et al., 2011; 
Baraquet et al., 2012; 
Chambers et al., 2014; 
Tschowri et al., 2014) 
Polynucleotide 
phosphorylase 
Unknown PnP (Tuckerman et al., 2011) 
GIL domain  RxGD BcsE (Xin Fang et al., 2014) 
ATPases GxxxxGKT/S 
FliI, HrnC, 
ClpB2, FleQ, 
MhseE 
(Baraquet and Harwood, 2013; 
Trampari et al., 2015) 
Acyl coenzyme 
A 
dehydrogenase 
Unknown Bd2924 (Rotem et al., 2015) 
YajQ family Unknown XC_3703 (An et al., 2014) 
Riboswitches  
Vc1, Vc2, Bc1, 
Bc2, Bc3-5, 
Cdi2_4 
(Sudarsan et al., 2008; 
Bordeleau et al., 2011; Zhou et 
al., 2016) 
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Specificity of the signal transduction system mediated by c-di-
GMP 
c-di-GMP is a small diffusible molecule that serves to integrate 
environmental cues from multiple sensory inputs and is synthetized by 
several proteins encoded in the same genome. Because many DGCs and 
PDEs can modify the levels of c-di-GMP, a question arises as to how the c-
di-GMP produced by a specific DGC can specifically transmit the signal 
without interfering with the c-di-GMP produced by another DGC. This 
question has been the focus of intense debate but is still lacking a definitive 
explanation. 
There are several mechanisms that might explain c-di-GMP signal 
specificity:  
 
Differential expression of GGDEF-EAL proteins  
One of the mechanisms to achieve specificity involves co-ordinate 
regulation of the expression of c-di-GMP components, in which c-di-GMP 
metabolizing enzymes would be expressed under the same conditions as 
their downstream receptors. Indeed, some c-di-GMP components are 
known to be under the transcriptional control of various signals (Weber et 
al., 2006; Pesavento et al., 2008). However, in Salmonella, a genome wide 
analysis of the expression of the twelve GGDEF domain proteins present in 
this bacteria showed that almost all genes encoding GGDEF proteins 
appear to be constitutively expressed in all conditions tested, except for 
sen3222, yfeA, sen2484 and adrA (Solano et al., 2009). In the case of 
sen3222, yfeA and sen2484, protein levels were not detectable in any of the 
conditions analyzed and in the case of the adrA gene, its expression was 
induced over time, being highly expressed after 72 h of growth in LB media, 
when a robust biofilm is clearly visible. Thus, this mechanism does not 
adequately account for Salmonella signalling specificity. Accordingly, 
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(Sommerfeldt et al., 2009) showed that out of a total of 28 GGDEF/EAL 
protein encoding genes present in E. coli, twenty-one are expressed in 
Luria–Bertani medium, with 15 being under σS control. 
 
Co-localization of GGDEF proteins with their receptors:  
Another proposed model for signaling specificity involves the spatial 
sequestration of individual c-di-GMP components, such that the generation 
and degradation of c-di-GMP would act locally on a particular target. There 
is some evidence to support local activity of c-di-GMP metabolizing 
enzymes in some organisms (Merritt et al., 2010; Massie et al., 2012). In 
Caulobacter crescentus, each cellular division results in a mother cell that is 
non-motile and remains attached to the abiotic surface via an adhesive 
structure called the stalk, and a daughter cell that is free-living and 
flagellated. Cell division is regulated by c-di-GMP, the DGC PleD and the 
PDE TipF that are directed to, and are active at different cell poles in a cell 
cycle-dependent manner. Progression of the cell cycle is also dependent on 
the GGDEF I site-type c-di-GMP effector protein PopA. This protein exerts 
its function allowing initiation of DNA replication through binding to the c-di-
GMP produced by PleD in the stalked cell (Christen et al., 2010). Although 
this kind of regulation may exist in particular cases, the rapid diffusion of c-
di-GMP in the bacterial cytoplasm would make it difficult to establish such 
local pools inside of the bacterial cell in the absence of some kind of 
compartmentalizing structure (Mills et al., 2011) and there is no firm 
evidence that such microdomains exist in bacteria.  
 
Affinity of the c-di-GMP by their receptors:  
Another mechanism, not mutually exclusive with the previous ones, by 
which c-di-GMP signalling specificity could be achieved, is through the 
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binding affinities of downstream receptors. In this scenario, the different 
GGDEF-EAL proteins of the cell would contribute to a common c-di-GMP 
cytoplasmic “pool”, and the receptor affinity for c-di-GMP would determine 
which receptors are activated at a particular cytoplasmic c-di-GMP level 
(Mills et al., 2011).  
Like most enterobacteria, S. Typhimurium has two known c-di-GMP 
receptors that contain a PilZ domain: YcgR, which controls flagellar-based 
motility, and BcsA, the bacterial cellulose synthase. The group of Samuel 
Miller (Pultz et al., 2012) used a FRET-based method to compare the 
affinities of the two PilZ domain proteins (YcgR and BcsA) in Salmonella 
and found that they differ by 43-fold. They also demonstrated that when 
cellular c-di-GMP levels are kept low, neither PilZ domain protein is bound 
to c-di-GMP, resulting in a motile cell that does not produce cellulose. As 
cellular DGCs increase the concentration of c-di-GMP past the Kd for YcgR, 
YcgR becomes bound to c-di-GMP and thus inhibits motility, even at levels 
of c-di-GMP that are not high enough to bind BcsA. Activation of AdrA 
expression results in enough c-di-GMP produced to bind to BcsA, and 
cellulose synthesis occurs. These data greatly supported the hypothesis 
that regulation by binding affinity of downstream receptors is a mechanism 
for the selective activation of c-di-GMP controlled processes.  
 
Overview of the c-di-GMP signal transduction system in 
Salmonella 
The Salmonella genome encodes 20 proteins that may be involved in 
c-di-GMP synthesis and/or degradation. Five of them are proteins that 
contain a GGDEF domain, eight contain an EAL domain and seven harbour 
both GGDEF and EAL domains (Fig. 10). Curiously, this bacterium does not 
encode any HD-GYP domain protein. Amongst the twelve proteins 
containing a GGDEF domain, eight show a conserved GGDEF motif, 
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suggesting that they may act as active diguanylate cyclases. All twelve 
proteins, with the exception of YciR harbor transmembrane domains and 
most of them also contain putative sensing domains (Fig. 10). Amongst the 
fifteen proteins containing an EAL domain, and according to conserved 
residues in such domain (Fig. 10), eleven may act as active 
phosphodiesterases.  
With respect to the environmental signals that control c-di-GMP 
synthesis and degradation in Salmonella, the group of Samuel I. Miller 
performed an outstanding study through the use of a biosensor that allowed 
the screening for signals that altered c-di-GMP concentrations (Mills et al., 
2015). Results showed that Salmonella senses several compounds, 
including glucose, N-acetyl-D-glucosamine (GlcNAc), salicylic acid, and 
specifically L-arginine, among the 20 common amino acids, and responds 
by rapidly altering the amount of free c-di-GMP. 
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Fig. 10. Summary of the Salmonella c-di-GMP metabolyzing proteins. The first column shows the genome position of each gene encoding for a c-di-GMP 
metabolizing protein. The second column shows the names of currently described genes. Organization of recognized domains by the pfam program 
(http://pfam.xfam.org/) is displayed through a graphic representation of each protein. The aminoacid sequence of the catalytic A site and the I site of the GGDEF domain 
is then shown. Conserved aminoacids in the EAL domain are highlighted as follows: residues involved in Mg2+ binding (blue); aminoacids that bind c-di-GMP (green); 
glutamate needed for c-di-GMP hydrolysis (red); loop 6 containing the extended conserved motif DDFG(T/A)GYSS that plays a determinative role in oligomerization of 
subunits, c-di-GMP binding, and catalysis is underlined. Canonical GGDEF and EAL sites appear in bold. 
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As it also happens in other bacteria, the large number of enzymes 
involved in c-di-GMP metabolism in Salmonella contrasts with only a 
handful of c-di-GMP receptors thus far identified (some of them have been 
inferred from studies performed in E. coli). These are (i) YcgR, that binds c-
di-GMP at a relatively high affinity (Christen et al., 2007) and inhibits 
flagellar motility by binding to the motor–stator complex and modulating its 
function (Boehm et al., 2010; Paul et al., 2010), (ii) BcsA (Ross et al., 1987; 
Ryjenkov et al., 2006), a c-di-GMP-dependent glycosyltransferase 
responsible for cellulose synthesis, (iii) PnpA, a 3′-polyribonucleotide 
polymerase and a 3′-to-5′ exoribonuclease involved in RNA degradation 
(Tuckerman et al., 2011), (iv) YciR, an unusual PDE that also functions as a 
c-di-GMP receptor (Lindenberg et al., 2013) and (v) BcsE, a protein 
encoded in the cellulose synthase operon that is involved in maximal 
cellulose synthesis (Fang et al., 2014).  
With the objective of analyzing the impact of c-di-GMP on Salmonella 
biology, a Salmonella strain in which all genes encoding for putative DGCs 
were deleted was created in our laboratory (Solano et al., 2009). The 
resulting strain (ΔXII) that was incapable of producing c-di-GMP was 
therefore unable to produce cellulose. Taken this strain as a basis, a 
collection of 12 strains, derivatives of ΔXII, each of which contained the 
chromosomal copy of a single gene encoding a GGDEF-domain protein in 
the original wild-type genomic location was generated. Phenotypic analysis 
of this collection of strains revealed that four GGDEF proteins AdrA, 
SEN1023, YegE and YfiN were individually able to activate cellulose 
production, supporting the hypothesis that c-di-GMP produced by different 
GGDEF-domain proteins is able to activate the same biological process and 
therefore, supporting the model of c-di-GMP specificity based on the affinity 
of c-di-GMP by their receptors. Virulence assays carried out with ΔXII 
showed that this strain was highly attenuated in orally and intraperitoneally 
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infected BALB/c mice. However, further work with ΔXII revealed that it 
contained an additional chromosomal deletion that included the rpoS gene. 
Since RpoS, which is the master sigma factor during stationary phase and 
under a variety of stress conditions, plays a critical role in Salmonella 
virulence, the involvement of c-di-GMP in virulence remained unclear. To 
decipher this and other questions related to c-di-GMP signaling, a new ΔXII 
strain was again generated in our laboratory, sequenced and confirmed to 
only lack DGC encoding genes (Zorraquino et al., 2013). This new ΔXII 
strain has been used throughout this doctoral thesis in order to analyze c-di-
GMP influence on Salmonella virulence and immunity of the host and also 
as a genetic tool to manipulate the source and levels of c-di-GMP. 
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OBJECTIVES  
We have used Salmonella Enteritidis as a model organism to analyse 
the role of c-di-GMP signalling in pathogenicity and also to evaluate the 
impact of the conserved biofilm exopolysaccharide, PGA, on bacterial 
biology.  
 
The specific objectives of this thesis are:  
1.- Analysis of the role of c-di-GMP signaling pathway in Salmonella 
virulence and evaluation of a strain lacking c-di-GMP and RpoS as a live 
oral vaccine. 
 
2.- Assessment of the implication of c-di-GMP recognition by its eukaryotic 
receptor, STING, in the Salmonella infection process.  
 
3.- Evaluation of the impact of PGA synthesis on Salmonella biology with 
the aim of elucidating the reasons behind the absence of PGA encoding 
genes in this bacterial pathogen. 
 
 

  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER I 
 
Evaluation of a Salmonella strain lacking the 
secondary messenger c-di-GMP and RpoS as a live 
oral vaccine 
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SUMMARY 
Salmonellosis is one of the most important bacterial zoonotic diseases 
transmitted through the consumption of contaminated food, with chicken 
and pig related products being key reservoirs of infection. Although 
numerous studies on animal vaccination have been performed in order to 
reduce Salmonella prevalence, there is still a need for an ideal vaccine. 
Here, with the aim of constructing a novel live attenuated Salmonella 
vaccine candidate, we firstly analyzed the impact of the absence of cyclic-di-
GMP (c-di-GMP) in Salmonella virulence. C-di-GMP is an intracellular 
second messenger that controls a wide range of bacterial processes, 
including biofilm formation and synthesis of virulence factors, and also 
modulates the host innate immune response. Our results showed that a 
Salmonella multiple mutant in the twelve genes encoding diguanylate 
cyclase proteins that, as a consequence, cannot synthesize c-di-GMP, 
presents a moderate attenuation in a systemic murine infection model. An 
additional mutation of the rpoS gene resulted in a synergic attenuating effect 
that led to a highly attenuated strain, referred to as ΔXIII, immunogenic 
enough to protect mice against a lethal oral challenge of a S. Typhimurium 
virulent strain. ΔXIII immunogenicity relied on activation of both antibody 
and cell mediated immune responses characterized by the production of 
opsonizing antibodies and the induction of significant levels of IFN-γ, TNF-α, 
IL-2, IL-17 and IL-10. ΔXIII was unable to form a biofilm and did not survive 
under desiccation conditions, indicating that it could be easily eliminated 
from the environment. Moreover, ΔXIII shows DIVA features that allow 
differentiation of infected and vaccinated animals. Altogether, these results 
show ΔXIII as a safe and effective live DIVA vaccine. 
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INTRODUCTION  
Salmonella remains a foodborne pathogen of rising concern to 
consumers and governments worldwide. In Europe, Salmonella is the 
second most frequently reported cause of foodborne outbreaks with known 
origin, with Salmonella enterica sv enteritidis (S. Enteridis) and Salmonella 
enterica sv typhimurium (S. Typhimurium) being the two most commonly 
detected serovars. The number of officially reported clinical cases of 
salmonellosis amounts to almost 90.000 according to the report of the 
European Food Safety Authority (EFSA) for the year 2014 
(https://www.efsa.europa.eu/en/efsajournal/pub/4329), and the overall 
economic burden has been estimated to be as high as 3 billion euros a 
year. 
The fact that Salmonella gastroenteritis cases usually follow the 
consumption of contaminated basic food products such as poultry 
derivatives or pig meat, in combination with the rapid spread of multidrug 
resistant Salmonella spp. triggered by the high-productivity-focused model 
of animal breeding (González-Zorn and Escudero, 2012; Doyle, 2015) has 
prompted the appearance of new policies aimed at the prevention of 
Salmonella intake into the food chain. Thus, public health programs 
including means such as the improvement of hygienic conditions in farms, 
the use of fodder supplements and the execution of effective vaccination 
protocols are being gradually implemented. Many Salmonella vaccines have 
been tested in poultry and swine, with varying degrees of success (for 
review, see (Denagamage et al., 2007; Arguello et al., 2012; Desin et al., 
2013)). These can be divided into three categories: live-attenuated, 
inactivated and subunit vaccines. As regards whole cell killed and 
subcellular vaccines, biosafety for both human and farm animals is their 
main advantage. However, it is generally accepted that protection conferred 
by these last preparations is fairly modest when they are compared to 
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vaccines based on live attenuated Salmonella strains (Mastroeni et al., 
1993; Simon et al., 2011). This assertion is supported by the potential of live 
bacteria to activate both humoral and cellular adaptive immune responses 
(Mastroeni and Ménager, 2003) and by their capacity to inhibit intestinal 
colonization during the “immunity gap” (period of time after neonatal 
vaccination when there is no longer sufficient maternal immunoglobulins to 
afford protection from infection but when there is still enough of this 
maternal protection to prevent the young animal from mounting its own 
protective immune response) (Methner et al., 2011). If other evidences like 
the easiness of production and administration are considered, we obtain a 
scenario in which the livestock industry calls for new live attenuated 
vaccines that display an improved balance between attenuation (safety) and 
immunogenicity (efficacy). 
Since the early 90´s, attenuation of Salmonella has been 
accomplished by the introduction of mutations in aro genes and global 
regulators like PhoPQ, Crp or RpoS (for review, see (Karasova et al., 
2009)). Other common attenuation strategies are based on auxotrophies 
raised by mutation of genes involved in the synthesis of purines (purA, purE 
mutants) or in the metabolism of carbohydrates (galE mutants) (O'Callaghan 
et al., 1990; McKenna et al., 1995) and on the elimination of determinants 
directly involved in infection establishment (e.g. pathogenicity islands, 
virulence plasmid, svp genes) (Bohez et al., 2008; Matulova et al., 2012). 
Present-day advances widening the knowledge about molecular 
mechanisms underlying Salmonella virulence and the development of novel 
DNA engineering tools are currently leading to more ambitious genetic 
approaches in the area of recombinant vaccines, and long-term visions 
include Salmonella strains with regulated delayed attenuation in vivo and 
their use as antigen carrier/delivery platforms (Kong et al., 2012). 
Nevertheless, fairly curious is the fact that some of the strains used as 
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commercial vaccines, such as SG 9R, VacT or VacE, have been generated 
by passages in the laboratory or by random mutagenesis and thus, the 
exact genetic basis of their attenuation is largely unknown (Karasova et al., 
2009).   
In our laboratory, we constructed a S. Enteritidis strain, called ΔXII, 
carrying mutations in the twelve genes encoding GGDEF domain proteins 
and thus, incapable of synthesizing the secondary messenger bis-(3–5)-
cyclic dimeric GMP (c-di-GMP) (Solano et al., 2009). This molecule is widely 
recognized as a key regulator of bacterial biology, including the transition 
from a planktonic to a biofilm lifestyle and from the virulent state in acute 
infections to a less virulent state characteristic of chronicity (Römling et al., 
2013). Furthermore, bacterial cyclic nucleotides have been recently involved 
in modulating the innate immune response, leading to induction of type I 
interferons, via direct binding to the eukaryotic Stimulator of Interferon 
Genes (STING) and to DDX41 (Woodward et al., 2010; Burdette et al., 
2011; Parvatiyar et al., 2012; Valle et al., 2013). Virulence assays with S. 
Enteritidis ΔXII showed that it was highly attenuated in orally and 
intraperitoneally infected BALB/c mice (Solano et al., 2009) and hence, this 
strain might be considered a potential vaccine candidate. However, further 
work with ΔXII revealed that it contained an additional chromosomal 
deletion of 16.8 kilobases that included the rpoS gene (Zorraquino et al., 
2013). Since RpoS, which is the master sigma factor during stationary 
phase and under a variety of stress conditions, plays a critical role in 
Salmonella virulence (Fang et al., 1992), it was unclear whether the 
absence of c-di-GMP played any role in virulence attenuation shown by 
ΔXII. To solve this and other questions related to c-di-GMP signaling, a new 
ΔXII strain was generated, sequenced and confirmed to only lack GGDEF 
proteins encoding genes (Zorraquino et al., 2013). 
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Taking new ΔXII strain as a basis, the present work was planned with 
three main objectives: (i) analyzing the contribution to Salmonella virulence 
of c-di-GMP signaling; (ii) confirming the attenuation of a strain deficient in 
c-di-GMP signaling and RpoS with the aim of identifying a genetic 
background that might lead to a novel attenuated Salmonella vaccine strain 
and, (ii) assessing its potential use as an effective vaccine to combat gut 
and organ colonization by Salmonellae. Here, we report that total depletion 
of c-di-GMP in new ΔXII correlated with a moderate loss of virulence in a 
murine model of infection. A ΔXII strain in which we also performed a rpoS 
mutation led to a strain that we called ΔXIII, more attenuated than a single 
rpoS mutant but still capable of eliciting a cellular/humoral balanced, long-
lasting immune response against a lethal oral-challenge of a S. 
Typhimurium virulent strain. Moreover, use of ΔXIII enabled serological 
differentiation of vaccinated and infected mice due to the lack of antibodies 
raised against the Salmonella specific GGDEF protein SEN4316 in 
vaccinated animals. 
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MATERIALS AND METHODS 
Ethics statement  
Animal studies were performed in accordance with the European 
Community guiding in the care and use of animals (Directive 2010/63/EU). 
Protocols were approved by the ethics committee of the Public University of 
Navarra (Comité de Ética, Experimentación Animal y Bioseguridad of the 
Universidad Pública de Navarra) (approved protocol PI-004/11). Work was 
carried out in the animal facility of the Instituto de Agrobiotecnología, 
Universidad Pública de Navarra. Animals were housed under controlled 
environmental conditions with food and water ad libitum. Mice were 
euthanized by CO2 inhalation followed by cervical dislocation and all efforts 
were made to minimize suffering. 
 
Bacterial strains and culture conditions 
Bacteria were grown in LB broth and on LB agar with appropriate 
antibiotics at the following concentrations: kanamycin (Km), 50 µg ml-1; 
ampicillin (Am), 100 µg ml-1; chloramphenicol (Cm), 20 µg ml-1 and 
apramycin (Apr), 60 µg ml-1. 
Bacterial strains used in this study are listed in Table 1. S. Enteritidis 
3934 (MIC-54) is a wild type clinical isolate described in (Solano et al., 
1998; Solano et al., 2002). S. Enteritidis ΔXII (MIC-1324) is a multiple 
mutant, derivative of 3934, carrying mutations in all genes encoding GGDEF 
domain proteins and thus incapable of synthesizing c-di-GMP (Zorraquino et 
al., 2013). This multiple mutant was generated by a markerless gene 
replacement method described in (Solano et al., 2009; Zorraquino et al., 
2013) and as a consequence, does not contain any exogenous DNA. To 
compare the virulence of the wild type and ΔXII strain we used a ΔXII 
derivative (MIC-3664), resistant to kanamycin and tetracycline, that was 
generated in (Zorraquino et al., 2013).  
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S. Typhimurium CNM 143/09 (MIC-1201) is a clinical strain isolated 
from a patient that suffered a pig meat borne gastroenteritis (Centro 
Nacional de Microbiología; Instituto de Salud Carlos III).  
To generate the single mutant ΔrpoS (MIC-2101), a PCR-generated 
linear DNA fragment in combination with the helper plasmid pKOBEGA 
were used (Chaveroche et al., 2000; Solano et al., 2002). A selectable 
antibiotic resistance gene was generated by PCR using oligonucleotides 
rpoS-Apra_fw 
(ctgaaagttcatgatttaaatgaagacgcggaatttgatgagaacggagtagaggctttttcccatccac
cggatcaatt) and rpoS-Apra_rv 
(tgcgctcgttgagacgaagcatacggctgacgtcatcaaccggtttatccagttgctctgtccttgttagac
attatttg) that included 60-nt homology extensions for the targeted locus and 
20-nt priming sequences for the apramycin resistance gene as template 
from a freshly isolated colony of E. coli MC4100 F´tet ΔtraD::aac (García et 
al., 2004). Electroporation (25 µF, 200 Ω, 2.5 kV) was carried out according 
to the manufacturer’s instructions (Bio-Rad) using 50 µl of cells and 1 to 5 
µg of purified and dialyzed (0.025 µm nitrocellulose filters; Millipore) PCR 
product. Shocked cells were added to 1 ml of LB broth, incubated overnight 
at 30°C, and then spread on LB agar with Apr to select AprR transformants 
after incubation at 30°C for 24 h. Mutants were then grown on LB broth with 
Apr at 43°C for 24 h and incubated overnight on LB agar with Am at 30°C to 
test for the loss of the helper plasmid. 
To generate the vaccine candidate, S. Enteritidis ΔXIII (MIC-1330), the 
rpoS gene was deleted in ΔXII (MIC-1324) strain as follows. DNA fragments 
corresponding to the upstream (fragment AB) and downstream (fragment 
CD) regions of the rpoS gene were amplified with the following 
oligonucleotides, with chromosomal DNA from strain S. Enteritidis 3934 as a 
template. Primers RpoS_1´_Fw (gaatcgtatacaatcgccag) and RpoS_B_XhoI 
(ctcgaggctcctacccgtgatcc) were used to amplify the AB fragment. Primers 
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RpoS_C_XhoI (ctcgagttgtcaaaaaaaggccagtc) and RpoS_D_BglII 
(agatctaatctgccacaggtgatg) were used to amplify the CD fragment. The 
PCR products were cloned in the pGEMt-easy vector (Promega), digested 
with NotI and XhoI enzymes in the case of the AB fragment and XhoI and 
BglII enzymes in the case of the CD fragment, and ligated in the same 
ligation mixture with the pKO3blue vector (Solano et al., 2009) digested with 
NotI and BglII enzymes. The recombinant pKO3blue::AD vector was 
extracted from E. coli XL1 Blue and electroporated into strain S. Enteritidis 
ΔXII. The following steps of integration and excision of the plasmid were 
performed as described previously (Solano et al., 2009). As a result, ΔXIII is 
a multiple mutant in all genes encoding GGDEF domain proteins and in 
rpoS and does not contain any exogenous DNA.  
 
Mice survival assays 
Mice were acclimated for 7 days after arrival before the experiments 
were started. In the case of oral infections, food and water were removed, 
twelve and two hours respectively, before the administration of bacterial 
suspension. Mice were prefed with 20µl of 10% sodium bicarbonate 30 min 
before bacterial inoculation. Water and food were again supplied right after 
inoculation.  
For mice survival assays, eight-week-old female BALB/c mice (Charles 
River Laboratories) were infected orally with 107 Salmonella wild type or 
mutant cells that had been grown overnight in LB broth and resuspended in 
100 µl of PBS. Mice survival was monitored for 20-28 days. Over the course 
of infection, mice were examined twice per day and a final disease score 
was given to each mouse according to clinical signs observed as follows. 
No clinical signs (0); mild clinical signs: ruffled fur (1); moderate clinical 
signs: ruffled fur plus, lethargy, hunched posture and decreased activity (2); 
severe clinical signs: paresis, paralysis, tremor, shivers, ataxia, rigidity (3). 
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When evident signs of disease (score 2 to 3) were observed, mice were 
euthanized by CO2 inhalation followed by cervical dislocation. 
 
Mice competitive infections 
Infection studies were carried out with 8-week-old female BALB/c mice 
(Charles River Laboratories). Mice were inoculated intraperitoneally (i.p.) or 
intragastrically (i.g.) with 100 µl of bacteria suspended in phosphate-
buffered saline (PBS; pH 7.4). The total bacteria inoculum was 2x104 cfu 
(i.p.) or 2x108 cfu (i.g.) of combined S. Enteritidis wild-type and mutant 
strains at a ratio of 1:1. The cfu of each strain in the inoculum (input) was 
quantified by plating dilution series on LB agar and using antibiotic 
resistance to distinguish between strains. Mice were euthanized after 3 days 
(i.p.) or 5 days (i.g.), and dilution series of liver and spleen lysates were 
plated on LB agar for enumeration of cfu (output), using antibiotic resistance 
to differentiate strains. Values for competitive index (CI) were calculated as 
the ratio of wild type to mutant in the output divided by that in the input, and 
the CI was expressed as log10 (Figueira et al., 2013). 
To compare the in vivo interaction of Salmonella strains with murine 
intestinal epithelial cells, the ligated ileal loop co-infection model was used 
as described previously (Solano et al., 2002). Values for CI were calculated 
as described above. 
 
Mice protection assay 
Groups of seven 8-week-old female BALB/c mice were orally 
inoculated with 107 cfu of the attenuated strains ΔXIII or ΔrpoS.  One control 
group only received PBS. On day thirty-three after immunization, immunized 
and control animals were intragastrically challenged with 106 cfu of virulent 
S. Typhimurium 143/09. Vaccinated and control mice were monitored daily 
to assess clinical signs as described above. When evident signs of disease 
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(score 2 to 3) were observed, mice were opportunely euthanized by CO2 
inhalation followed by cervical dislocation. 
 
Preparation of ΔXIII heat-killed lysate 
The vaccine strain, ΔXIII, was cultured overnight at 37°C on LB agar 
plates. Bacteria were resuspended in PBS and the OD600 was adjusted to 
0.2 (1x108 cfu ml–1, based on viable cell counts on LB agar). Bacteria were 
then incubated at 75°C in a water bath for 30 min. The effectiveness of the 
inactivation was assessed by plating 100 µl of the suspension on LB agar, 
after treatment. 
 
Determination of antibody titers 
Blood samples from the orbital vein of each mouse from the control 
and the ΔXIII-immunized groups were collected before immunization and 14 
and 28 days after immunization. Samples were centrifuged and sera from 
each group were collected. Serum IgG and IgM were detected by ELISA. 
For that, Nunc Maxisorp 96-well plates (Thermo Fisher Scientific, San Jose, 
CA) were coated with 107 cfu of heat-killed ΔXIII bacteria and incubated at 
4°C overnight. Plates were then washed three times with PBS containing 
0.05% Tween 20 (PBS-T; pH 7.4) and blocked with 5% nonfat dried milk 
powder in PBS-T at room temperature for 1 h. After three washes with PBS-
T, immune mouse sera were serially diluted from an initial dilution of 1:20. A 
100 µl volume of diluted sample was added to duplicate wells and incubated 
at 4ºC overnight. Wells were washed three times with PBS-T and 100 µl of 
horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG, IgM (H+L) 
secondary antibody diluted 1:2500 (Thermo Scientific) was added to each 
well. The plates were incubated for 1 h at room temperature and then 
washed three times. One hundred microliters of 3,3′,5,5′-
Tetramethylbenzidine (TMB) (Sigma-Aldrich) were added to each well and 
Chapter I 
104 
the absorbance at 405 nm was determined on an ELISA reader. Endpoint 
titers were expressed as the reciprocal log2 values of the last positive 
sample dilution. Absorbance readings higher than the mean plus two 
standard deviations of preimmune serum baseline values were considered 
indicative of positive reactions.  
 
Opsonophagocytosis uptake assay 
The murine macrophage-like cell line J774.2 was grown in RPMI 1640 
with 10% heat-inactivated fetal bovine serum (FBS) and 1% 
Penicillin/Streptomicin (Lonza) at 37ºC with 5% CO2. Cells were seeded in 
24-well tissue culture plates. Once in confluence (0.2 x 106 cells per well), 
cells were washed with PBS, and medium without FBS was added 16 hours 
prior to the experiment. Fourteen hours later, the medium was replaced by 
medium without antibiotics. 2 x 106 cfu of an overnight culture of S. 
Typhimurium143/09 was mixed with 10% of pooled immune serum, pre-
immune serum or PBS in 500 µl of Minimum Essential Medium Eagle 
(MEM) with 1% Bovine Serum Albumin (BSA) and complement 
(complement sera rabbit, Sigma-Aldrich). After incubation at room 
temperature for 15 minutes, the mix was added to the monolayer cells 
(multiplicity of infection of 10) and plates were incubated for 30 minutes at 
37ºC in 5% CO2. To kill extracellular bacteria, cells were washed and 
incubated for 90 minutes with 500 µl of RPMI 1640 containing 100 µg/ml 
gentamicin (Sigma-Aldrich). Cells were washed three times with sterile PBS 
and lysed with 0.1% Triton X-100. The number of phagocytosed bacteria 
was determined by plating serial dilutions of the lysates on LB agar and data 
were represented as relative bacterial uptake of bacteria mixed with serum 
with respect to the uptake of bacteria suspended in PBS, which was given a 
value of 1.0. Experiments were conducted in triplicate.  
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ELISPOT assay 
The number of IFN-γ producing cells was measured by ELISPOT 
using a kit from BD-Biosciences (BD Biosciences, San Diego, CA) 
according to the manufacturer´s instructions. Splenocytes were harvested 
from individual mice 28 days after immunization. Ninety-six-well Multi-
Screen high protein binding Immobilon-P membrane plates (Millipore, 
Billerica, MA) were coated with mouse anti–IFN-γ capture antibody, 
incubated overnight, and blocked for 2 h with RPMI containing 10% fetal calf 
serum. Then, 1 x 106 splenic cells in 10% fetal calf serum-RPMI were added 
to each well in triplicate and cultured in the presence or in the absence of 
107 cfu of heat-killed ΔXIII bacteria. Following overnight incubation, the 
plates were washed three times with PBS and incubated with biotinylated 
anti-IFN-γ antibody for two hours. Wells were washed three times and 
incubated with a solution of streptavidin-peroxidase for one hour. Then, 
plates were washed and developed with freshly prepared 3,3′-
Diaminobenzidine (DAB) solution. The reaction was stopped with distilled 
water and spots were counted using an ELISPOT automated reader (CTL; 
Aalen, Germany). 
 
Measurement of cytokine production by ELISA 
1 x 106 splenic cells harvested from individual mice 28 days after 
immunization were co-cultured with 107 cfu of heat-killed ΔXIII bacteria 
during 48 h. RPMI media was used as negative control. IL-2, IL-10 and IL-
17 released to the supernatant were measured by ELISA using specific kits 
from BD Biosciences (San Diego, CA) according to the manufacturer´s 
instructions. 
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Levels of IFN-γ and IL-5 in serum were determined using a Mouse 
Procarta Cytokine 2Plex Assay (eBioscience). Levels of IL-10 in serum were 
determined with a Mouse IL-10 ELISA Ready-SET-Go!® kit (eBioscience). 
 
Flow cytometry analysis 
Splenocytes (2x106/well) harvested from individual mice 28 days after 
immunization were either stimulated with 106 and 107 cfu of heat-killed 
ΔXIII bacteria or rested unstimulated for 1h. Golgi-Plug and Golgi-Stop (BD 
Biosciences, San Diego, CA) were added and plates were incubated for five 
hours. Then, cells were washed with staining buffer (PBS, 0.5% BSA, 2 mM 
EDTA), surface stained with anti-CD8a-APC (53-6-7) and anti-CD4-FITC 
(RM45) monoclonal antibodies (mAbs), fixed and permeabilized with 
Cytofix/Cytoperm solution (BD Biosciences) and finally stained for 
intracellular cytokines with anti-TNF-α-PE-Cy7 (MP6-XT22) and anti-IFN-γ-
PE (XMG1,2) mAbs. All mAbs were from Biolegend (San Diego, CA). Dead 
cells were excluded by FSC and SSC. Data were collected in a 
FACSCalibur cytometer (BD Biosciences) and analyzed using FlowJo 
software (Tree Star, San Carlos, CA).  
 
Biofilm formation and desiccation experiments 
Biofilm formation in a rich-medium condition (LB) was determined and 
visualized as previously described (Solano et al., 2002). Colony morphology 
and color on Congo red agar plates were tested after 48 hours of incubation 
at 28 °C (Romling et al., 1998).  
The desiccation experiment was adapted from a described protocol 
(White et al., 2006). Briefly, 100 µl from overnight cultures grown in LB 
medium at 37 °C were tested immediately (initial numbers) or air dried and 
stored in 24 well tissue culture plates at room temperature for 12 days. After 
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rehydration of bacteria in 500 µl PBS, pH 7.4, the number of viable cells 
remaining in each sample was determined by serially diluting cell mixtures 
and plating in duplicate. The experiment was conducted in triplicate. 
 
Production of recombinant SEN4316 
The sen4316 gene was amplified from wild type genomic DNA with 
primers sen4316 BamHI-fw (ggatccatgacaacaccatcctggcg) and sen4316 
SalI-rv (gtcgactcatagggcgcgcatgtcgt), using Phusion High-Fidelity DNA 
Polymerase (Fermentas-Thermo Scientific). The PCR-amplified fragment 
was cloned in pGEM-T Easy (Promega), sequenced and digested with 
BamHI and SalI to clone it into the pET28a vector (Novagen). The resulting 
plasmid pET28a::sen4316 was electroporated into E. coli BL21 C43 (DE3) 
(Miroux and Walker, 1996). Cultures were grown at 37°C, 250 rpm, to an 
optical density (OD600) of 0.5, and isopropyl-D-thiogalactopyranoside (IPTG) 
was added to a final concentration of 0.4 mM. Cells were then grown 
overnight at 23°C. Harvested cells were lysed with BugBuster HT Protein 
Extraction Reagent (Merck Millipore). SEN4316 accumulated in inclusion 
bodies was obtained by centrifugation and suspension of insoluble material 
in CTAB 1%, incubation at room temperature for 1 h and recovery of the 
supernatant by centrifugation at 20,000 x g. This supernatant was dialyzed 
against binding buffer (20 mM sodium phosphate, 500 mM NaCl, 20 mM 
imidazole, pH 7.4) and the recombinant protein was purified with a His 
GraviTrap affinity column according to standard protocols (GE Healthcare). 
Eluted protein was dialyzed against sterile water, analyzed by SDS–PAGE 
and Western-Blot and lyophilized. 
 
SEN4316 based ELISA 
Groups of ten mice were orally inoculated with a single dose of 107 cfu 
or 104 cfu of ΔXIII or the wild type strain, respectively. Blood samples from 
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the orbital vein of each mouse were collected before inoculation and 33 and 
44 days after inoculation. Samples were centrifuged and sera from each 
group were collected and pooled. Nunc Maxisorp 96-well plates (Thermo 
Fisher Scientific, San Jose, CA) were coated with SEN4316 (2 µg/well) in 
carbonate-bicarbonate buffer (pH 9.6) and incubated at 4°C overnight. 
Plates were then washed three times with PBS-T and blocked with 5% 
nonfat dried milk powder in PBS-T at room temperature for 2 h. After three 
washes with PBS-T, 100 µl of pooled sera diluted 1:100 in PBS-T containing 
2.5 % of BSA were added to each well and incubated at room temperature 
for 2 h. Wells were washed three times with PBS-T and 100 µl of 
horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG, IgM (H+L) 
secondary antibody diluted 1:1250 (Thermo Scientific) was added to each 
well. The plates were incubated for 2 h at room temperature and then 
washed three times. One hundred microliters of ABTS (Sigma-Aldrich) were 
added to each well and the absorbance at 420 nm was determined on an 
ELISA reader. 
 
sen4316 PCR to differentiate vaccinated from infected mice 
Faecal samples from the wild type and ΔXIII infected groups were 
pooled and collected at day 1, 7, 14 and 21 post-infection. Cages were 
cleaned daily to remove non collected faeces. DNA from stool was extracted 
using a QIAamp DNA Stool Mini Kit (Qiagen). Oligonucleotides DIVA-1 
(cacgattacgccaactcgagttgt) and DIVA-2 (gtaagataactgtgcgaag) were used to 
amplify a 632 bp fragment from ΔXIII DNA. Amplification of invA with 
oligonucleotides invA-fw (ggcgatattggtgtttatgg) and invA-rv 
(catattatcgctatcgccat) was used to amplify a 658 bp fragment from wild type 
and ΔXIII DNA. The PCR amplification conditions were as follows: 1 cycle at 
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95°C for 5 min; 30 cycles of the following: 94°C for 30 s, 54°C for 30 s and 
72°C for 35 s; 1 cycle of 72°C for 7 min. 
 
Statistical analyses 
All statistical analyses were performed in GraphPad Prism 5.01. A 
Log-rank (Mantel-Cox) test was used to assess significance in mice survival 
assays. A Wilcoxon signed-rank test was used to determine whether the CI 
values were significantly different from the hypothetical value of zero. A two-
way analysis of variance combined with the Bonferroni test was used to 
analyze statistical significance in antibody titers, cytokine serum levels and 
data from flow cytometry assays. A nonparametric Mann-Whitney test was 
used to assess significant differences in the opsonization assay. Differences 
in cytokine production in splenocytes assayed by ELISPOT and ELISA were 
determined using the unpaired Student’s t test.  
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Table 1. Strains used in this study 
 
aNumber of each strain in the culture collection of the Laboratory of Microbial Pathogenesis, 
Navarrabiomed-Universidad Pública de Navarra. 
Strain  Genotype Degree of 
attenuation 
MICa Reference 
or source 
S. Enteritidis     
3934 Wild-type clinical isolate - 54 (Solano et 
al., 1998) 
(Solano et 
al., 2002) 
ΔXII  3934 ΔadrA Δsen1023 ΔyeaJ 
ΔyciR ΔyegE ΔyfiN Δyhda 
Δsen3222 ΔyhjK Δsen2484 
ΔyfeA Δsen4316 
+ 1324 (Zorraquino et 
al., 2013) 
ΔXII KmR TcR 3934 ΔadrA Δsen1023 
yeaJ::TcR ΔyciR ΔyegE ΔyfiN 
Δyhda Δsen3222 ΔyhjK 
Δsen2484 yfeA:: KmR 
Δsen4316 
+ 3664 (Zorraquino et 
al., 2013) 
ΔXIII 3934 ΔadrA Δsen1023 ΔyeaJ 
ΔyciR ΔyegE ΔyfiN Δyhda 
Δsen3222 ΔyhjK Δsen2484 
ΔyfeA Δsen4316 ΔrpoS 
+++ 1330 This study 
ΔrpoS 3934 rpoS::AprR ++ 2101 This study 
S. Typhimurium     
S. Typhimurium 
143/09 
Wild-type clinical isolate - 1201 Centro 
Nacional de 
Microbiología 
E.coli     
XL1-Blue recA1 endA1 gyrA96 thi-1 
hsdr17 supE44 relA1 lac 
[F´proAB laclq Z ΔM15 Tn10 
(TcR)] 
 797 Stratagene 
MC4100 AprR MC4100 F´tet ΔtraD::aac  1087 (García et al., 
2004) 
E.coli BL21 
C43(DE3) 
huA2 [lon] ompT gal (λ DE3) 
[dcm] ∆hsdS λ DE3 = λ 
sBamHIo ∆EcoRI-B 
int::(lacI::PlacUV5::T7 gene1) 
i21 ∆nin5 
 1637 (Miroux et al.,  
1996) 
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RESULTS 
Analysis of the contribution of c-di-GMP signaling to Salmonella 
virulence 
To evaluate the impact of the absence of c-di-GMP on Salmonella 
virulence, we firstly compared the survival rates of groups of seven BALB/c 
mice, which are susceptible to systemic infection with Salmonella, orally 
infected with 107 cfu of the wild type S. Enteritidis strain 3934 or its 
derivative, new ΔXII strain. ΔXII showed virulence attenuation that 
manifested by a latter time to death than animals infected with wild type 
Salmonella. However, the difference between survival curves was no 
statistically significant (p=0.2287) and at the end of the experiment ten and 
twenty percent of mice survived after infection with the wild type and ΔXII 
respectively (Fig. 1A). Virulence of ΔXII after infection by the natural oral 
route was further investigated by carrying out a competitive index (CI) 
analysis in an ileal loop coinfection experiment and also, by assessing the 
level of organ colonization following oral co-inoculation of the wild type and 
ΔXII strains. ΔXII showed a significantly reduced capacity to adhere and 
invade the intestinal epithelium (Fig. 1B) and a significantly lower ability to 
colonize livers and spleens of orally infected mice (Fig. 1C). Defectiveness 
of ΔXII colonization at systemic sites was additionally confirmed by 
evaluating organ colonization after intraperitoneal (i.p) infection. ΔXII mutant 
colonized both the spleen and liver of i.p infected mice significantly less than 
the wild type strain (Fig. 1D). Taking together, these results showed that c-
di-GMP signaling is required for natural virulence of Salmonella in BALB/c 
mice, since absence of c-di-GMP rendered bacteria significantly less able to 
adhere and invade the intestinal epithelium and to colonize systemic organs 
during acute infection. However, the overall outcome of the lack of c-di-GMP 
signaling in pathogenicity is subtle, resulting in a non significant virulence 
attenuation.   
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Fig. 1. c-di-GMP signaling in Salmonella is required for intestinal epithelium 
and organ colonization of BALB/c mice but its absence does not significantly affect 
BALBc mice survival. (A) Comparative lethality between wild-type (black circles) and ΔXII 
(black squares) strains in an oral infection mouse model. Inoculum administered was 107 
cfu/mouse. P-value was determined by a Log-rank (Mantel-Cox) test.  ns; no significant 
difference. (B) Competitive index (CI) analysis of wild type and ΔXII strains after performing 
an ileal loop coinfection experiment. Nine ileal loops were coinfected with 2x107 cfu 
containing equal numbers of the parental and ΔXII strains. (C) CI analysis following 
intragastric inoculation of ten BALBc mice with a 1:1 mixture of wild type and ΔXII strains 
(total inoculum administered was 2 x 108 cfu). Mice were sacrificed after five days and 
bacteria were enumerated from livers and spleens. (D) CI analysis following intraperitoneal 
inoculation of seven BALBc mice with a 1:1 mixture of wild type and ΔXII strains (total 
inoculum administered was 2 x 104 cfu). Mice were sacrificed three days postinoculation 
and bacteria were enumerated from livers and spleens. CI was defined as the log10 of the 
ratio of wild type strain to ΔXII strain recovered (Output) divided by the ratio of wild type 
strain to ΔXII strain present in the inoculum (Input). A CI > 0 indicates wild type with a 
colonization advantage compared to ΔXII and a CI < 0 indicates wild type with a 
colonization disadvantage over ΔXII. The plots display values obtained from individual 
samples and the median CI is represented by horizontal bars. P-values were determined by 
a Wilcoxon signed-rank test. *P < 0.05; ** P < 0.01; *** P < 0.001.  
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Construction and virulence characterization of a Salmonella 
strain lacking all GGDEF proteins and the RpoS sigma factor 
Results described above carried out with new ΔXII strain, which only 
lacks GGDEF proteins encoding genes, demonstrated that absence of c-di-
GMP has a restrained impact on virulence. On the other hand, the firstly 
described ΔXII strain, that also contains a chromosomal deletion that 
includes the rpoS gene, is completely avirulent in mice (Solano et al., 2009). 
Hence, we next wondered whether this avirulent phenotype was solely 
caused by the absence of RpoS or by the synergic effect of the lack of 
RpoS and c-di-GMP. To analyze this, we compared the pathogenic behavior 
of the wild type strain, a single rpoS mutant, and a derivative of new ΔXII 
strain in which we deleted the rpoS gene. This novel mutant was named 
ΔXIII. A survival experiment of orally infected BALB/c mice with 107 cfu of 
each strain showed that, in agreement with our previous results, ΔXIII strain 
exhibited a total attenuated behavior and thus, all mice infected with this 
strain survived at day 28 and did not present any morbid symptoms (Fig. 
2A). In contrast, the survival rate of mice infected with the wild type strain 
was only 10% at the end of the experiment, whereas infection with the rpoS 
mutant rendered a final survival of 60% of infected mice (Fig. 2A). To certify 
virulence loss of ΔXIII, mice inoculated with this strain were sacrificed at the 
end of the experiment and a complete clearance of infection was confirmed 
by the absence of Salmonella in livers, spleens and faeces.   
Since a Salmonella vaccine strain needs to be invasive enough to 
induce durable immunity in the host and thus, an excessive attenuation of 
ΔXIII strain was not desirable, we tested its invasiveness capacity at an 
earlier time of infection. For that, we orally infected groups of seven BALB/c 
mice with 2x107 cfu of a 1:1 mixture of the wild type and ΔrpoS or ΔXIII 
strains. At day 7 post infection, animals were euthanized, bacterial load in 
spleens was determined and the CI was calculated. As shown in Fig. 2B, 
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ΔXIII was capable of reaching and colonizing internal organs, although, 
when compared to the wild type strain, it presented an approximately 104 
fold defect in its ability to colonize spleens of infected mice. Again, ΔrpoS 
mutant exhibited an intermediate attenuation phenotype, confirmed by a 102 
deficiency in spleen colonization. 
Altogether, these data show that in ΔXIII strain, the absence of both c-
di-GMP signaling and the sigma factor RpoS exerts a synergistic 
attenuating effect on Salmonella virulence, that turns this novel mutant 
strain into a potential live attenuated vaccine. 
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Fig. 2. The synergic effect of the absence of RpoS and c-di-GMP signaling in 
ΔXIII strain results in high virulence attenuation. (A) Comparative lethality between 
wild-type (black circles), ΔrpoS (black triangles) and ΔXIII (open squares) strains in an oral 
infection mouse model. Groups of ten mice were orally infected with 107 cfu/mouse. P-
values were determined by a Log-rank (Mantel-Cox) test. (B) CI analysis following 
intragastric inoculation of seven BALBc mice with a 1:1 mixture of wild type and ΔXIII or 
ΔrpoS strains (total inoculum administered was 2 x 107 cfu). Mice were sacrificed after 
seven days and bacteria were enumerated from spleens. CI for the wild type and mutant 
strains was defined as stated in Figure 1 legend.   
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Evaluation of the protection conferred by vaccination with ΔXIII 
With the aim of investigating the efficacy of ΔXIII strain as an orally 
administered vaccine against salmonellosis, a vaccination-challenge 
analysis was carried out in BALBc mice, using a clinical isolate of S. 
Typhimurium as the challenge strain. The reason why this strain was used 
for challenge is that, according to the report of the European Food Safety 
Authority (EFSA) for the year 2014 
(https://www.efsa.europa.eu/en/efsajournal/pub/4329), S. Enteritidis and S. 
Typhimurium are the two most commonly reported serovars in confirmed 
human cases. Moreover, S. Enteritidis is the second most commonly 
reported serovar from broiler meat and S. Typhimurium is the most 
frequently reported serovar in pigs and cattle and also in pig meat. By using 
S. Typhimurium for challenge we assessed both ΔXIII vaccination efficacy 
and also the level of cross-protection against other Salmonella serovar. 
Groups of 7 mice were orally immunized with a single dose of 107 cfu of 
either the ΔXIII or ΔrpoS strain. This last strain was used as an immunizing 
control. A third group of mice was given 100 µl of sterile PBS. Vaccinated 
and control untreated mice were challenged 33 days post immunization with 
106 cfu (10 fold the LD50) of S. Typhimurium 143/09 and data on number of 
dead mice were daily collected. As shown in Fig. 3, all non vaccinated 
animals died within a 10 day period post challenge. In contrast, 90% of ΔXIII 
immunized mice survived after challenge. Vaccination with ΔrpoS resulted 
much less effective, firstly because, according to the results presented 
above, 30% of mice died before challenge, and secondly, because, after 
challenge, only 30% of initial mice remained alive. These results 
demonstrated that immunization with ΔXIII confers a very significant degree 
of crossprotection against salmonellosis by S. Typhimurium in mice. 
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Fig. 3. Vaccination-challenge analysis of the protection conferred by ΔXIII. 
Groups of seven BALBc mice were orally vaccinated with 107 cfu of ΔXIII (open squares), 
ΔrpoS (black triangles) or PBS as a control (black circles). 33 days post immunization, mice 
were challenged with 106 cfu/mouse of S. Typhimurium 143/09. Survival curves were 
plotted and P-values were determined by a Log-rank (Mantel-Cox) test. 
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Characterization of the immune response generated by 
immunization with ΔXIII strain 
While performing the vaccination experiments described above, and in 
order to know the basis of the protection conferred by ΔXIII, serum from 
mice of the control and ΔXIII immunized groups were collected right before 
immunization and 14 and 28 days after immunization. An ELISA assay was 
then carried out to measure the levels of IgG and IgM against a ΔXIII heat-
killed lysate in individual sera. Results showed a very significant antibody 
response in mice immunized with ΔXIII strain when compared to control 
mice, treated with PBS (Fig. 4A). Then, pooled sera samples were used to 
examine the efficiency of such generated antibodies to promote 
opsonization and phagocytosis of S. Typhimurium 143/09 by J774.2 murine 
macrophage cells. As shown in Fig. 4B, the number of phagocytized 
bacteria was significantly higher when bacteria were preincubated with 10% 
of sera from ΔXIII immunized animals than when incubated with preimmune 
sera. The specificity of these antibodies against Salmonella was confirmed 
by the fact that the uptake of bacteria preincubated with preimmune sera 
was very similar to the uptake of bacteria suspended in PBS (relative 
bacterial uptake close to one). 
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Fig. 4. Humoral immune responses in mice immunized with ΔXIII strain. A) Sera 
obtained 14 and 28 days post-immunization from mice immunized with ΔXIII present 
significantly higher levels of IgG and IgM against heat-killed ΔXIII bacteria than sera from 
non immunized mice (control, treated with PBS) as determined by ELISA. No antibody to 
heat-killed ΔXIII bacteria was detected in sera from control mice (reciprocal titer, <1:20). 
Error bars represent standard deviation between individual antibody titers. Statistical 
analysis was carried out using a two-way analysis of variance combined with the Bonferroni 
test. *** P < 0.001. B) Opsonization with immune serum enhances the uptake of Salmonella 
by murine macrophage cells. Opsonization and phagocytosis of S. Typhimurium143/09 by 
J774.2 macrophages was tested by counting the number of phagocytosed bacteria that had 
been previously mixed with 10% immune serum obtained 28 days post immunization (IM), 
pre-immune serum (PreIM) or PBS. The relative bacterial uptake of bacteria mixed with 
serum with respect to the uptake of bacteria suspended in PBS (value of 1.0) is 
represented. Results from duplicates on three separate days are shown. Statistical analysis 
was performed using the Mann–Whitney test. *P < 0.05. 
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Since both humoral and cellular responses are necessary for immunity 
to oral challenge with virulent S. Typhimurium (Simon et al., 2011), we next 
determined serum levels of IFN-γ (a prototype Th1 cytokine), as well as IL-
10 and IL-5 (prototype Th2 cytokines). Remarkably, significant IFN-γ and IL-
10 levels were detected in pooled sera from ΔXIII immunized animals and 
not from PBS treated mice (Fig. 5A). In particular, 14 days after 
immunization, IL-10 levels in sera from ΔXIII immunized mice were much 
higher than in sera from control mice (p<0.001). These levels decreased 
over time, although 28 days after immunization, they were still significantly 
higher than in control sera (p<0.01). As regards IFN-γ, it was also 
significantly present in sera from ΔXIII immunized mice (p<0.05) collected 
14 and 28 days after immunization. On the other hand and in the case of IL-
5, it is important to note that this cytokine was barely detectable in all 
samples analyzed.  
To confirm the results obtained from sera and to evaluate the ΔXIII 
specific stimulation of cytokines production by spleen cells from immunized 
mice, we performed the following experiments. Supernatants of stimulated 
splenocytes with 107 cfu of heat-killed ΔXIII bacteria were analyzed for the 
production of IL-2 (prototype Th1 cytokines), IL-10 (prototype Th2 
cytokines), and the Th17-associated cytokine IL-17. Remarkably, levels of 
the three cytokines were significantly higher in supernatants from 
splenocytes of immunized mice than in supernatants from splenocytes of 
control mice (Fig. 5B). It is important to note that differences were higher in 
the case of IL-2 and IL-17 production (p<0.001) than in the case of IL-10 
(p<0.05). Also, an ELISPOT assay was carried out to investigate IFN-γ 
production and results showed that splenic lymphocytes from mice 
immunized with ΔXIII strain produced significantly more levels of IFN-γ 
secreting T cells than those of control mice (p<0.001) (Fig. 5C). Finally, we 
used flow cytometry coupled with stimulations with heat-killed ΔXIII bacteria 
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to measure IFN-γ and TNF-α production by CD4 and CD8 T cells (Fig. 5D 
and S1 Fig.). A strong CD4 T cell response specific of ΔXIII heat-killed 
bacteria was detected in AXIII immunized mice. Curiously, IFN-γ and TNF-α 
production was not detected in CD8 T cells (Fig. 5D, left). It is likely that the 
use of heat-killed bacteria for the intracellular detection of cytokines might 
have hindered the accurate analysis of the CD8 T cell response, since heat-
killed bacteria are not efficiently processed and presented by MHC-I 
molecules (Lo et al., 2004). The assessment of the CD8 T cell response 
induced by AXIII requires further work that involves the identification of 
bacterial antigens and/or the use of recombinant bacteria expressing 
reporter antigens. 
Overall, these data indicate that mechanisms underlying ΔXIII 
mediated protection include the production of opsonizing antibodies and a 
mixed T cell response characterized by significant levels of IFN-γ, TNF-α, 
IL-2, IL-17 and IL-10.   
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Fig. 5. ΔXIII induced cellular immune responses. A) Sera from ΔXIII immunized 
mice present significantly higher levels of interferon gamma (IFN-γ) and IL-10 than sera 
from the control group, treated with PBS. Quantification (pg/ml) of IFN-γ, IL-5 and IL-10 in 
pooled sera from the control group (PBS) and from the ΔXIII immunized group was carried 
out using respective ELISA kits. Error bars represent standard deviation between duplicate 
wells. Statistical analysis was carried out using a two-way analysis of variance combined 
with the Bonferroni test. ns=no significant difference; *P < 0.05; ** P < 0.01; *** P < 0.001. 
B) ΔXIII immunization induces production of cytokines in splenocytes. 28 days 
postimmunization, splenocytes were harvested from control and ΔXIII immunized mice and 
restimulated for 48 h with 107 cfu of heat-killed ΔXIII bacteria. RPMI media was used as a 
non-stimulating control. Cell supernatants were harvested and analyzed for IL-2, IL-10 and 
IL-17 production using respective ELISA kits. Statistical analysis was carried out using the 
unpaired Student t test. C) Numbers of IFN-γ producing cells in spleens from control and 
ΔXIII immunized mice were determined by ELISPOT assay. Splenocytes were harvested 
from all mice at 28 days after immunization. The results are expressed as spots per million 
splenocytes minus background from cells stimulated with 107 cfu of heat-killed ΔXIII 
bacteria. Each point represents an individual mouse. Lines indicate the mean of the 
replicates. Significant differences between groups are indicated and were determined using 
the unpaired Student t test. *** P < 0.001. D) CD4+ T cells produce IFN-γ and TNF-α upon 
ex vivo re-stimulation following vaccination with ΔXIII. 28 days after immunization, 
splenocytes from control and ΔXIII immunized mice were plated and stimulated for 6 hours 
with medium, 106 or 107 cfu of heat-killed ΔXIII bacteria. Cells were surface stained with 
anti-CD4 and anti-CD8 mAbs and intracellularly stained with anti-IFN-γ and anti-TNF-α 
antibodies. Shown are percentages of IFN-γ and TNF-α cells out of total CD4+ and CD8+ T 
cells. Each point represents an individual mouse. Lines indicate the mean of the replicates. 
Significant differences between control and vaccinated groups are indicated and were 
determined using the unpaired Student t test. ns=no significant difference; ** P < 0.01; *** P 
< 0.001.  
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Evaluation of ΔXIII as a live DIVA vaccine 
A Salmonella ideal vaccine must not interfere with control programs, in 
the sense that infected animals with virulent field Salmonella strains must be 
differentiated from vaccinated animals. Therefore, we next aimed at 
exploring the properties of ΔXIII strain as a DIVA (Differentiation of Infected 
and Vaccinated Animals) vaccine. Since ΔXIII strain is a multiple mutant 
carrying deletions in rpoS and also in all GGDEF domain proteins encoding 
genes, we investigated the possibility of using the absence of one GGDEF 
protein as a DIVA marker. Interestingly, the GGDEF domain protein 
encoding gene sen4316 does not show any orthologous gene in other 
enterobacteriaceae and thus, we found conceivable the idea of using the 
antibodies raised against this protein, that could only be developed in 
animals that had been colonized by a natural wild type strain but would be 
absent in vaccinated ones, in order to differentiate infected and vaccinated 
individuals. To prove so, groups of 10 mice were orally inoculated with a 
single dose of 107 cfu of ΔXIII or a sublethal dose (104 cfu) of the wild type 
strain and sera samples were obtained periodically up to day 44 post 
inoculation. Concurrently, we designed a specific ELISA assay in which a 6-
His–tagged recombinant version of SEN4316 was used as the bound 
antigen.  This assay showed that titers of antibodies against SEN4316 in 
pooled sera from animals infected with the wild type strain rose gradually 
after infection. On the contrary, and as expected, titers in pooled sera 
proceeding from ΔXIII immunized animals remained negative (Fig. 6A).  
In addition to the immunoassay, we also explored the possibility of 
using the sen4316 gene as a positive genetic marker to identify vaccinated 
animals through PCR.  To do so, faecal samples from each group were 
pooled and collected periodically and bacterial genetic material was 
extracted. Oligonucleotide DIVA-1 was designed so that the 5´end of the 
oligonucleotide hybridizes to a DNA sequence downstream sen4316 whilst 
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the 3´end of the oligonucleotide hybridizes to a DNA sequence upstream 
sen4316 (Fig. 6B). Oligonucleotide DIVA-2 hybridizes to a DNA sequence 
downstream sen4317 (Fig. 6B). PCR conditions were designed in such a 
way that amplification only took place if the ΔXIII genome acted as template 
DNA. On the other hand, amplification of the Salmonella specific gene invA 
with oligonucleotides invA-fw and invA-rv was used as an internal positive 
control in all samples. Faecal samples proceeding from animals infected 
with the wild type strain resulted invA positive, DIVA negative, while 
samples proceeding from vaccinated animals resulted invA positive, DIVA 
positive (Fig. 6B).   
These results confirmed that ΔXIII can be considered a DIVA vaccine 
since the GGDEF protein SEN4316 enables discrimination of vaccinated 
animals either by immunological or by molecular non sophisticated 
approaches.  
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Fig. 6. ΔXIII is a DIVA vaccine that allows differentiation of infected and 
vaccinated animals. (A) SEN4316 based ELISA of pooled sera from wild type and ΔXIII 
infected animals, obtained before infection (PreIM) and 33 and 44 days post infection. Sera 
from animals infected with the wild type strain and not with ΔXIII present antibodies against 
the SEN4316 protein. Error bars represent standard deviation between triplicate wells. (B) 
DNA from pooled faecal samples from wild type and ΔXIII infected animals, collected at day 
1, 7, 14 and 21 post infection, were analyzed by PCR. Amplification of stool DNA with 
primers DIVA-1 and DIVA-2 allowed the identification of vaccinated animals with ΔXIII 
strain. Amplification with primers invA-fw and invA-rv served as a control of the presence of 
Salmonella DNA. Results shown are representative of results obtained throughout time, 
since Salmonella DNA was present in faecal samples since day one post infection.  
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Survival of ΔXIII in the environment 
One important drawback of live attenuated vaccines is that the strain, 
once excreted by vaccinated animals, may persist for long periods in the 
environment. To determine whether this might be a handicap to the use of 
ΔXIII strain, phenotypic traits involved in environmental persistence, such as 
resistance to desiccation in the absence of nutrients and biofilm formation 
were assessed.  
Results showed that almost 100% of wild type bacteria remained 
viable after 12 days under waterless conditions. On the contrary, both 
ΔrpoS and ΔXIII strains showed to be dramatically sensitive to desiccation, 
since, at the end of the experiment, there were not any live bacteria left (Fig 
7A). Biofilm formation capacity was analyzed by incubating bacteria in LB 
broth under static and room temperature conditions for 72 hours and also, 
by analyzing colony morphology on plates containing the Congo Red dye 
(Fig. 7B). ΔrpoS and ΔXIII strains did not form a biofilm in LB and showed a 
“saw” (smooth and white) morphotype, which corresponds with the inability 
to produce cellulose and fimbriae, the main components of the Salmonella 
biofilm matrix, and thus a total absence of multicellular behavior.  
These results demonstrate that ΔXIII might be easily eliminated from 
the environment when excretion by vaccinated animals occurs.  
 
  
Results 
127 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 7. ΔXIII strain is unable to form a biofilm and does not survive after twelve 
days of desiccation in the absence of nutrients. (A) Survival of the wild type strain, new 
ΔXII (absence of c-di-GMP), the single ΔrpoS mutant and the vaccine candidate ΔXIII after 
twelve days of desiccation. Surviving bacteria were enumerated by viable plate counts, and 
their numbers were compared with those of initial inocula, which defined 100% survival. 
Means and standard deviations of results from three independent experiments are shown. 
(B) Biofilm formation capacity of the same strains. Biofilm phenotypes were visualized after 
growth in LB medium conditions and on congo red agar plates. 
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DISCUSSION 
C-di-GMP is recognized as a universal bacterial second messenger 
implicated in the regulation of a large number of cellular functions, including 
cell cycle progress, differentiation, biofilm formation and dispersion, motility 
and virulence. As regards virulence, it is generally assumed that high levels 
of c-di-GMP in bacterial cells promote biofilm formation and the 
establishment of chronic infections, whilst low c-di-GMP levels promote 
virulence factor synthesis and thus, acute infections (Tamayo et al., 2007; 
Povolotsky and Hengge, 2012; Römling et al., 2013). In contrast to this 
general view, our results with new ΔXII strain, which lacks all GGDEF 
domain proteins and thus cannot make c-di-GMP, have demonstrated that, 
in Salmonella, absence of c-di-GMP signaling is detrimental for the 
development of an acute infection. Virulence decrease shown by ΔXII strain 
was subtle but consistent enough to indicate that either an specific GGDEF 
domain protein or a certain c-di-GMP related phenotype or c-di-GMP itself 
might be required at some stage of the Salmonella acute infection. These 
results are in line with recent evidences that are revealing a more 
complicated picture about the relationship of the c-di-GMP network and 
virulence than expected. Individual mutants in not only c-di-GMP degrading 
enzymes (phosphodiesterases; PDEs) but also synthesizing enzymes 
(diguanylate cyclases; DGCs) have shown to display attenuation in infection 
models (Kulasakara et al., 2006; Ahmad et al., 2011; Allombert et al., 2014), 
suggesting that  opposite c-di-GMP-metabolizing processes might play a 
role at different disease stages (Römling et al., 2013). Also, putative DGCs 
and PDEs with no c-di-GMP metabolizing activity have been described to 
affect virulence (Shang et al., 2009; Stewart and Cummings, 2011; Ahmad 
et al., 2013; Spurbeck et al., 2013; Yang et al., 2014). Accordingly, virulence 
defect of ΔXII strain might be explained by the fact that several Salmonella 
GGDEF domain proteins harbor a degenerated consensus signature and 
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might somehow control virulence independently of c-di-GMP levels. With 
respect to the participation in virulence of a particular c-di-GMP controlled 
phenotype, we showed in a previous study that production of cellulose is not 
involved in the virulence of S. Enteritidis in BALB/c mice infected orally or 
intraperitoneally (Solano et al., 2002). However, a very recent report by 
Pontes et al. (Pontes et al., 2015) has demonstrated that Salmonella makes 
cellulose inside macrophages and that its synthesis hinders Salmonella 
replication inside host cells. Thus, a cellulose mutant strain was 
hypervirulent in C3H/HeN mice injected intraperitoneally. In any case, 
results of both studies do not correspond with results obtained here which 
show that ΔXII strain, that cannot synthesize cellulose, is less virulent than 
the wild type strain. Hence, virulence defect of ΔXII strain cannot be 
attributed to a lack of cellulose synthesis. With regard to the direct 
contribution of c-di-GMP to virulence, it is known that it binds to the 
eukaryotic proteins STING and DDX41 (Woodward et al., 2010; Burdette et 
al., 2011; Parvatiyar et al., 2012; Valle et al., 2013), leading to induction of 
type I interferons and thus, apparently contributing to successful pathogen 
elimination. This fact, again, does not agree with ΔXII strain being less 
virulent than the wild type strain. On the contrary, ΔXII virulence attenuation 
might be related to a very recent research of Li et al. (Li et al., 2015) finding 
that c-di-GMP directly binds to human siderocalin (LCN2). LCN2 sequesters 
bacterial siderophores to prevent iron acquisition and inhibit bacterial growth 
under iron-limited conditions (Goetz et al., 2002; Flo et al., 2004). Li et al. 
showed that c-di-GMP competes with bacterial siderophores to bind to 
LCN2, therefore, preventing LCN2 from inhibiting bacterial growth. These 
results indicated that c-di-GMP interferes with LCN2 to ensure bacterial 
survival during infection and that inhibition of c-di-GMP production should 
attenuate virulence. Further detailed analysis of the contribution of the c-di-
GMP signaling network to Salmonella virulence will be required to figure out 
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the reasons why ΔXII strain presents an attenuated phenotype. 
Once we cleared up the effect of the absence of c-di-GMP signaling in 
Salmonella virulence, and with the final aim of constructing a novel vaccine 
candidate, we performed a mutation of the rpoS gene in ΔXII, giving rise to 
strain ΔXIII. Absence of all GGDEF domain proteins and also of RpoS had a 
synergistic attenuating effect that made ΔXIII extremely safe and capable to 
protect vaccinated mice from a lethal dose challenge of a wild type S. 
Typhimurium strain. The cross-talk between T and B cells is of fundamental 
importance for the establishment of solid acquired immunity to salmonellosis 
(Mastroeni and Ménager, 2003). Accordingly, mice protection with ΔXIII 
strain was found to occur via different immune responses including 
Salmonella-specific IgGs that showed a moderate opsonic activity and high 
levels of the pro-inflammatory cytokines IFN-γ, TNF-α, IL-2, IL-17 and also 
of the anti-inflammatory cytokine IL-10. IFN-γ has a crucial role for clearing 
infections caused by intracellular bacteria, given that its major effect is 
macrophage recruiting and that activation and high titters of this cytokine 
generally implies a strong immune response that is accompanied by T-
lymphocyte expansion (Mastroeni et al., 2000; Dougan et al., 2011). Thus, 
mice treated with anti- IFN-γ antibodies and also, mice and humans 
genetically deficient in immunity mediated by IFN-γ are highly susceptible to 
Salmonella (Muotiala and Mäkelä, 1990; VanCott et al., 1998; Jouanguy et 
al., 1999). With respect to IL-17, it is emerging as a central element of 
mucosal immunity to microbial challenge since it enhances basic innate 
barrier defenses such as antimicrobial peptide production and neutrophil 
recruitment (Rubino et al., 2012). Accordingly, S. Typhimurium-infected IL-
17-receptor-A-deficient mice have lower amounts of inflammatory cytokines, 
less neutrophil recruitment and increased bacterial translocation to the 
spleen and mesenteric lymph nodes (Raffatellu et al., 2008). On the other 
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hand, IL-10 is a well-characterized anti-inflammatory cytokine that inhibits 
synthesis of Th1 cytokines and proliferation of T cells, preventing the 
detrimental consequences of systemic inflammation (Moore et al., 2001). 
The presence of IL-10 in ΔXIII immunized animals suggests that the 
immune response was tightly balanced (Schulte et al., 2011; Voinnet, 2011) 
and that ΔXIII might exploit the immunosupresive effects of IL-10 to persist 
in mice organs, eliciting a long-lasting immunity (Cyktor and Turner, 2011).  
Up to date there is no ideal vaccine available for control of 
salmonellosis in farm animals. Such a vaccine should be cheap, minimally 
reactive and preferably live and invasive but still safe to induce strong 
immunity (Singh, 2009). Furthermore, the use of attenuated vaccines as 
veterinary drugs can only be recommended if differentiation of vaccinated 
from infected animals (DIVA) is feasible in a basic bacteriology laboratory 
(Selke et al., 2007; Singh, 2009). In response to this need, antigenic, 
genetic and phenotypic markers have been incorporated into or eliminated 
from attenuated vaccines (Henderson, 2005; Leyman et al., 2011). 
However, bacterial “tagging” is normally achieved through genetic 
engineering methods and serious concerns are being raised about the 
effects that genetically modified microbes (GMMs) may have if massively 
used or released into the environment (Moe-Behrens et al., 2013). In order 
to avoid the use of antibiotic markers, ΔXIII strain is the result of thirteen 
consecutive deletion steps in which an allelic exchange strategy with sacB 
as the counterselectable marker was used (Solano et al., 2009; Zorraquino 
et al., 2013). Thus, ΔXIII does not contain any trace of exogenous DNA and 
is indistinguishable from a naturally occurring mutant, fact that eludes its 
classification as a GM organism according to the European Directive [EC] 
2001/18.  Amongst the thirteen candidates to become a negative selectable 
marker, we found several reasons for choosing the GGDEF protein 
SEN4316. In contrast to other GGDEF proteins, SEN4316 is conserved in 
Discussion 
133 
all S. enterica serovars and thus, it can be considered a “broad spectrum” 
marker since seroconversion is likely to occur upon infection of animals with 
any Salmonella serovar, thereby activating the DIVA function (Selke et al., 
2007). On the other hand, E. coli and other gram negative species lack this 
member of the GGDEF family (data not shown). We designed a SEN4316 
based ELISA that allowed the serological discrimination of vaccinated from 
infected mice. In addition, and since such DIVA strategy identifies infected 
animals, we developed a very simple molecular method to positively identify 
vaccinated animals. However, its application would be restricted to the 
period of time in which the vaccine is present in faeces.  
Because live vaccines can be potentially excreted into the environment 
by immunized animals, another condition of increasing interest in vaccine 
development is the easiness to eliminate it from the environment (Leyman 
et al., 2012; Desin et al., 2013). Undoubtedly, this is one of the strengths 
when considering ΔXIII strain as a live vaccine candidate since it is totally 
incapable of synthesizing a protective biofilm matrix and lacks RpoS, a 
regulator that is indispensable to mount an adequate response against 
environmental stresses.  Accordingly, less than two weeks were sufficient to 
end up with 100% of ΔXIII bacteria under waterless conditions. 
Salmonella mutants of reduced virulence that still display high 
immunogenicity have already been described (Denagamage et al., 2007; 
Karasova et al., 2009; Arguello et al., 2012; Desin et al., 2013). We propose 
that the c-di-GMP signaling and RpoS defective Salmonella strain described 
here, which shows a delicate safety-immunogenicity balance, promising 
DIVA features and can be easily eliminated from the environment is a 
noticeable new candidate to include in this list. Future work will be 
conducted to analyze its potential use in field vaccination trials.  
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Fig. S1. Representative IFN-γ  and TNF-α /CD4 staining for ΔXIII stimulated 
splenocytes. 28 days after immunization, splenocytes from control and ΔXIII immunized 
mice were plated and stimulated for 6 hours with medium, 106 or 107 cfu of heat-killed ΔXIII 
bacteria. Cells were surface stained with anti-CD4-FITC antibody and intracellularly stained 
with anti IFN-γ-PE and anti-TNF-α-PE-Cy7 mAbs. Shown are percentages of IFN-γ and 
TNF-α cells out of total CD4+ T cells.  
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SUMMARY 
The endoplasmic protein stimulator of IFN genes (STING) has been 
recognized as an eukaryotic cyclic diguanylate monophosphate (c-di-GMP) 
receptor. Upon c-di-GMP sensing, STING activates a signaling cascade to 
stimulate a type I interferon response. Therefore, synthetic c-di-GMP has 
been shown to be a potent stimulator of innate immunity in eukaryotic 
organisms and thus, there has been an ongoing focus on using c-di-GMP as 
an adjuvant to improve vaccine efficiency. However, whether the c-di-
GMP/STING pathway functions in host defense mechanisms against 
pathogens with the ability to synthesize c-di-GMP is an issue that remains 
unclear. Salmonella is a facultative intracellular pathogen that produces c-
di-GMP to control critical cellular processes such as biofilm formation, 
motility and virulence. A Salmonella strain unable to synthesize c-di-GMP, 
named ΔXII is biofilm-deficient and shows a moderate attenuation in 
virulence. Here, through the use of STING-/- bone marrow-derived 
macrophages and STING-/- mice we report that, Salmonella stimulates the 
IFN response via STING in murine macrophages independently of c-di-
GMP. On the other hand, STING deficient mice were equally susceptible 
than wild type mice to a Salmonella infection in a systemic murine infection 
model. Altogether, our results indicate that the c-di-GMP/STING pathway 
does not play a significant role in host defense against a Salmonella 
infection. 
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INTRODUCTION 
Innate immunity is the first line of defense against infection. It 
recognizes and provides nonspecific defense against pathogens. The 
recognition depends on receptors (pattern-recognition receptors, PRRs) that 
bind molecules expressed by microbial organisms that are chemically 
different from those produced by host cells (pathogen-associated molecular 
patterns, PAMPs) (Iwasaki and Medzhitov, 2010). Thus, binding of the 
PAMP to the PRR triggers signaling pathways not only to alert the immune 
system to the presence of infection but also to initiate adaptive immune 
responses through activation of dendritic cells and antigen presentation 
(Medzhitov and Janeway, 2000). Recent studies have shown that bacterial 
cyclic dinucleotides (c-di-NMPs) act as PAMPs eliciting a host type I 
interferon (IFN) innate immune response characterized by activation of IFN 
production (McWhirter et al., 2009; Woodward et al., 2010; Abdullah et al., 
2012; Burdette and Vance, 2013). Such bacterial c-di-NMPs include cyclic 
diguanylate monophosphate (c-di-GMP), cyclic diadenylate monophosphate 
(c-di-AMP) and 3´3´ cyclic-GMP-AMP (cGAMP) (Woodward et al., 2010; 
Davies et al., 2012; Burdette and Vance, 2013). Two distinct PRRs able to 
directly bind bacterial c-di-NMPs and mediate the induction of type I IFN 
have been described. Binding of c-di-NMPs to a dimer of the stimulator of 
interferon genes (STING) results in the activation of the IRF3 transcription 
factor, which is required for host transcriptional activation of type I IFNs 
(Sauer et al., 2011; Jin et al., 2011; Burdette et al., 2011). More recently, 
DDX41, a DEAD-box helicase, has been shown to directly bind c-di-NMPs 
and mediate the induction of IFN through a pathway that likely converges 
upstream of STING (Parvatiyar et al., 2012; Bowie, 2012). Remarkably, 
STING dependent type I IFN production can also be strongly induced by an 
eukaryotic endogenous cyclic nucleotide. A very recently identified cytosolic 
DNA sensor, cGAS (cyclic-GMP-AMP synthase), is activated upon binding 
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to DNA and as a consequence, produces an unusual cyclic dinucleotide, 
2´3´ cyclic-GMP-AMP (cGAMP), from ATP and GTP substrates. The 
cGAMP product then acts as a second messenger by binding and activating 
STING (Sun et al., 2013; Wu et al., 2013; Shi et al., 2015) (Fig. 1). 
Studies for evaluating the immunostimulatory and immunomodulatory 
properties of c-di-AMP and c-di-GMP confirm that these molecules exhibit 
potent adjuvant properties (Hu et al., 2009; Chen et al., 2010; Libanova et 
al., 2011; Blaauboer et al., 2014). With regard to c-di-GMP, its direct 
administration as a pure molecule has been shown to induce innate immune 
responses that can enhance protection of mice against challenges with 
Klebsiella pneumonia (Karaolis et al., 2007), Staphylococcus aureus 
(Brouillette et al., 2005; Hu et al., 2009), Bordetella pertussis (Elahi et al., 
2014), Acinetobacter baumannii (Zhao et al., 2011) and Streptococcus 
pneumoniae (Yan et al., 2009). Also, bacterial diguanylate cyclases have 
been incorporated into adenovirus vaccines in order to foster production of 
c-di-GMP as well as proinflammatory responses in mice (Koestler et al., 
2014; Alyaqoub et al., 2016).	
In spite of these already known immunostimulatory properties of c-di-
NMPs as adjuvants, there is little information about these dinucleotides 
being actually produced in vivo, during a bacterial infection process, and 
also about their exact role in pathogenicity. On one hand, c-di-NMPs would 
need to be released from bacteria at sufficient levels to activate host 
receptors. In the case of c-di-AMP, it has been shown that Listeria 
monocytogenes releases this nucleotide to the cytoplasm through two major 
multidrug resistance (MDR) efflux pumps (Woodward et al., 2010). 
However, with respect to c-di-GMP, there is no evidence suggesting the 
secretion of this nucleotide outside bacteria. On the other hand, there is 
currently not any developed method to measure the accumulation of c-di-
NMPs in infected tissues and thus, it is difficult to provide evidence of c-di-
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NMPs production during in vivo bacterial infections. One remarkable step 
forward in the analysis of c-di-NMPs role during infection and their 
interaction with the immune system has been the generation of STING 
mutant mice (Goldenticket or Gt mice) (Sauer et al., 2011). This mouse 
strain harbors a point mutation (T596A) in STING that results in an 
isoleucine-to-asparagine substitution (I199N) in the STING protein, 
rendering a nonfunctional allele that fails to produce detectable protein. Gt 
bone marrow-derived macrophages do not make IFN-β in response to either 
purified c-di-GMP and c-di-AMP or to Listeria monocytogenes infection 
(Sauer et al., 2011; Woodward et al., 2010). Gt mouse lung fibroblasts fail to 
induce a type I IFN response to Chlamydia trachomatis, which also 
synthesizes c-di-AMP (Barker et al., 2013). However, although Gt mice 
present a significantly lower amount of IFN-β in the serum during a L. 
monocytogenes infection, they present a bacterial burden in spleens similar 
to wild type mice and thus, are not significantly more resistant to this 
bacterial infection (Sauer et al., 2011).  
In summary, there is convincing support for the idea that c-di-NMPs 
are detected by the innate immune system as a novel PAMP type. However, 
a deeper insight into the mechanisms of c-di-NMPs detection by the host 
cell and the role that bacterial c-di-NMPs play during infection is needed. In 
the previous chapter, we described that a Salmonella strain unable to 
synthesize c-di-GMP, the ΔXII strain, is slightly less virulent than the wild 
type strain. Therefore, we decided to investigate whether this attenuation 
had a connection with the STING recognition pathway, and the role, if any, 
of the STING signaling pathway during Salmonella infection, making use of 
Gt bone marrow-derived macrophages and Gt mice. 
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Fig. 1: Stimulation of type I IFN production through DDX41 helicase, cGAS and 
STING activation by c-di-NMPs and DNA during bacterial infections. Bacterial 
infections of eukaryotic cells lead to accumulation of cyclic dinucleotides and/or 
extracellular DNA that signal the presence of pathogens to the cellular immune system. A) 
Bacterial cyclic dinucleotides, that include c-di-AMP (cdAMP), c-di-GMP (cdGMP), and 3´-
5´,3´-5´cGAMP (cAMP-GMP) interact with DDX41 helicase and STING. B) Cytosolic 
dsDNA is recognized by DDX41 and cGAS inducing the production of 2´-5´, 3´-5´cGAMP to 
stimulate STING. Binding of STING to an activating ligand induces conformational changes 
in STING and the following STING relocation to discrete foci in the cell cytosol. Activated 
STING recruits TBK1 and IKK kinases, which in turn activate IRF-3, STAT6, and NF-kB. 
Upon translocation of activated transcriptional factors to the nucleus, they bind to their 
corresponding promoters, resulting in induction of type I IFN and cytokines. 
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MATERIAL AND METHODS 
Bacterial strains and culture media 
The wild type strain S. enterica subsp. enterica serovar Enteritidis 
3934 (S. Enteritidis 3934) and its derivative ΔXII strain were grown in LB 
broth. The strains and oligonucleotides used in this chapter are described in 
Table 1. The media used for bone marrow macrophages differentiation is 
detailed below:  
Bone Marrow Macrophage Differentiation Media (BMDM) 
Iscove´s modified MEM (Invitrogen) 500 ml 
DFBS (Gibco) 50 ml 
L-cell conditionated media 150 ml 
100x Non-essential amino acids (Gibco) 5 ml 
50 mM b-mercaptoethanol(Gibco) 0,45 ml 
100x Penicillin/Streptomicin (Gibco) 5 ml 
 
L-cell Conditioned Media 
2,5 x105 L-cells were seeded on 75 cm2 flask containing 50 ml of IMEM 
media supplemented with 10% FBS and 1% Penicillin/Streptomycin. When 
cells reached confluency (6-7 days), media was harvested, filtered and 
stored at 4ºC until use.  
 
Extraction and culture of Bone Marrow Derived Macrophages 
(BMDM) 
Bone marrow-derived macrophages (BMDM) were prepared form 
femurs of C57BL/6J wild type and STING-/- mice. Femurs and tibias were 
surgically removed, freed from muscles and tendons, and briefly suspended 
in PBS. Ends were cut, the marrow was flushed with PBS and the cell 
suspension was filtered over a 70-µm cell strainer (BD Falcon) and 
centrifuged for 5 min at 1800 rpm. Red blood cells were removed using ACK 
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(Ammonium-Chloride-Potassium) lysing buffer. After two washes, cells were 
resuspended at a concentration of 1x106 ml-1 in Bone Marrow Macrophage 
Differentiation Media, seeded in tissue treated plates and incubated at 37ºC 
with 5% CO2. Two days after, media was changed and cells were incubated 
again during two days. On day 5, adherent cells were harvested, 
centrifuged, washed, and resuspended in Roswell Park Memorial Institute 
1640 medium (RPMI) (Gibco) supplemented with 10% FBS (Invitrogen) and 
1% Penicillin/Streptomycin (Gibco). After counting the cells, macrophages 
were seeded at a density of 5 x 105 cells per well in 12-well plates, 24 h 
prior to infection.  
 
Macrophages infection:  bacterial uptake and survival 
Bone marrow derived macrophages (BMDMs) from C57BL/6J wild 
type and STING-/- mice were propagated in (RPMI) (Gibco) supplemented 
with 10% fetal bovine serum (Invitrogen) and 1% Penicillin/Streptomycin 
(Gibco). Macrophages were seeded at a density of 5 x 105 cells per well in 
12-well plates 24 h prior to infection. Salmonella overnight cultures grown at 
37ºC in LB broth were sonicated (30 sec; potency 3; Branson sonifier 250; 
microtip) and diluted 1:100 in LB broth. Cultures were incubated at 37ºC in 
an orbital shaker (200 r.p.m) to an OD600nm of 1 and the suspension was 
sonicated again and washed twice with RPMI deprived of serum. 
Macrophages were then infected with Salmonella strains at a multiplicity of 
infection of approximately 10:1 and plates were centrifuged at 1000 r.p.m. 
for 10 minutes at room temperature. After 20 min of phagocytosis, 
monolayers were washed twice with PBS and treated with gentamicin (100 
µg ml-1) for 2 h. To estimate phagocytosed bacteria, samples were then 
washed three times with sterile PBS and macrophages were lyzed with 1% 
(vol/vol) Triton X-100-PBS to release intracellular bacteria that were counted 
by plating 25 µl of serial dilutions onto LB plates. To assess bacterial 
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survival, medium was replaced by RMPI supplemented with 10% FBS and 
12 µg ml-1 gentamycin and the cells were incubated at 37ºC. After 2 h, wells 
were washed twice with PBS and treated with Triton X-100 as indicated 
above. Experiments were done in triplicate on three independent occasions. 
 
Macrophages immune response: determination of cytokines 
BMDMs were infected as described above. Two and four hours after 
bacterial uptake, cells were collected for RNA extraction and cytokines 
levels were determined by qRT-PCR. Total cellular RNA was isolated using 
RiboPureTM RNA Purification Kit (Ambion™) according to the 
manufacturer’s instructions. One microgram of each RNA sample was 
subjected per duplicate to 0,3 U/µl of DNAse TURBO DNA-FreeTM (Ambion) 
treatment for 30 min at 37ºC. The enzyme was inactivated at 65ºC in the 
presence of EDTA 0.25 mM during 10 min. The RNA samples were reverse 
transcribed in the presence of the enzyme M-MLV (Moloney Murine 
Leukemia Virus) Reverse Transcriptase (Applied Biosystems) according to 
the manufacturer’s instructions. 
qRT-PCR was performed in 96-well microplates using GoTaq® qPCR 
Master Mix (Promega) and 1µg of cDNA. Amplification and detection of the 
PCR products were performed using a C1000 Thermal Cycler (BioRad) with 
an initial denaturation at 95º C for 10 min and 40 cycles at 95º C for 15 s, 
60ºC for 1 min and 72ºC for 25 s. Each sample was subjected to qRT-PCR 
in duplicate and the mean values of the duplicates were used for 
subsequent analysis. The Ct values of the genes of interest were 
normalized (ΔCt) to an average Ct value of the house-keeping gene 
(GAPDH) and the relative expression of the gene of interest was calculated 
as 2−ΔCt. These expression levels were used for data analysis. Primers used 
in qRT-PCR are listed in Table 1. 
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Mice 
C57BL/6J-Tem173gt/J heterozygous transgenic mice (named as 
Goldenticket) were purchased from Jackson Laboratory and supplied from 
the Gene Therapy lab of the Center for Applied Medical Research (CIMA). 
These Tem173gt/J chemically induced mutant mice carry a missense 
mutation in exon 6 of the transmembrane protein 173 (TMEM173 or STING) 
gene, which results in an isoleucine to asparagine change in aminoacid 199 
(I-199-N), in the C-terminal of the protein, that functions as a null allele and 
fails to produce detectable protein (Sauer et al., 2011). The heterozygous 
mice were interbred to obtain wild type and golden ticket homozygous litter-
mates. Genotypes of mice were determined from ear tissue by genomic 
PCR with STING Fw and STING Rv oligonucleotides using a KAPA Mouse 
Genotyping Kit (KAPA Byosistems). DNA sequencing allowed differentiation 
of wild type (T596) and golden ticket mice (A596). Mice were bred and 
maintained under pathogen-free conditions in the animal facility of CIMA. 
The experimental design was approved by the Ethical Committee for Animal 
Testing of the University of Navarra (Ethical protocol 130-12). 
 
Ileal loop infection assay 
To compare the in vivo interaction of Salmonella strains with murine 
intestinal epithelial cells of wild type and STING-/- mice, the ligated ileal loop 
infection model was used as described previously, (Solano et al., 2002) 
(Latasa et al., 2005). Strains were incubated overnight under shaking 
conditions at 37ºC, suspended in PBS and sonicated (30 sec; potency 3; 
Branson sonifier 250; microtip) prior to infection. Each ileal loop was 
infected with only one strain to avoid possible interferences of strains with 
the host immune response during a coinfection experiment.  
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Colonization experiments 
Colonization experiments were carried out with 8-week-old female 
C57BL6/J and C57BL6/J STING-/- mice in the animal facility of CIMA. In the 
case of intragastric inoculation, food and water were removed, twelve and 
two hours respectively, before the administration of bacterial suspension. 
Mice were prefed with 20 µl of 10% sodium bicarbonate 30 min before 
bacterial inoculation. Water and food were again supplied right after 
inoculation. 
Strains were incubated overnight under shaking conditions at 37ºC, 
suspended in PBS and sonicated (30 sec; potency 3; Branson sonifier 250; 
microtip) prior to infection. Mice were inoculated intraperitoneally (i.p) or 
intragastrically (i.g) with 100 µl of bacterial suspensions containing 1 x 104 
cfu or 1 x 108 cfu, respectively. The cfu of each strain in the inoculum (input) 
were quantified by plating dilution series on LB. Mice were euthanized after 
three days (i.p) or five days (i.g), and then dilution series of liver, spleen and 
gallbladder lysates were plated on LB agar for enumeration of cfu.   
 
Statistical analyses 
All statistical analyses were performed in GraphPad Prism 5.01. using 
a two-way analysis of variance combined with the Bonferroni test.  
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Table 1. Strains and oligonucleotides used in this study 
Strain  Relevant characteristics MICa Reference or source 
S. Enteritidis 3934 Wild-type clinical isolate 54 (Solano et al., 1998) 
S. Enteritidis ΔXII 
3934 ΔadrA Δsen1023 ΔyeaJ 
ΔyciR ΔyegE ΔyfiN Δyhda 
Δsen3222 ΔyhjK Δsen2484 
ΔyfeA Δsen4316 
1324 
(Zorraquino et al., 
2013) 
 
 
Oligonucleotides for qPCR analysis of INF-β and TFN-α 
Primer  Sequence 5´à3´   
IFN-β Fw ATGAGTGGTGGTTGCAGGC 
IFN-β Rv ACCTTTCAAATGCAGTAGATTCA 
TNF-α Fw CTTCCAGAACTCCAGGCGGT 
TNF-α Rv GGTTTGCTACGACGACGTGGG 
GADPH Fw TGCACCACCAACTGCTTA 
GADPH Rv GGATGCAGGGATGATGTTC 
STING Fw GCTCCAGGCCCGGATCCGAATG 
STING Rv CTGTTGGAATAAACCCGATTC 
 
aNumber of each strain in the culture collection of the Laboratory of Microbial Pathogenesis, 
Navarrabiomed-Universidad Pública de Navarra. 
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RESULTS 
Salmonella DNA recognition by STING induces IFN-β production 
in macrophages independently of c-di-GMP.  
Many intracellular pathogens induce expression of type I interferons 
through recognition of bacterial PAMPs by PRRs located at the cell surface 
and in the cytosol (Trinchieri, 2010). C-di-NMPs either produced by invading 
bacterial pathogens (such as c-di-AMP and c-di-GMP) or produced 
endogenously in response to foreign DNA (cGAMP) trigger type I IFN 
induction through direct interaction with the endoplasmic reticulum 
membrane protein STING (McWhirter et al., 2009; Woodward et al., 2010; 
Burdette et al., 2011; Sun et al., 2013). 	
To test the role of STING during a Salmonella infection and to evaluate 
the involvement of the lack of c-di-GMP in ΔXII strain attenuation, primary 
murine bone marrow-derived macrophages (BMDMs) were isolated from 
wild-type C57BL/6 and STINGgt/gt (STING-/-) mice and infected with the wild 
type S. Enteritidis strain 3934 or its derivative, ΔXII strain. Bacterial uptake 
and accumulation of IFN-β-mRNA was analyzed two and four hours post 
infection. Results showed that both strains were phagocytosed at similar 
rates and survived equally in wild type and STING-/- macrophages, 
indicating that neither the absence of c-di-GMP nor STING interfere with 
bacterial phagocytosis and survival (Fig. 2A). Two hours post infection, both 
strains induced significantly higher levels of IFN-β-mRNA in wild-type than 
in STING-/- BMDMs (Fig. 2B). These results suggested that induction of IFN-
β production by Salmonella wild type and ΔXII strains was due to exposure 
of DNA in the cytosol and also that endogenous levels of c-di-GMP were not 
a contributor in triggering this response during macrophage infection. 
Since c-di-GMP has also been shown to stimulate the STING-
dependent induction of TNF-α when used as a nasal mucosal adjuvant 
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(Blaauboer et al., 2014) and TNF-α together with other cytokines play a 
critical role in controlling Salmonella infection and the rate of growth 
(Dougan et al., 2011), we then analyzed the STING mediated TNF-α 
production in the samples described above. Salmonella wild type and ΔXII 
strains induced high levels of TNF-α-mRNA both in wild-type and in   
STING-/- BMDMs (Fig. 2B), indicating that this TNF-α induction was related 
neither to STING nor to c-di-GMP. 
Altogether, these results suggest that a Salmonella infection triggers 
induction of IFN-β production in macrophages that is independent of the 
presence of c-di-GMP and specific to the STING/TBK1/IRF3 pathway.   
Results 
159 
 
 
Fig. 2. Macrophage infection with Salmonella triggers induction of IFN-β 
production independently of c-di-GMP. A) WT and STING deficient bone marrow 
derived macrophages (BMDMs) were infected with Salmonella wild type and ΔXII strains at 
a multiplicity of infection (MOI) of 10 for 2 and 4 h and CFU were determined. B) Relative 
levels of expression of INF-β and TNF-α mRNA by WT and STING deficient BMDMs 2h 
and 4h postinfection with wild type and ΔXII strains. Mock representes cytokine levels of 
uninfected cells as a control. (n = 3 independent experiments). Statistical significance was 
determined using a two-way analysis of variance combined with the Bonferroni test. *P< 
0.05; **P< 0.01; ***P<0.001.  
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ΔXII mutant attenuation is not a result of c-di-GMP/STING 
recognition 
To further study how Salmonella and host cells use c-di-GMP and 
STING as a virulence factor and receptor of the innate immune system, 
respectively, we evaluated Salmonella wild type and ΔXII strains virulence 
in wild-type C57BL/6J and STING-/- mice.   
Salmonella infections are usually initiated by ingestion of contaminated 
food or water followed by the passage of the bacteria from the stomach to 
the intestine. There, bacteria adhere and invade intestinal epithelial cells. 
Thus, we firstly compared the interaction of wild type and ΔXII strains with 
C57BL/6J and STING-/- mice intestinal epithelial cells, using the ligated ileal 
loop infection model (Solano et al., 2009; Latasa et al., 2016). The wild type 
strain showed a similar capacity to adhere and invade the intestinal 
epithelium of wild type and STING-/- mice, indicating that STING does not 
play a relevant role in the host during this step of infection. Accordingly, the 
ΔXII strain also invaded equally intestinal epithelial cells of wild type and 
STING-/- mice (Fig. 3). 
 
 
Fig. 3. The c-di-GMP/STING pathway does not play a significant role in the capacity of 
Salmonella to adhere and invade the intestinal epithelium. Adhesion and internalization rates of 
wild type and ΔXII strains using ileal loop infection experiments in wild type C57BL/6J (white bars) 
and STING-/- (black bars) mice. Seven ileal loops of each type of mouse were infected with 1x107 cfu 
of wild type or ΔXII strains. Differences between wild type and STING-/- ileal loop colonization were 
statistically analysed by using a two-way analysis of variance combined with the Bonferroni test. *P< 
0.05; **P< 0.01; ***P<0.001.  
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After penetrating the epithelial barrier, Salmonella preferentially infects 
naturally phagocytic cells in the mouse, such as dendritic cells and/or 
macrophages, within the lamina propia that favor dissemination through the 
lymphatics and blood to visceral organs: the mesenteric lymph nodes, 
spleen, and liver (Dougan et al., 2011). Therefore, we then performed 
intraperitoneal infections with the wild type or ΔXII strains in wild-type 
C57BL/6 and STING-/- mice and addressed colonization at systemic sites by 
evaluating organ colonization. Both the wild type and ΔXII strains similarly 
colonized the spleen and liver of wild type and STING-/- mice (Fig. 4A). 
Finally, and in order to determine whether STING is involved in the 
colonization ability of Salmonella after infection by a natural route, we 
performed oral infections of wild-type C57BL/6 and STING-/- mice with the 
wild type or ΔXII strains and determined the number of infecting bacteria in 
the spleen, liver and caecum. Again, both strains colonized to the same 
extent the caecum and deeper tissues of wild-type and STING-/- mice (Fig. 
4B).  
Taken together, these findings indicated that host sensing of either 
DNA or c-di-GMP of Salmonella through the STING protein does not seem 
to play a significant role in the outcome of infection and hence, that ΔXII 
attenuation is not a result of STING-dependent host IFN responses. 
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Fig. 4. The c-di-GMP/STING pathway is not involved in Salmonella organ 
colonization of i.p. and orally infected mice. (A) Colonization and invasiveness of livers 
and spleens from wild type C57BL/6J (white bars) and STING-/- (black bars) mice i.p. 
inoculated with 1x104 cfu/mouse of wild type or ΔXII strains. Bacterial counts were 
performed 72 h after infection. (n = 6). (B) Colonization and invasiveness of spleens, livers 
and caecum from wild type C57BL/6J (white bars) and STING-/- (black bars) mice orally 
inoculated with 1x108 cfu/mouse of wild type or ΔXII strains. Bacterial counts were 
performed 5 days after infection. (n = 6). Differences between wild type and STING-/- mice 
colonization were statistically analyzed by using a two-way analysis of variance combined 
with the Bonferroni test. *P< 0.05; **P< 0.01; ***P<0.001. 
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DISCUSSION 
In a previous study we showed that a Salmonella multiple mutant, 
named ΔXII, deficient in the synthesis of c-di-GMP, presents a moderate 
attenuation in a systemic murine infection model (Latasa et al., 2016), 
indicating that c-di-GMP signaling is needed for the development of an 
acute infection by a wild type strain. Based on these findings, in the current 
study we tried to elucidate whether c-di-GMP recognition by STING and the 
subsequent induction of type I interferons, contributes to Salmonella 
pathogenicity and is therefore related to ΔXII mutant attenuation. We thus 
considered the hypothesis that binding of c-di-GMP, synthesized by a wild 
type strain during infection, to the STING protein might induce the 
production of type I interferons. It is important to note that this is the first 
work that addresses the contribution of the c-di-GMP synthesized by 
Salmonella in triggering an innate immune response via STING during in 
vitro and in vivo infection processes.  
Our results showing that a Salmonella wild type strain induces 
significantly higher levels of IFN-β-mRNA in wild-type than in STING-/- 
BMDMs supported our hypothesis. However, infection of macrophages with 
ΔXII mutant led to similar results indicating that Salmonella DNA rather than 
c-di-GMP activates the STING pathway in murine macrophages. These 
results contrasts with several studies that show a positive correlation 
between c-di-NMPs levels and IFN-I expression during in vitro macrophage 
infection. In this respect, it has been proven that c-di-AMP from Listeria 
monocytogenes (Woodward et al., 2010; Sauer et al., 2011; Jin et al., 2011; 
Watson et al., 2015), Chlamydia trachomatis (Barker et al., 2013) and 
Mycobacterium tuberculosis (Dey et al., 2015) and also c-di-GMP from 
Legionella pneumophila  (Abdul-Sater et al., 2012) activates a host type I 
interferon response in murine cells. With respect to Salmonella, our results 
differ from a previous work that demonstrated that macrophage infection 
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with Salmonella enterica serovar Typhimurium led to normal levels of IFN-β 
mRNA in STING-/- BMDMs, indicating that Salmonella predominantly 
activates type I IFNs via a STING independent mechanism, likely via the 
TLR4/TRIF pathway  (Watson et al., 2015).	
While type I IFNs are potent antiviral signaling molecules, the role that 
they play during a bacterial infection is less clear and appears to depend on 
the bacterial species (Stetson and Medzhitov, 2006; Eshleman and Lenz, 
2014). IFN-β expression protects against Legionella pneumophila 
(Schiavoni et al., 2004; Plumlee et al., 2009), Chlamydia trachomatis 
(Vignola et al., 2010), group B streptococci, pneumococci, and Escherichia 
coli (Mancuso et al., 2007), whereas promotes infection of several 
intracellular bacteria, including Listeria monocytogenes (Auerbuch et al., 
2004; Carrero et al., 2004; O'Connell et al., 2004) and Francisella novicida 
(Henry et al., 2010). In the case of Mycobacterium tuberculosis, there are 
conflicting reports as to whether the IFN-β response is beneficial or 
detrimental to the host during tuberculosis (Manca et al., 2001; Stanley et 
al., 2007; Dey et al., 2015). In most of these cases, the contribution of the c-
di-NMPs-STING pathway to the overall IFN-β response to the in vivo 
bacterial infection remains unclear. STING is required for the type I IFN 
response to L. monocytogenes in vivo (Sauer et al., 2011). However, STING 
deficiency in STING-/- and STING-knockout mice did not impact bacterial 
burdens in infected mice (Sauer et al., 2011; Jin et al., 2011). C-di-AMP also 
mediates IFN-β induction during Mycobacterium tuberculosis infection. Such 
an induction requires STING signaling and is independent of cGAMP. The 
enhanced levels of IFN-β activated by a Mycobacterium tuberculosis strain 
that secretes excess c-di-AMP leads to substantial virulence attenuation in 
mice (Dey et al., 2015). In the case of Salmonella, the induction of type I 
interferon and its role in infection appear to depend on the route of entry 
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(Owen et al., 2016). Intravenous infection with S. Typhimurium elicits a 
robust type I IFN response which drives necroptosis of macrophages and a 
compromised innate immune response (Robinson et al., 2012). In contrast, 
oral infection induces barely detectable IFN-β expression in mice because 
Salmonella suppresses the TRIF-dependent Type I interferon response in 
macrophages as a virulence strategy (Owen et al., 2016). Our in vitro data 
that suggest that IFN-β is produced in wild type BMDMs in response to a 
Salmonella infection do not correlate with in vivo results showing that a wild 
type Salmonella strain colonizes equally wild type and STING-/- mice, 
regardless of the route of entry. Therefore, our data establish that even if 
induction of IFN-β via STING actually occurred in vivo, the 
STING/TBK1/IRF3 pathway is not involved in Salmonella pathogenesis.  
A recent study has shown that Salmonella makes cellulose inside 
macrophages (Pontes et al., 2015) providing evidence of c-di-GMP 
production inside the cell, since cellulose synthesis is absolutely dependent 
on the allosteric activation by this dinucleotide. However, our results indicate 
that c-di-GMP does not play a role in modulating the innate immune 
response since both the wild type strain and ΔXII mutant colonized similarly 
wild type and STING-/- mice. This might be explained by the fact that there is 
no proof of c-di-GMP release from infecting bacteria to the cytosol that 
would allow its binding to STING. On the other hand, similar colonization of 
wild type and STING-/- mice by the wild type strain and ΔXII mutant also 
indicated that ΔXII mutant attenuation is not due to the lack of c-di-GMP 
sensing by STING. Our future studies will explore the reasons behind this 
attenuation. 
In conclusion, analyses of the deviation of the immune response 
through c-di-NMPs accumulation in the host cell and of the consequences in 
the outcome of infection are still very incipient and the results seem to 
largely depend on the bacterial species and the type of c-di-NMP under 
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study. In the case of Salmonella, c-di-GMP binding to its eukaryotic receptor 
STING does not control the outcome of infection and thus, c-di-GMP does 
not seem to be an appropriate target for the treatment and prevention of 
Salmonella diseases.   
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SUMMARY 
Many bacteria build biofilm matrices using a conserved 
exopolysaccharide named PGA or PNAG (poly-β-1,6-N-acetyl-D-
glucosamine). Interestingly, while E. coli and other members of the family 
Enterobacteriaceae encode the pgaABCD operon responsible for PGA 
synthesis, Salmonella lacks it. The evolutionary force driving this difference 
remains to be determined. Here, we report that Salmonella lost the 
pgaABCD operon after the divergence of Salmonella and Citrobacter 
clades, and previous to the diversification of the currently sequenced 
Salmonella strains. Reconstitution of the PGA machinery endows 
Salmonella with the capacity to produce PGA in a cyclic dimeric GMP (c-di-
GMP) dependent manner. Outside the host, the PGA polysaccharide does 
not seem to provide any significant benefit to Salmonella: resistance against 
chlorine treatment, ultraviolet light irradiation and phage infection remained 
the same as in a strain producing cellulose, the main biofilm 
exopolysaccharide naturally produced by Salmonella. In contrast, PGA 
production proved to be deleterious to Salmonella survival inside the host, 
since it increased susceptibility to bile salts and oxidative stress, and 
hindered the capacity of S. Enteritidis to survive inside macrophages and to 
colonize extraintestinal organs, including the gallbladder. Altogether, our 
observations indicate that PGA is an antivirulence factor whose loss may 
have been a necessary event during Salmonella speciation to permit 
survival inside the host. 
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INTRODUCTION 
Escherichia coli and Salmonella enterica are the two core species of 
the family Enterobacteriaceae, that constitutes a diverse group of bacteria 
that generally inhabit the gastrointestinal tract of animals. Although these 
two species are closely related, E. coli comprises commensal bacteria that 
do not normally cause disease, with the exception of certain pathogenic 
clones, whereas all members of S. enterica are considered pathogenic. 
Hence, an intriguing issue regarding bacterial evolution is the identification 
of determinants that make Salmonella able to establish parasitic interactions 
but enable E. coli to establish beneficial interactions with the human host. In 
this regard, it is believed that a combination of different genetic factors 
accounts for such a difference in virulence: first, Salmonella may harbor 
virulence genes that are not present in E. coli; second, Salmonella may 
have lost genes from the ancestral core genome that if present, would 
diminish its pathogenic potential; third, E. coli may carry a virulence 
suppressor gene(s) that interferes with the synthesis and/or stability of a 
virulence protein(s); and fourth, Salmonella and E. coli may differ in the 
regulation of cellular factors important for survival in the host (Ochman et 
al., 2000; Bliven and Maurelli, 2012; Baumler and Fang, 2013). 
An intriguing difference between Salmonella and E. coli that might 
account for their distinctive lifestyles as regards the human host is the 
exopolysaccharide that each species uses to build the biofilm matrix. 
Bacteria spend most of their lives inside a biofilm surrounded by a highly 
hydrated layer that provides protection against desiccation, diffusion of 
antibiotics, toxic metal ions and other compounds, predation by protozoans 
and the host immune system, amongst others (Costerton et al., 1987; 
Flemming and Wingender, 2010). Diversity in biofilm exopolysaccharides 
composition is high, with some bacterial species being able to produce 
different types depending on the environmental conditions (Lembré et al., 
Chapter III 
178 
2012; Flemming et al., 2016). In parallel to such high diversity and for 
reasons that remain unknown, a wide range of phylogenetically distant 
bacteria make use of the same exopolysaccharide to embed themselves 
inside a biofilm. One example of a “universal” exopolysaccharide is 
cellulose, composed of β(1-4)-linked D-glucose units, used by a wide variety 
of bacteria, including both E. coli and Salmonella (Zogaj et al., 2001; Solano 
et al., 2002; Römling and Galperin, 2015), as a significant biofilm matrix 
component. Another example corresponds to a homopolysaccharide 
composed of N-acetylglucosamine with β(1–6) glycosidic linkage (Cywes-
Bentley et al., 2013). Production of this exopolysaccharide was firstly 
described in Staphylococcus epidermidis and S. aureus where it was 
referred to as PIA/PNAG (Mack et al., 1996; McKenney et al., 1998; 
Cramton et al., 1999). Later on, the synthesis of a similar exopolysaccharide 
was also reported in E. coli where it was named as PGA (Wang et al., 
2004), and also in Acinetobacter baumannii (Choi et al., 2009), Klebsiella 
pneumonia (Chen et al., 2014), Bordetella bronchiseptica and B. pertussis 
(Sloan et al., 2007; Conover et al., 2010), Actinobacillus pleuropneumoniae 
(Izano et al., 2007), Yersinia pestis (Bobrov et al., 2008), Burkholderia 
species (Yakandawala et al., 2011) and Bacillus subtilis (Roux et al., 2015). 
In these bacteria, several functions have been ascribed to PGA such as 
surface attachment, intercellular adhesion, biofilm formation, epithelial cell 
attachment, and resistance to antibiotics, antimicrobial peptides and human 
PMNs (Vuong, Kocianova, et al., 2004; Maira-Litran et al., 2005; O'Gara, 
2007; Izano et al., 2008; Choi et al., 2009; Conover et al., 2010; Bobrov et 
al., 2010; Yakandawala et al., 2011; Bentancor et al., 2012). In E. coli, the 
production, modification, and export of PGA requires the machinery 
encoded by the pgaABCD operon (Wang et al., 2004). PgaA and PgaB are 
needed for poly-GlcNAc export and PgaC and PgaD are necessary for poly-
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GlcNAc synthesis (Itoh et al., 2008; Little et al., 2012; Whitney and Howell, 
2013; Steiner et al., 2013). As it generally occurs for bacterial 
exopolysaccharides, PGA synthesis is allosterically activated by the second 
messenger bis-(3’-5’)-cyclic dimeric GMP (c-di-GMP) (Steiner et al., 2013; 
Romling et al., 2013; Pérez-Mendoza and Sanjuán, 2016). Strikingly, 
Salmonella lacks the pgaABCD operon and any identifiable genetic loci 
similar to pga required for PGA synthesis.   
Here, we pursue the reasons that explain why E. coli and Salmonella 
differ in their capacity to produce the PGA exopolysaccharide. We provide 
evidence that production of PGA reduces Salmonella resistance against bile 
salts and its capacity to survive inside macrophages, completely impairing 
the infection cycle and rendering Salmonella avirulent. Together, these 
observations highlight the relevance of gene loss in the adaptation to novel 
pathogenic niches and define the loss of the PGA exopolysaccharide as a 
landmark event during Salmonella speciation. 
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MATERIALS AND METHODS 
 
Phylogenetic analyses 
Protein sequences from E. coli PgaABCD and PhoH were used in a 
Blastp search against the NCBI non-redundant database accessed in July 
2016, using an e-value threshold of 10-5 and excluding from the results hits 
taxonomically assigned to E. coli.  The sequences from the top 500 hits 
were retrieved for each search and aligned using MUSCLE v 3.8 (Edgar, 
2004) and then trimmed using trimAl v1.4 (Capella-Gutiérrez et al., 2009) 
(gap-score cut-off 0.9). A Maximum Likelihood phylogenetic reconstruction 
was performed using  phyML v3.0 (Guindon et al., 2010) with the JTT 
model, setting the number of rate categories to four, and inferring the 
number of invariant positions and the parameters of the gamma distribution 
from the data. Branch support was computed using an aLRT (approximate 
likelihood ratio test) based on a chi-square distribution.  
 
Ethics statement  
Animal studies were performed in accordance with the European 
Community guiding in the care and use of animals (Directive 2010/63/EU). 
Protocols were approved by the ethics committee of the Public University of 
Navarra (Comité de Ética, Experimentación Animal y Bioseguridad of the 
Universidad Pública de Navarra) (approved protocol PI-004/11). Work was 
carried out in the animal facility of the Instituto de Agrobiotecnología, 
Universidad Pública de Navarra. Animals were housed under controlled 
environmental conditions with food and water ad libitum. Mice were 
euthanized by CO2 inhalation followed by cervical dislocation and all efforts 
were made to minimize suffering. 
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Bacterial strains, plasmids and growth conditions  
The strains and plasmids used in this work are described in S1 Table. 
Escherichia coli and S. enterica subsp. enterica serovar Enteritidis (S. 
Enteritidis) cells were grown in LB broth and on LB agar (Pronadisa) with 
appropriate antibiotics at the following concentrations: kanamycin (Km), 50 
µg ml-1; ampicillin (Am), 100 µg ml-1; carbenicillin (Cb), 50 µg ml-1; 
chloramphenicol (Cm), 20 µg ml-1; and streptomycin (Sm) 500 µg ml-1.  
 
DNA manipulations 
Routine DNA manipulations were performed using standard procedures 
unless otherwise indicated. Plasmid DNA from E. coli was purified using a 
Quantum Prep plasmid kit (BioRad). Plasmids were transformed into E. coli 
and S. Enteritidis by electroporation. Transformants carrying Red helper 
plasmids were made electro-competent as described (Solano et al., 2002; 
Blank et al., 2011). Restriction enzymes were purchased from 
ThermoFisher Scientific and used according to the manufacturer’s 
instructions. Oligonucleotides were synthesized by StabVida (Caparica—
Portugal) and are listed in S2 Table. Phage P22 HT105/1 int-201 
(Schmieger, 1972) was used to carry out transductions between strains 
according to recommended protocols (Maloy and Nunn, 1981). 
 
Construction of a collection of strains containing a single GGDEF 
domain protein  
S. Enteritidis 3934 ΔXII is a multiple mutant carrying mutations in all 
genes encoding GGDEF domain proteins (Zorraquino et al., 2013). 
Derivatives of ΔXII containing the following single GGDEF protein encoding 
gene, namely adrA, yeaJ, sen1023, yciR, yegE, yfiN, yhdA, sen3222, and 
yhjK were constructed as described (Solano et al., 2009). In the case of 
ΔXII+sen2484, ΔXII+yfeA and ΔXII+sen4316 strains, DNA fragments 
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corresponding to the coding sequences of sen2484, yfeA and sen4316 
genes were amplified with primer pairs A and D and chromosomal DNA 
from S. Enteritidis 3934 as a template. Amplified fragments were sequenced 
and cloned into the pKO3blue plasmid that was electroporated into ΔXII. 
Integration and excision of the plasmid was performed as described (Solano 
et al., 2009) in order to obtain the corresponding restored strains.  
 
Chromosome expression of adrA under PcL and PphoP promoters  
To express adrA under the PcL constitutive promoter in S. Enteritidis 
3934, a PCR generated linear DNA fragment was used as described 
(Datsenko and Wanner, 2000) with some modifications. The Red helper 
plasmid pKD46 was transformed into S. Enteritidis 3934, and transformants 
were selected on LB agar Am after incubation at 30ºC for 24 h. One 
transformant carrying pKD46 was made electrocompetent as described 
(Solano et al., 2002). A DNA fragment containing a kanamycin resistance 
gene, the PcL promoter and the RBS sequence of the PcL cassette was 
generated by PCR using primers adrA Km PcL rbs Fw and adra Km PcL rbs 
Rv and chromosomal DNA from strain MG1655 Km PcL-λATT-GFP as 
template (Da Re et al., 2007). Electroporation (25 mF, 200 W, 2.5kV) was 
carried out according to the manufacturer’s instructions (Bio-Rad) using 50 
 µl of cells and 1 to 5  µg of purified and dialysed (0.025  µm nitrocellulose 
filters; Millipore) PCR product. Shocked cells were added to 1 ml of LB 
broth, incubated for 1 h at 28ºC and then spread on LB Km agar to select 
KmR transformants after incubation at 37ºC for 24 h. Transformants were 
then grown on LB Km broth at 44ºC for 24 h and incubated overnight on LB 
Am agar at 28ºC to test for loss of the helper plasmid. 
To place the adrA gene under the control of the phoP promoter, a protocol 
described previously was carried out with some modifications (Blank et al., 
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2011). In a first step, primers Km SceI PphoP adrA Fw and Km SceI PphoP 
adrA Rv, with 60-bp homology extensions, were used to amplify a 
kanamycin resistance cassette and an I-SceI recognition site from plasmid 
pWRG717. This DNA was integrated upstream the adrA gene via λ Red-
mediated recombination using plasmid pWRG730, a temperature-sensitive 
plasmid for independent inducible expression of the λ Red recombinase and 
I-SceI endonuclease. After confirming proper insertion of the resistance 
cassette by colony PCR with primers 01-E and Km SceI PphoP adrA Rv, a 
DNA fragment generated by PCR and derived from oligonucleotides PphoP 
adrA Fw and PphoP adrA Rv and S. Enteritidis 3934 chromosomal DNA as 
template, was electroporated into the mutant strain still containing the 
pWRG730 plasmid. This DNA fragment included the phoP promoter and 
homology regions used for its upstream adrA integration. After 1 h of 
incubation at 28°C, 100 µl of a 10-2 dilution was plated on LB agar plates 
containing 500 ng ml-1 anhydrotetracycline, which induced expression of I-
SceI endonuclease. After overnight incubation at 28°C, single colonies were 
purified and successful recombination was checked by monitoring absence 
of antibiotic resistance, colony PCR with oligonucleotides 01-E and PphoP 
adrA Rv, and sequencing of the resulting fragment. Finally, pWRG730 was 
cured by incubating selected colonies at 44°C. 
 
Construction of a Salmonella strain that constitutively expresses 
the pgaABCD operon from the chromosome  
To insert the pgaABCD genes from E. coli K-12 MG1655 into the S. 
Enteritidis 3934 chromosome, the T64B prophage site was chosen 
(Mmolawa et al., 2003). Two DNA fragments, sb13 AB and sb13 CD, of 
∼500 bp length of the S. Enteritidis sb13 gene, were amplified with primer 
pairs SmaI sb13 AB Fw/SphI sb13 AB Rv and SphI sb13 CD Fw/SalI sb13 
Material and methods 
185 
CD Rv, respectively. The PCR products were cloned into the pJET 1.2 
vector (ThermoFisher Scientific) and resulting plasmids were digested with 
SmaI and SphI enzymes in the case of the AB fragment and SphI and SalI 
enzymes in the case of the CD fragment.  AB and CD fragments were 
ligated in the same ligation mixture with the pKO3 vector (Link et al., 1997) 
digested with SmaI and SalI enzymes, resulting in plasmid pKO3::sb13AD. 
The pJET::pga plasmid constructed in this study was digested with SphI to 
obtain a DNA fragment containing the pga promoter and pgaABCD genes. 
Ppga::pgaABCD was ligated with pKO3::sb13AD digested with SphI, 
resulting in pKO3::sb13AD-Ppga::pgaABCD plasmid. Integration and excision 
of the plasmid was used as described (Link et al., 1997) to obtain WT 
Ppga::pgaABCD strain. Insertion of Ppga::pgaABCD into the sb13 gene was 
confirmed by PCR using primers sb13 OK Fw and pgaA comp Rv. The 
ability of this strain to produce PGA was not detectable by Dot Blot, 
probably because heterologous chromosomal expression of the pgaABCD 
operon under its own promoter was not sufficient to produce evident PGA 
levels. Thus, a second Salmonella strain was generated in order to express 
pgaABCD under the PcL constitutive promoter and in the chromosome. To 
do so, a 427 bp DNA fragment, namely sb13 AB2, of the S. Enteritidis sb13 
gene was amplified with primers BglII sb13 AB Fw and BamHI sb13 AB Rv, 
using S. Enteritidis 3934 chromosomal DNA as template, and cloned into 
the pJET 1.2 vector (ThermoFisher Scientific). A second DNA fragment 
containing the PcLrbs promoter (Da Re et al., 2007) and the first 543 bp of 
the pgaA gene coding sequence was constructed by overlapping PCR, 
using two separate PCR products. Primers BamHI PcLrbs Fw and sb13 
PcLpga Rv were used to amplify the PcLrbs promoter, using E. coli MG1655 
Km PcL-λATT-GFP chromosomal DNA as template (Da Re et al., 2007). 
Primers PcL pgaA Fw and PstI PcL pgaA Rv were used to amplify 543 bp of 
the pgaA gene, using E. coli MG1655 chromosomal DNA as template. 
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These two purified PCR products were mixed, and a second PCR using 
BamHI PcL rbs Fw and PstI  PcL pgaA Rv primers was performed to obtain 
a single DNA fragment, PcLrbs::pgaA, that was cloned into the pJET 1.2 
vector (ThermoFisher Scientific). Plasmids pJET::sb13AB2 and pJET:: 
PcLrbs::pgaA were digested with BglII /BamHI  and  BamHI/PstI enzymes, 
respectively, and digestion products were ligated in the same ligation 
mixture with the pKO3Blue vector (Solano et al., 2009) digested with BglII 
and PstI enzymes, resulting in plasmid pKO3Blue::sb13AB2-PcLrbs::pgaA 
that was electroporated in WT Ppga::pgaABCD strain.  Integration and 
excision of the plasmid was used as described (Solano et al., 2009) to 
generate Wt PcLrbs::pgaABCD. Insertion of PcLrbs::pgaABCD into the sb13 
gene was confirmed by PCR using primers sb13 OK Fw and sb13 PcL pgaA 
Rv. Finally, a bcsA mutation was transduced from ΔbcsA strain to generate 
ΔbcsA::CmR PcLrbs::pgaABCD, which is hereafter abbreviated as ΔbcsA 
PcL::pga. 
 
Construction of an E. coli strain that constitutively expresses the 
pgaABCD operon from the chromosome  
To express the pgaABCD operon under the PcL promoter in E. coli 
MG1655, a PCR generated linear DNA fragment and the Red helper 
plasmid pKD46 were used as described above. Primers used to generate 
the DNA fragment containing a kanamycin resistance gene, the PcL 
promoter and the RBS sequence of the PcL cassette were Km PcL rbs pga 
Fw and Km Pcl rbs pga Rv. 
 
Construction of an E. coli MG1655 ΔpgaC mutant  
To delete a 500 bp fragment of the pgaC gene in E. coli MG1655, and 
as a consequence suppress PGA production in E.coli (Wang et al., 2004), a 
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protocol described previously was carried out with some modifications 
(Blank et al., 2011). First, primers pgaC Km SceI Fw and pgaC Km SceI Rv, 
with 60-bp homology extensions, were used to amplify a kanamycin 
resistance cassette and an I-SceI recognition site from plasmid pWRG717. 
This DNA was integrated in the pgaC gene using plasmid pWRG730 
plasmid and integration was confirmed by colony PCR with primers pgaC 
Km SceI Fw and pgaD Rv. Phosphorylated 80-mer double-stranded DNA 
derived from oligonucleotides ΔpgaC Fw and ΔpgaC Rv was electroporated 
into the mutant strain still containing the pWRG730 plasmid. After 1 h of 
incubation at 28°C, 100 µl of a 10-2 dilution was plated on LB agar plates 
containing 500 ng ml-1 anhydrotetracycline, which induced expression of I-
SceI endonuclease. After overnight incubation at 28°C, single colonies were 
purified, and successful recombination was checked by monitoring absence 
of antibiotic resistance and colony PCR with oligonucleotides ΔpgaC Fw 
and pgaD Rv. Finally, pWRG730 was cured by incubating selected colonies 
at 44°C. 
 
PGA quantification 
PGA exopolysaccharide levels were quantified as previously described 
(Cramton et al., 1999) with minor modifications. Briefly, cultures in 5 ml LB 
or LB Am broth of the strains tested were adjusted to the same number of 
cells and centrifuged at 18,000 x g for 5 min. Pellets were resuspended in 
50 µl of 0.5 M EDTA (pH 8.0) and suspensions were incubated for 5 min at 
100°C and centrifuged at 18,000 x g for 5 min. Each supernatant (40 µl) was 
incubated with 10 µl of proteinase K (20 mg ml-1) (Sigma) for 30 min at 
37°C. After the addition of 10 µl of Tris-buffered saline (20 mM Tris-HCl, 150 
mM NaCl [pH 7.4]) containing 0.01% bromophenol blue, 5 µl were spotted 
on a nitrocellulose membrane using a Bio-Dot microfiltration apparatus (Bio-
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Rad). The membrane was blocked overnight with 5% skimmed milk in 
phosphate-buffered saline (PBS) with 0.1% Tween 20, and incubated for 2 h 
with specific anti-PNAG antibodies diluted 1:10,000 (Maira-Litran et al., 
2005). Bound antibodies were detected with peroxidase-conjugated goat 
anti-rabbit immunoglobulin G antibodies (Jackson ImmunoResearch 
Laboratories, Inc., West- grove, PA) diluted 1:10,000 and developed using 
the SuperSignal West Pico Chemiluminescent Substrate (ThermoFisher 
Scientific).  All extracts assayed in a particular experiment were analyzed on 
the same membrane. Images obtained in a GBox Chemi HR16 system 
(Syngene) were cut and put together to assemble horizontal figures showing 
PGA quantification.  
 
Biofilm formation 
The cellulose mediated biofilm formed in glass tubes on standing rich 
cultures was examined visually after growth in 5 ml of LB broth at room 
temperature for 72 h (Solano et al., 2002). The PGA mediated biofilm was 
visualized after growth in LB broth at 28ºC in an orbital shaker (250 r.p.m) 
for 16 h (Valle et al., 2003). Macrocolony biofilms formed on the surface of 
LB agar plates were formed after spotting 50 µl drops of overnight liquid 
cultures and incubating at 28ºC for 48 hours (Serra, Richter, Klauck, et al., 
2013). 
 
Scanning electron microscopy 
For scanning electron microscopy bacterial strains were grown under 
biofilm forming conditions. Growth medium was removed and bacterial cells 
were fixed by adding a fixation solution (1.3% glutaraldehyde, 0.07M 
cacodylate buffer and 0.05% rhutenium red). Samples were then washed in 
and post-fixed by incubation with 2% osmium tetroxide for 1 h. Bacteria 
were then fully dehydrated in a graded series of ethanol solutions and dried 
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in hexamethyldisilazane (HMDS, Sigma). Finally, samples were coated with 
40 Å platinum, using a GATAN PECS 682 apparatus (Pleasanton, CA), 
before observation under a Zeiss Ultra plus FEG-SEM scanning electron 
microscope (Oberkochen, Germany) (Laboratoire de Biologie Cellulaire et 
Microscopie Electronique, UFR Médecine (Tours, France)). 
 
Hydrophobicity assay 
Macrocolony biofilms were formed on the surface of LB or LB Cb agar 
plates as described above, and a 10 µl water droplet stained with red food 
colouring was placed on the biofilm to show the hydrophobicity exhibited by 
the structure (Cairns et al., 2014). 
 
Sodium hypochlorite treatment of macrocolony biofilms  
To perform sodium hypochlorite survival analyses, a protocol 
described previously was carried out with some modifications (Solano et al., 
2002). Macrocolony biofilms were formed on the surface of LB or LB Cb 
agar plates as described above and then treated with 10 ml PBS containing 
200 p.p.m. sodium hypochlorite for 40 min at 37ºC. Control samples were 
incubated with 10 ml of PBS. Macrocolonies were harvested with a bent tip 
and bacteria were washed in PBS three times and suspended in 5 ml of 
PBS. After vortexing and sonicating (30 sec; potency 3; Branson sonifier 
250; microtip), bacteria were enumerated by viable plate counts.  
 
UV light treatment 
Bacterial strains were grown in LB Cb broth at 28ºC in an orbital 
shaker (200 r.p.m) for 16 h. After sonication (30 sec; potency 3; Branson 
sonifier 250; microtip), the OD600nm was adjusted to 1 and serial dilutions 
were plated on four plates of N media agar supplemented with Cb (Pontes 
et al., 2015). After 24h of growth at 28ºC, two plates were irradiated with UV 
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light for 5 min. All plates were then incubated at 28ºC for 48h and the 
numbers of surviving bacteria were counted. Results are shown as % 
survival relative to non-irradiated samples. Experiments were conducted in 
triplicate.  
In order to incubate all strains on the same plates, strains ΔbcsA PcL::adrA 
and WT PcL::adrA were transformed with a pJET empty plasmid.   
 
Susceptibility of biofilms to phage infection 
Overnight cultures in LB or LB Cb broth were sonicated (30 sec; 
potency of 3; Branson sonifier 250; microtip) and the OD600nm was adjusted 
to 1. Sterile polymer membrane filters (diameter 47 mm; Millipore) were 
placed on LB or LB Cb agar plates and seeded with a 50 µl drop of each 
bacterial suspension. Plates were inverted and incubated at 28°C for 48 h to 
allow macrocolony biofilm formation on top of the filters, that were then 
transferred to an empty petri dish and treated with a P22 phage lysate 
generated from the streptomycin resistant strain S. Typhimurium SL1344. 
After 1h of incubation at 37ºC, the entire content of the plates was collected, 
washed in PBS and plated on LB Sm agar. The number of streptomycin 
resistant cfu were indicative of transduction efficiency. Experiments were 
conducted in triplicate.  
 
Macrophage survival assay 
Macrophage survival assay was conducted essentially as described 
(Pontes et al., 2015) with some modifications. The murine macrophage cell 
line RAW 264.7 was propagated in Dulbecco’s modified Eagle’s medium 
(DMEM) (Gibco) supplemented with 10% fetal bovine serum (Invitrogen) 
and 1% Penicillin/Streptomycin/Glutamine (Gibco). Macrophages were 
seeded at a density of 2 x 105 cells per well in 24-well plates 24 h prior to 
infection. Salmonella overnight cultures grown at 37ºC in LB broth were 
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sonicated (30 sec; potency 3; Branson sonifier 250; microtip) and diluted 
1:100 in LB broth. Cultures were incubated at 37ºC in an orbital shaker (200 
r.p.m) to an OD600nm of 1 and the suspension was sonicated again and 
washed twice with DMEM deprived of serum. Macrophages were then 
infected with Salmonella strains at a multiplicity of infection of approximately 
10:1 and plates were centrifuged at 1000 r.p.m. for 10 minutes at room 
temperature. After 20 min of phagocytosis, monolayers were washed twice 
with PBS and treated with gentamicin (100 µg ml-1) for 1 h. To estimate 
phagocytosed bacteria, samples were then washed three times with sterile 
PBS and macrophages were lyzed with 1% (vol/vol) Triton X-100-PBS to 
release intracellular bacteria that were counted by plating 25 µl of serial 
dilutions onto LB plates. To assess bacterial survival, medium was replaced 
by DMEM supplemented with 10% FBS and 12 µg ml-1 gentamycin and the 
cells were incubated at 37ºC. After 18 h of infection, wells were washed 
twice with PBS and were treated with Triton X-100 as indicated above. The 
percentage survival was obtained by dividing the number of bacteria 
recovered after 18 h by the number of phagocytosed bacteria and 
multiplying by 100. At each stage when infected cells were lysed, the 
number of viable cells in duplicate monolayers infected with each strain was 
assessed by 0.4% trypan blue exclusion and counting viable cells. No 
difference in viability was noted between cells infected with the different 
strains. Experiments were done in triplicate on three independent 
occasions. 
 
Polymyxin B resistance assay 
One-hour polymyxin susceptibility assays were performed as 
described (Groisman et al., 1997). Polymyxin B Sulfate (Sigma) was used at 
a final concentration of 2.5 µg ml-1. Data are presented as survival 
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percentage relative to samples incubated in LB without polymyxin. 
Experiments were conducted in triplicate. 
 
Hydrogen peroxide sensitivity assay 
Sensitivity to hydrogen peroxide was tested as previously described 
(Bogomolnaya et al., 2013) with minor modifications. Briefly, overnight 
cultures were subcultured at 1/100 in 5 ml LB containing either no or 1 mM 
H2O2 (Merk). Replica cultures were used for each time point. Cultures were 
grown at 37°C with aeration and collected hourly. LB broth contains ∼30-40 
µM Mg2+ (Maguire and Papp-Wallace, 2008), which activates the phoP 
promoter, thus, leading to adrA expression. After sonication (30 sec; 
potency 3; Branson sonifier 250; microtip) the number of surviving bacteria 
were counted by plating serial dilutions onto LB plates. Experiments were 
performed on three separate occasions. 
 
Ileal loop co-infection experiment 
In order to differentiate strains in all mice competitive infections 
performed, the wild type and ΔbcsA PcL::pga strains were made 
streptomycin (Sm) resistant through P22 phage transduction of the aadA 
gene from the natural streptomycin resistant strain S. Typhimurium SL1344 
(Suar et al., 2006). 
To compare the in vivo interaction of Salmonella strains with murine 
intestinal epithelial cells, the ligated ileal loop co-infection model was used 
as described previously (Solano et al., 2002; Latasa et al., 2005). Strains 
were incubated on LB agar for 48 hours at room temperature, suspended in 
PBS and sonicated (30 sec; potency 3; Branson sonifier 250; microtip) prior 
to infection. Competitive index (CI) was defined as the log10 of the ratio of 
the exopolysaccharide producing strain to control strain recovered (Output) 
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divided by the ratio of the exopolysaccharide producing strain to control 
strain present in the inoculum (Input). A CI > 0 indicates the 
exopolysaccharide producing strain with a colonization advantage 
compared to the control and a CI < 0 indicates the exopolysaccharide 
producing strain with a colonization disadvantage over the control. 
 
Colonization experiments 
Colonization experiments were carried out with 8-week-old female 
BALB/c mice (Charles River Laboratories). Mice were acclimated for 7 days 
after arrival before the experiments were started in the animal facility of the 
Instituto de Agrobiotecnología, Universidad Pública de Navarra. Food and 
water were removed, twelve and two hours respectively, before the 
administration of bacterial suspension. Mice were prefed with 20 µl of 10% 
sodium bicarbonate 30 min before bacterial inoculation. Water and food 
were again supplied right after inoculation. 
Strains were incubated on LB agar for 48 hours at room temperature, 
suspended in PBS and sonicated (30 sec; potency 3; Branson sonifier 250; 
microtip) prior to infection. Mice were inoculated intragastrically with 100 µl 
of bacterial suspensions. In the case of coinfection experiments, the total 
bacteria inoculum was 2 x 108 cfu of combined polysaccharide producing 
strain and ΔbcsA strain at a ratio of 1:1. In the case of individual infections, 
inoculum was 1 x 108 cfu of the strain analysed. The cfu of each strain in the 
inoculum (input) were quantified by plating dilution series on LB agar 
supplemented with chloramphenicol and LB agar supplemented with 
streptomycin to distinguish between strains. Over the course of infection, 
mice were examined twice per day and a final disease score was given to 
each mouse according to clinical signs observed as follows. No clinical 
signs (0); mild clinical signs: ruffled fur (1); moderate clinical signs: ruffled 
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fur plus, lethargy, hunched posture and decreased activity (2); severe 
clinical signs: paresis, paralysis, tremor, shivers, ataxia, rigidity (3). When 
evident signs of disease (score 2 to 3) were observed, mice were 
euthanized by CO2 inhalation followed by cervical dislocation. Then, dilution 
series of liver, spleen and gallbladder lysates were plated on LB agar for 
enumeration of cfu (output), using antibiotic resistance to differentiate 
strains. Values for CI were calculated as described above. 
 
Bile and SDS sensitivity assays 
Bile bovine sensitivity assay was performed as described (Ramos-
Morales et al., 2003) with minor modifications. Bacterial strains were grown 
in LB broth at 28ºC for 48 h in an orbital shaker (200 r.p.m). Two microliter 
portions of serial dilutions were incubated for 24 h at 37°C in LB agar plates 
containing either no or bile bovine (Sigma). The bile concentration used was 
24% or 13% when assessing Salmonella and E. coli bile sensitivity, 
respectively. 
To carry out the SDS MIC analysis, bacterial strains were grown in LB broth 
at 28ºC for 48 h in an orbital shaker (200 r.p.m) and diluted such that 
samples of 2x103 CFU/ml were subjected to various concentrations of SDS 
in polypropylene microtiter plates (ThermoFisher Scientific). The plates were 
incubated overnight at 37°C under nonaerated conditions and the wells of 
the plate were visually analyzed to determine the MICs.  
 
Statistical analyses 
All statistical analyses were performed in GraphPad Prism 5.01. 
Sodium hypochlorite survival, UV light irradiation data, susceptibility of 
biofilms to phage infection, macrophage survival and Polymyxin B 
resistance analyses were analysed by the Mann-Whitney U test. A two-way 
analysis of variance combined with the Bonferroni test was used to analyse 
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statistical significance in hydrogen peroxide sensitivity assays. A 
nonparametric Mann-Whitney U test and an unpaired Student’s t test were 
used to assess significant differences in individual colonization or 
coinfection experiments, respectively.  
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Table 1. Strains and plasmids used in this study.  
Strain or plasmid Relevant characteristics MICa  Reference or source  
Strains    
S. Enteritidis    
3934 Wild-type clinical isolate 54 (1) 
ΔXII  3934 ΔadrA Δsen1023 yeaJ::TcR 
ΔyciR ΔyegE ΔyfiN Δyhda 
Δsen3222 ΔyhjK Δsen2484 
yfeA::KmR Δsen4316 
 
3664 (2) 
ΔbcsA 3934 ΔbcsA::CmR 3702 (2) 
WT PcL::adrA 3934 KmR PcL rbs::adrA 4397 This study 
ΔbcsA PcL::adrA  3934  ΔbcsA::CmR KmR PcL 
rbs::adrA  
5583 This study 
WT PphoP::adrA 3934  PphoP::adrA 5624 This study 
ΔbcsA PphoP::adrA 3934 ΔbcsA::CmR  PphoP::adrA 5626 This study 
ΔbcsA  PphoP::adrA 
PcL::pga 
ΔbcsA::CmR PphoP::adrA PcL 
rbs::pga 
5860 This study 
ΔbcsA PcL::pga 3934 ΔbcsA::CmR   PcL 
rbs::pgaABCD 
5735 This study 
ΔXII + adrA 3934 Δsen1023 yeaJ::TcR ΔyciR 
ΔyegE ΔyfiN Δyhda Δsen3222 
ΔyhjK Δsen2484 yfeA::KmR 
Δsen4316 
 
2785 This study 
ΔXII + yeaJ 3934 ΔadrA Δsen1023 ΔyciR 
ΔyegE ΔyfiN Δyhda Δsen3222 
ΔyhjK Δsen2484 yfeA::KmR 
Δsen4316 
 
2786 This study 
ΔXII + yciR 3934 ΔadrA Δsen1023 yeaJ::TcR 
ΔyegE ΔyfiN Δyhda Δsen3222 
ΔyhjK Δsen2484 yfeA::KmR 
Δsen4316 
 
2787 This study 
ΔXII + sen1023 3934 ΔadrA yeaJ::TcR ΔyciR 
ΔyegE ΔyfiN Δyhda Δsen3222 
ΔyhjK Δsen2484 yfeA::KmR 
Δsen4316 
 
2788 This study 
ΔXII + yegE 3934 ΔadrA Δsen1023 yeaJ::TcR 
ΔyciR ΔyfiN Δyhda Δsen3222 
ΔyhjK Δsen2484 yfeA::KmR 
Δsen4316 
 
2789 This study 
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ΔXII + yfeA 3934 ΔadrA Δsen1023 yeaJ::TcR 
ΔyciR ΔyegE ΔyfiN Δyhda 
Δsen3222 ΔyhjK Δsen2484 
Δsen4316 
 
2790 This study 
ΔXII + yfiN 3934 ΔadrA Δsen1023 yeaJ::TcR 
ΔyciR ΔyegE Δyhda Δsen3222 
ΔyhjK Δsen2484 yfeA::KmR 
Δsen4316 
 
2791 This study 
ΔXII + yhdA 3934 ΔadrA Δsen1023 yeaJ::TcR 
ΔyciR ΔyegE ΔyfiN Δsen3222 
ΔyhjK Δsen2484 yfeA::KmR 
Δsen4316 
 
2792 This study 
ΔXII + sen3322 3934 ΔadrA Δsen1023 yeaJ::TcR 
ΔyciR ΔyegE ΔyfiN Δyhda ΔyhjK 
Δsen2484 yfeA::KmR Δsen4316 
 
2793 This study 
ΔXII + yhjK 3934 ΔadrA Δsen1023 yeaJ::TcR 
ΔyciR ΔyegE ΔyfiN Δyhda 
Δsen3222 Δsen2484 yfeA::KmR 
Δsen4316 
 
2794 This study 
ΔXII + sen4316 3934 ΔadrA Δsen1023 yeaJ::TcR 
ΔyciR ΔyegE ΔyfiN Δyhda 
Δsen3222 ΔyhjK Δsen2484 
yfeA::KmR 
  
3831 This study 
ΔXII + sen2484 3934 ΔadrA Δsen1023 yeaJ::TcR 
ΔyciR ΔyegE ΔyfiN Δyhda 
Δsen3222 ΔyhjK yfeA::KmR 
Δsen4316 
 
2795 This study 
E.coli    
XL1Blue recA1 endA1 gyrA96 thi-1 hsdr17 
supE44 relA1 lac [F´proAB laclq Z 
ΔM15 Tn10 (TcR)] 
 
797 Stratagene 
K-12 MG1555 Wild type commensal strain 5359 Provided by J. M. Ghigo 
MG1655 Km PcL-
λATT-GFP 
MG1655 KmR PcL-λATT-GFP 3023 (3) 
MG1655 ΔpgaC MG1555 ΔpgaC 5487 This study 
MG1655 PcL::pga MG1555 KmR PcL rbs::pgaABCD 5732 This study 
Plasmids    
pJET 1.2 Cloning vector AmR 
 
 Thermo Scientific 
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pKD46 Temperature-sensitive plasmid 
containing λ red recombinase 
genes under the control of an 
arabinose-inducible promoter; 
AmR 
 
 (4) 
pWRG717 Plasmid with I-SceI recognition 
site, KmR. Use for kanamycin 
cassette amplification in rapid 
mutagenesis. 
 
 Provided by R. G. 
Gerlach 
pWRG730 Plasmid with I-SceI endonuclease 
under control of tetracycline-
inducible promoter (PtetA), 
temperature- 
sensitive, CmR 
 
 Provided by R. G. 
Gerlach 
pKO3 CmR vector for recombination 
experiments 
 
 (5) 
pKO3Blue CmR, derivative of pKO3 carrying 
the pMAD lacZ gene under the 
control of the PclpB promoter.  
 
 {CristinaSolanoa:2009uo} 
pJET::pga pJET 1.2 containing the 
pgaABCD operon of E.coli 
MG1655  
 
 This study 
pKO3::sb13AD pKO3 containing fragments AB 
and CD from the sb13 gene of 
T64B phage.  
 
 This study 
pKO3::sb13AD-
Ppga::pgaABCD 
pKO3 containing fragments AB 
and CD from the sb13 gene of 
T64B phage and the pgaABCD 
operon of E.coli MG1655 under its 
own promoter 
 
 This study 
pKO3Blue::sb13AB2-
PcLrbs::pgaA 
pKO3Blue containing fragment 
AB2 from the sb13 gene of T64B 
phage and the pgaA gene under 
the PcLrbs promoter 
 
 This study 
pCN40 Vector encoding ampicillin 
resistance 
 (6) 
 
aNumber of each strain in the culture collection of the Laboratory of Microbial Pathogenesis, 
Navarrabiomed-Universidad Pública de Navarra. 
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Table 2. Oligonucleotides used in this study. 
Primer  Sequence 5´à3´ 
Cloning and sequencing of pgaABCD and pgaABCD-ycdT genes into the pJET vector 
pgaA Fw GCATGCCCGAAATCATGCATCGGAATTTACTGATT 
pgaD Rv GCATGCTTATGCCCGGACTAGCGCTT 
pgaA sec Fw CCGCACTGCCCAGTACCA 
pgaB sec Fw GTGCGCGCGTAAAAGCCAT 
pgaC sec Fw GCCCTGGCAGAAGTGGGTTA 
adrA chromosome expression under the PcL promoter 
adrA Km PcL rbs Fw CCGAAATTTCATACTTCCTCCATGCGCCCTGTTTCTATAATTTG
GGAAAATTGTTTCTAATTCGCTCAAGTTAGTAATTCTCACa 
adrA Km PcL rbs Rv TACCGCCTGTTCAACCGCTTTTCGGTAAAAATTTTCATCATTCA
TTATTTTTGGGAACATGCGGTACCTTTCTCCTCTTTAATGb 
adrA chromosome expression under the phoP promoter 
Km SceI PphoP adrA 
Fw 
GTAGCAAGTTTATGAGCGCCTGCCTGAAAAAAGCGGCGTAGT
GCTATCGGGTGAGCCCTGAGGTTTTCCCAGTCACGACc 
Km SceI PphoP adrA 
Rv 
TACCGCCTGTTCAACCGCTTTTCGGTAAAAATTTTCATCATTCA
TTATTTTTGGGAACATTGCTTCCGGCTCGTATGTTGc 
PphoP adrA Fw GTAGCAAGTTTATGAGCGCCTGCCTGAAAAAAGCGGCGTAGT
GCTATCGGGTGAGCCCTGACTATTTGTCTGGTTTATTAACTGd 
PphoP adrA Rv TACCGCCTGTTCAACCGCTTTTCGGTAAAAATTTTCATCATTCA
TTATTTTTGGGAACATCTCGTCTCCCTTGTGTTAACAATAAGAA
Cd 
01-E CACAGTTGTTATAACGTTAC 
pgaABCD expression from the Salmonella chromosome 
SmaI sb13 AB Fw CCCGGGAACTGTATGTCATTGCCGTA 
SpHI sb13 AB Rv GCATGCCCGATATAATCGAACGGCT 
SpHI sb13 CD Fw GCATGCAGACGCCTGCTGATGAACT 
SalI sb13 CD Rv GTCGACTGCAGACGGAACTGGTTAA 
BglII sb13 AB Fw AGATCTAACTGTATGTCATTGCCGTAC 
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BamHI sb13 AB Rv GGATCCATAAAACGAAAGGCCCAGTCTTTCGACTGAGCCTTTC
GTTTTACCGATATAATCGAACGGCTCAT 
BamHI PcLrbs Fw GGATCCAAATCTATCACCGCAAGGGA 
sb13 PcLpgaA Rv           GCTACTTGAATACATGCGGTACCTTTCTCCTCTTT 
PcL pgaA Fw AAAGAGGAGAAAGGTACCGCATGTATTCAAGTAGC 
PstI PcL pgaA Rv CTGCAGCCCCGCCAGTTTATAGATAT 
sb13 OK Fw ATCGGTTGATTATGCCCGTCA 
pgaA comp Rv CCATTTGGTTTTCGGGCACC 
pgaABCD operon expression in E. coli under the PcL promoter 
Km Pcl rbs pga Fw  CATTAGGAATAACAATTAAATCCGTGAGTGCCGTAGCGCAGCC
TTTCATCAGGACTTTCGTTCGCTCAAGTTAGTAATTCTCACa 
Km Pcl rbs pga Rv  
 
AGTAAGAAGTTTCAAAGCCCATTTGGTTTTCGGGCACCTTTTTC
TGCTACTTGAATACATGCGGTACCTTTCTCCTCTTTAATGb 
Mutation of the pgaC gene in E. coli 
pgaC Km SceI Fw TAGACCTTATTCGTCCTGAGTTTTCAACAGCCTGGTATCCGAA
AAATGATTAATCGCATCAGGTTTTCCCAGTCACGACc 
pgaC Km SceI Rv TACCGGTTACGGCACCCACACGCGGGTTGTACAACATCGGTT
CCACAATATATGCCGCCTGCTTCCGGCTCGTATGTTGc 
ΔpgaC_Fw TTTTCAACAGCCTGGTATCCGAAAAATGATTAATCGCATCGGC
GGCATATATTGTGGAACCGATGTTGTACAACCCGCGT 
ΔpgaC_Rv ACGCGGGTTGTACAACATCGGTTCCACAATATATGCCGCCGAT
GCGATTAATCATTTTTCGGATACCAGGCTGTTGAAAA 
Construction of a collection of strains, derivative of ∆XII containing a single GGDEF 
domain protein 
01-A GCGGCCGCTGCCAGTGTAACTGTGGAe 
01-D AGATCTCTGGGACACGACCGTAAe 
02-H GCGGCCGCATGAATTTGCATCATAAAGCGe 
02-D AGATCTGGCGATGCGCAGATAGTe 
03-A GCGGCCGCGATATCACCCAACAAATGe 
03-D AGATCTCAGATACGCCGGTAATTTTe 
04-A GCGGCCGCGGAATTGTCGTACACGGTe 
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04-D AGATCTCTCACAACGAAATCCGCCe 
05-A GCGGCCGCACCGGTAATTCAATCGCCe 
05-D AGATCTGTTTGAACAGGGCGTGCe 
06-A2 GCGGCCGCCGTCATCCGTTCCTTGAACATAACGCGTCATCCG
TTCCTTGAACATAACGe 
06-D2 AGATCTCTGGGTTACATCTTCTACCCGGTCCTGGGTTACATCT
TCTACCCGGTCe 
07-A GCGGCCGCGACGATATGGCAAAATAATGe 
07-D AGATCTAGCAACTTGAACAAGAGCAe 
08-A GCGGCCGCCACAGCATGGCGGTAAAAe 
08-D AGATCTGATATTGCCCGGCGTACe 
09-A GCGGCCGCAGTTTCACCACAGGCGCe 
09-D AGATCTTTGAGAATAAAACGCAGTTGe 
10-A GCGGCCGCTATAGCCCGCAGGAATACe 
10-D AGATCTATCGAGCGTTGCCGGATe 
11-A GCGGCCGCGTAAGATAACTGTGCGAAGe 
11-D AGATCTTCCTGATGCACATCAAGCe 
12-A GCGGCCGCTAACAGCTTAACGTTGTCCe 
12-D AGATCTCAGCTTGAAGCGTTGCTTe 
Restriction enzymes recognition sites are shown in bold. 
a Priming sequence for the Km resistance cassette underlined. 
b Priming sequence for the PcL promoter underlined.   
c Priming sequence for plasmid pWRG717 underlined, used for Km resistance cassette and 
I-SceI site amplification. 
d Priming sequence for the phoP promoter underlined.  
eEquivalences of gene names and the internal code used to name primers utilized for 
pKO3blue experiments: 01 (adrA); 02 (yeaJ); 03 (yciR); 04 (sen1023); 05 (yegE); 06 (yfeA); 
07 (yfiN); 08 (yhdA); 09 (sen3222); 10 (yhjK); 11 (sen4316); 12 (sen2484). 
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RESULTS 
Absence of the pgaABCD operon in Salmonella is likely the result 
of a secondary loss 
To investigate whether the presence of the pgaABCD operon in 
Escherichia and its absence in Salmonella is due to a lineage-specific 
acquisition in Escherichia or to a loss in Salmonella, we performed different 
comparative and phylogenetic analyses (see Materials and Methods). 
Analysis of the genomic context of E. coli PgaA protein in the STRING 
database (Szklarczyk et al., 2015) correctly identified the presence of four 
genes in the pgaABCD operon as significantly associated using exclusively 
gene neighborhood and gene co-occurrence information. The gene cluster, 
often only presenting the first three upstream genes, is widespread among 
Enterobacteriaceae, being present in 22 species of the 83 available in the 
database. Besides Escherichia, the genera with the cluster include 
Klebsiella, Pectobacterium, Yersinia, Citrobacter, and Enterobacter, among 
others. Analyses of the presence/absence of the genes revealed a similar 
pattern, confirming the absence of the genes in Salmonella species and 
other genera. Importantly, both analyses revealed a patchy 
presence/absence pattern, including many recent apparent losses within 
some genera such as Citrobacter or Escherichia. We then reconstructed 
individual phylogenies in each of the genes  in the cluster by aligning the top 
500 hits of a blastP search in NCBI nr database, after setting a filter to 
exclude sequences assigned to E. coli. All the top hits belonged to related 
species of Enterobacteriaceae excluding the possibility of recent, 
independent transfers of the cluster from a non-Enterobacteriaceae species. 
Maximum likelihood phylogenies of the four genes produced roughly similar 
topological arrangements of the included taxa (schematically depicted in 
Fig. 1A). We performed a similar analysis with phoH, the gene located in the 
vicinity of the cluster, encoding a protein with a nucleoside triphosphate 
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hydrolase domain. This gene has a broader distribution, present in 68 of the 
83 taxa, a pattern suggesting a vertical inheritance with few independent 
losses. Importantly, however, for the shared species, the phylogenies of 
phoH and that of the four genes in the pgaABCD cluster showed an overall 
similarity (Fig. 1B). This indicates that the five genes followed a similar 
evolutionary history, with the exception of differential loss of genes in 
alternative lineages. This topology was congruent with the species tree for 
Enterobacteriaceae provided in the PATRIC database, which is based on 
the analysis of several shared genes (Williams et al., 2010) (Wattam et al., 
2013), with the notable exception of the position of Yersinia or Serratia 
strains. Previous studies have shown that losses are more frequent than 
lateral transfer in the evolution of prokaryotic genomes (Snel et al., 2002), 
and lateral transfer would generate discordance between gene trees (Soucy 
et al., 2015). Hence, our results point to an overall dominance of vertical 
inheritance and differential gene loss in the evolution of this gene cluster 
within Enterobacteriaceae. Considering this scenario, the pgaABCD cluster 
was lost somewhere after the divergence of Salmonella and Citrobacter 
clades, and previous to the diversification of the currently sequenced 
Salmonella strains.  
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Fig. 1. Schematic representation of the phylogenetic relationships of 
homologues of the proteins analyzed in groups that are closely related to 
Salmonella. (A) Schematic representation of the pgaABCD operon and the phoH gene in 
E. coli K-12 MG1655. The proteins PgaA, PgaB, and PgaC showed the same pattern (B), 
with PgaD showing a more restricted distribution (C). PhoH showed a phylogenetic pattern 
(D) that is compatible with those of PgaABCD if three losses are inferred (E). PgaABCD in 
Salmonella/Erwinia, top red cross; PgaD in Leclercia/E. Vulneris (bottom red cross), and 
PhoH in Plesiomonas (not shown in the tree). The full phylogenies comprising the closest 
250 homologues are provided in supplementary datafile 1 
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Expression of the pgaABCD operon in Salmonella is sufficient for 
PGA production 
If Salmonella inability to synthesize PGA is exclusively due to loss of 
the pgaABCD operon, complementation with pgaABCD should be sufficient 
to restore PGA production. To test this hypothesis, we transformed a S. 
Enteritidis wild type strain with plasmid pJET::pga carrying the pgaABCD 
operon of E. coli MG1655 under the control of its own promoter, and 
analyzed PGA synthesis upon growth under Salmonella biofilm forming 
conditions (incubation in LB broth, at room temperature, without shaking) 
using a dot blot assay and an anti-PIA/PNAG antiserum. As expected, PGA 
was not detected in cell extracts of the wild type strain whereas WT 
pJET::pga produced PGA and accumulated it throughout the incubation 
time (Fig. 2A and Fig. S1A).  
We next examined if, as it happens in E. coli (Steiner et al., 2013), 
PGA production in Salmonella is also dependent on c-di-GMP. To do so, we 
firstly complemented S. Enteritidis ΔXII with the pgaABCD operon. S. 
Enteritidis ΔXII is a multiple mutant, derivative of the wild type strain, 
carrying mutations in all twelve genes encoding GGDEF domain proteins 
(putative c-di-GMP synthases) and thus incapable of synthesizing c-di-GMP 
(Solano et al., 2009; Zorraquino et al., 2013). The dot-blot assay showed 
that ΔXII pJET::pga was unable to produce PGA, confirming that c-di-GMP 
is indeed essential for PGA production in Salmonella (Fig. 2A). Secondly, 
we constructed a strain in which the adrA gene of Salmonella, which 
encodes a c-di-GMP synthase, is under the control of a constitutive 
promoter. This strain (WT PcL::adrA) constitutively produces high levels of 
c-di-GMP. Upon transformation with pJET::pga, this strain produced higher 
PGA levels than the wild type strain (Fig. 2A and Fig. S1A), showing that 
heterologous PGA synthesis in Salmonella is commensurate to cellular c-di-
GMP levels. Finally, and in order to identify the source of c-di-GMP in WT 
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pJET::pga that triggers PGA production, we used a collection of twelve 
strains, derivatives of ΔXII, each of which contained the chromosomal copy 
of a single gene encoding a GGDEF domain protein in the original wild type 
genomic location (Solano et al., 2009; Zorraquino et al., 2013). The analysis 
of cell extracts of each strain complemented with pJET::pga showed that 
five GGDEF domain proteins, namely AdrA, YedQ, YegE, YfiN and 
SEN4316, when individually present in the chromosome of the cell, were 
able to elicit c-di-GMP dependent PGA synthesis (Fig. S1B). Overall, these 
results showed that heterologous pgaABCD expression is sufficient to 
restore Salmonella capacity to synthesize PGA and that this synthesis is 
dependent on c-di-GMP levels that are provided as a pool by different 
Salmonella c-di-GMP synthases.  
 
Heterologous PGA production bestows biofilm lifestyle behavior 
upon Salmonella 
In staphylococcal cells, production of PGA can be visualized as a ring 
of cells adhered to the glass wall at the air–liquid interface, when bacteria 
are incubated in a glass tube under shaking conditions (Valle et al., 2003). 
To investigate whether Salmonella is likewise able to build a PGA mediated 
biofilm, we analyzed biofilm formation by WT pJET::pga and WT PcL::adrA 
pJET::pga after incubation in LB broth, at 28°C for 16 hours under shaking 
conditions. Only the second strain, which produces constitutive and high 
levels of c-di-GMP, produced a visible ring of bacteria adhered to the glass 
wall (Fig. 2B). Structure of this PGA based biofilm was then compared with 
the natural cellulose based biofilm formed by Salmonella using scanning 
electron microscopy (Fig. 2C). To do so, we used a cellulose 
overexpressing strain (WT PcL::adrA), a PGA positive and cellulose minus 
strain (ΔbcsA PcL::adrA pJET::pga) and a control strain that produces 
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neither cellulose nor PGA (ΔbcsA PcL::adrA). In the case of the PGA 
dependent biofilm, cells were tangled up in an abundant extracellular matrix 
mesh that interconnected the bacteria. Furthermore, spherical, knob-like 
structures were evident on the bacterial cell surface. These knob-like 
structures have already been described in PGA (PIA/PNAG) related biofilms 
of E. coli, Yersinia pestis and Staphylococcus epidermidis (Vuong, Voyich, 
et al., 2004; Erickson et al., 2008; Boehm et al., 2009). On the other hand, 
bacteria inside a cellulose based biofilm were covered by a sheet-like 
material (Serra, Richter, and Hengge, 2013) that totally encased bacteria 
and that appeared more compact and structured than the PGA biofilm. To 
further investigate the differences between both types of biofilms, 
macrocolony biofilms were grown on LB agar plates (Fig. S2A) and a water-
droplet analysis of colony hydrophobicity was performed (Cairns et al., 
2014). Results showed that a cellulose mediated biofilm is highly 
hydrophobic, whereas a PGA based biofilm exhibits intermediate 
hydrophobicity compared with the non-biofilm producing strain, ΔbcsA 
PcL::adrA (Fig. S2B). Collectively, these findings showed that heterologous 
PGA expression alongside high c-di-GMP levels enable Salmonella to build 
a PGA mediated biofilm that greatly differs at the structural level from the 
natural cellulose based biofilm. 
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Fig. 2. Heterologous expression of the pgaABCD operon in Salmonella drives 
PGA synthesis in response to c-di-GMP levels and makes Salmonella able to build a 
PGA mediated biofilm. (A) Dot blot analysis of the PGA accumulated by S. Enteritidis wild 
type, ΔXII and WT PcL::adrA and their corresponding transformed strains with plasmid 
pJET::pga after 48 hours of incubation in LB or LB Cb broth, at room temperature, under 
static conditions. Serial dilutions (1/10) of the samples were spotted onto nitrocellulose 
membranes and PGA production was detected with specific anti PIA/PNAG antibodies. UD; 
undiluted sample. (B) Biofilm phenotypes of wild type, WT PcL::adrA and their 
corresponding transformed strains with plasmid pJET::pga after incubation in LB or LB Cb 
broth, at 28°C for 16 hours under shaking conditions. A ring of cells adhered to the glass 
wall at the air–liquid interface corresponds with a PGA based biofilm. (C) Scanning electron 
microscopy analysis of the biofilms developed by the PGA overproducing strain, ΔbcsA 
PcL::adrA pJET::pga, after incubation in LB broth, at 28°C for 16 hours under shaking 
conditions and by the cellulose overproducing strain, WT PcL::adrA, after incubation in LB 
broth, at room temperature under static conditions for 72 hours. A control strain, ΔbcsA 
PcL::adrA, that produces neither PGA nor cellulose was also analyzed after incubation in 
LB broth, at 28°C for 16 hours under shaking conditions. 
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Effects of PGA on Salmonella protection from environmental 
stresses 
Biofilm exopolysaccharides provide protection from the external 
environment. Thus, a consequence of PGA loss might be a reduction in 
Salmonella resistance to environmental threats, unless another compound 
assumed such a function. To test this hypothesis, we compared the 
resistance provided by PGA and cellulose to several environmental 
stresses. Since it has already been described that cellulose mediates 
chlorine survival of Salmonella and other bacteria (Solano et al., 2002; 
White et al., 2006; Prigent-Combaret et al., 2012), we first analyzed the 
susceptibility of macrocolony biofilms formed by the cellulose-positive strain 
(WT PcL::adrA) and the PGA-positive cellulose-negative strain (ΔbcsA 
PcL::adrA pJET::pga) to chlorine. The non-biofilm producing strain, ΔbcsA 
PcL::adrA, was used as a control. A 40 min exposure to sodium 
hypochlorite (200 p.p.m.) caused a decrease of ~5.5 logs in the number of 
control bacteria, compared to samples treated with only PBS (Fig. 3A). 
Conversely, the same sodium hypochlorite treatment caused a reduction of 
~1 log in the number of bacteria inside a cellulose or a PGA based biofilm 
(Fig. 3A). These results determined that the protection against chlorine 
conferred by PGA is equivalent to that provided by cellulose.  
Next, we tested the resistance that PGA and cellulose confer to five 
minutes of UV light irradiation. Although both exopolysaccharide 
overproducing strains survived better than the control strain that produces 
neither polysaccharide, the cellulose-positive cells showed a significantly 
higher survival rate than the PGA-positive cellulose-negative strain (Fig. 
3B). Thus, under our experimental conditions, cellulose provides better 
protection against ultraviolet radiation than PGA.  
Phages are found in abundance in environmental settings and 
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bacteria have developed sophisticated mechanisms, including biofilm 
formation, to limit phage reproduction. To address the impact of cellulose 
and PGA biofilm extracellular matrices on phage infection, we infected 
bacteria that had been grown on membrane filters under biofilm forming 
conditions with a P22 phage lysate and analyzed the transduction frequency 
of a streptomycin resistance cassette. Results showed that, under our 
experimental conditions, neither exopolysaccharide protected Salmonella 
from phage infection (Fig. 3C).  
Overall, these findings suggested that PGA provides, at the most, 
similar benefits to those conferred by cellulose against environmental 
threats, at least under the conditions tested. Since both polysaccharides 
seem to have redundant roles in environmental survival, our results support 
the idea that during speciation the PGA pathway was lost without affecting 
survival outside the host during the Salmonella cyclic lifestyle. 
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Fig. 3. PGA and cellulose confer equal protection to Salmonella from chlorine 
treatment, UV light irradiation and phage infection. (A) The cellulose overproducing 
strain, WT PcL::adrA, the PGA overproducing strain, ΔbcsA PcL::adrA pJET::pga, and the 
control strain, ΔbcsA PcL::adrA,  were incubated on LB agar or LB agar Cb media for 48h 
at 28ºC. Macrocolonies were then exposed to 200 p.p.m. sodium hypochlorite for 40 min. 
Surviving bacteria were enumerated by viable plate counts, and their numbers were 
compared with that of control bacteria that had not been incubated with NaOCl. Note the 
logarithmic scale in the y axis. The data represent the mean of two independent 
experiments performed in triplicate. (B) Serial dilutions of the cellulose overproducing 
strain, the PGA overproducing strain and the exopolysaccharide minus strain were plated 
on N minimal medium containing carbenicillin and after 24 hours of incubation at 28°C, 
plates were exposed to five minutes of UV light irradiation. Replica plates were not 
subjected to treatment and served as controls. After 48 hours of incubation at 28°C, 
numbers of surviving bacteria were counted. Results are shown as % survival relative to 
untreated samples. ΔbcsA PcL::adrA and WT PcL::adrA carried an empty plasmid so that 
the three strains could be incubated on the same plates. Note the logarithmic scale in the y 
axis. The data represent the mean of three independent experiments. (C) Macrocolony 
biofilms were grown on polyvinylidene membranes and then subjected to phage infection 
with a P22 phage lysate generated from a streptomycin resistant strain. Transductants 
were enumerated by plate counts on LB Sm media and their numbers were compared with 
those of the exopolysaccharide minus strain, ΔbcsA PcL::adrA, which defined 100% 
transduction. The data represent the mean of three independent experiments. Statistical 
analysis in all assays was carried out using a Mann-Whitney U test. ns=no significant 
difference; * P < 0.05; ** P < 0.01.  
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PGA production hinders Salmonella intramacrophage survival 
During infection, the ability of Salmonella to survive and replicate in the 
vacuole within host phagocytic cells is essential for systemic disease (Fields 
et al., 1986). To investigate the consequences of PGA production in 
Salmonella intramacrophage replication, we tested the ability of a PGA 
producing strain to replicate in RAW264.7 murine macrophages and 
compared it with that of a cellulose producing strain. To guarantee the 
synthesis of PGA or cellulose inside macrophages, we created Salmonella 
strains displaying high c-di-GMP levels inside these cells through the use of 
the macrophage activated phoP promoter fused to the adrA gene (Pontes et 
al., 2015). We firstly constructed WT PphoP::adrA and confirmed that it 
produced a cellulose based biofilm in response to the low Mg2+ signal 
activating the phoP promoter (Fig. S3). Then, we engineered ΔbcsA 
PphoP::adrA PcL::pga, a cellulose mutant that constitutively expresses the 
PGA synthesis machinery from the chromosome but that synthesizes PGA 
in a phoP dependent fashion (Fig. S3). As a control, we constructed WT 
ΔbcsA PphoP::adrA producing neither cellulose nor PGA. The three strains 
were phagocytosed at similar rates and as it has already been described, 
the cellulose overproducing strain was defective for replication inside 
macrophages (Pontes et al., 2015), showing an ~50% intramacrophage 
survival  relative to the control strain ΔbcsA PphoP::adrA (Fig. 4A). 
Remarkably, the PGA producing strain was significantly more attenuated 
than the cellulose overproducing strain, showing a 7% intramacrophage 
survival relative to the control strain (Fig. 4A).   
Salmonella contained within the phagosomal environment encounter 
a diversity of antimicrobial factors including cationic antimicrobial peptides 
(CAMP) and reactive oxygen species (ROS) (Flannagan et al., 2009). To 
investigate the cause(s) behind the low intramacrophage survival phenotype 
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related to PGA production, we firstly performed one-hour polymyxin 
susceptibility assays (Groisman et al., 1997) of bacterial cells previously 
grown under low Mg2+ levels, a condition that promotes polymyxin 
resistance through activation of the PhoP regulon (Vescovi et al., 1996; 
Groisman et al., 1997). The presence of either polysaccharide, cellulose or 
PGA, did not have an effect on Salmonella polymyxin resistance (Fig. 4B). 
Then, we investigated whether reduced intracellular replication was linked to 
increased sensitivity to ROS production by assessing the ability to grow in 
the presence of 1mM H2O2 (Fig. 4C). When wild type Salmonella were 
inoculated into 1 mM peroxide-containing medium at 107 CFU/ml, there was 
no increase in cell numbers for the first 3 h of incubation, followed by fast 
recovery (Bogomolnaya et al., 2013). Growth of the cellulose overproducing 
and control strains were indistinguishable from that of the wild type, whilst 
the PGA overproducing strain showed a significant viability loss throughout 
the incubation time (Fig. 4C). Taken together, these results indicated that 
PGA production has a detrimental effect on Salmonella intramacrophage 
survival and that such survival decrease may be partially explained by the 
fact that PGA makes Salmonella more sensitive to oxidative stress. 
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Fig. 4. A Salmonella strain that makes PGA inside macrophages is highly 
defective for intramacrophage survival and shows increased sensitivity to H2O2. (A) 
CFU of phagocytosed bacteria after a 1.5 h incubation with 2 × 105 RAW 264.7 
macrophages at a multiplicity of infection of 10 (left panel). Replication within RAW 264.7 
macrophages at 18 h postinfection (right panel). Replication of the exopolysaccharide 
minus strain, ΔbcsA PphoP::adrA, defined 100% intramacrophage survival. Significance was 
determined by a Mann-Whitney U test. The data represent the mean of three independent 
experiments performed in triplicate. ns=no significant difference; * P < 0.05; ** P < 0.01. (B) 
Strains ΔbcsA PphoP::adrA, WT PphoP::adrA and ΔbcsA PphoP::adrA PcL::pga were grown to 
logarithmic phase in N minimal medium with 10 µM MgCl2. Washed bacteria were diluted 
1:10 in LB and LB medium containing Polymyxin B at a final concentration of 2.5 µg ml-1, 
and were incubated for 1 h at 37°C. Samples were diluted in PBS and plated on LB agar 
plates to assess bacterial viability. Survival values of bacteria incubated in LB Polymyxin 
are relative to values of bacteria incubated in LB. Strain ΔbcsA PphoP::adrA incubated in N 
minimal medium with 10 mM MgCl2 prior to polymyxin treatment showed a highly sensitive 
phenotype and served as a control of the resistance phenotype induced by low MgCl2 
concentrations. Data were analyzed by a Mann-Whitney U test. Bars are means of 
replicates ± s.e. (n = 3). ns=no significant difference. (C) Overnight cultures were diluted 
1/100 in LB broth or LB broth supplemented with 1 mM H2O2 and incubated at 37°C with 
aeration. Aliquots were collected hourly, serially diluted and plated. Statistical analysis was 
carried out using a two-way analysis of variance combined with the Bonferroni test. ** P < 
0.01; *** P < 0.001. Bars are means of replicates ± s.e. (n = 3).  
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PGA production renders Salmonella avirulent in mice 
Since heterologous expression of PGA makes Salmonella less 
capable to survive inside macrophages, we hypothesized that PGA 
production might result in virulence attenuation upon infection by the natural 
oral route of BALB/c mice, which are susceptible to systemic infection with 
Salmonella. Taking into account that c-di-GMP is involved in modulating the 
innate immune response (Burdette et al., 2011; Parvatiyar et al., 2012), we 
constructed a Salmonella strain that constitutively produced PGA from the 
chromosome, without altering natural c-di-GMP levels. As expected, levels 
of PGA production by this strain, WT PcL::pga, were lower than those 
produced by WT pJET::pga (Fig. S4). Additionally, the bcsA gene was 
mutated in this strain, resulting in ΔbcsA PcL::pga, which produced PGA but 
not cellulose. Thus, virulence assays were carried out by comparing the 
pathogenic behavior of the control strain, ΔbcsA, which produces neither 
cellulose nor PGA, with that of either the PGA producing strain ΔbcsA 
PcL::pga or the wild type strain, which produces natural levels of cellulose 
during infection. These two strains did not show any discernable fitness cost 
compared to ΔbcsA when grown in LB broth at 37 °C (Fig. S5). Firstly, the 
impact of PGA and cellulose synthesis on the capacity of Salmonella to 
adhere and invade the intestinal epithelium was analyzed by carrying out a 
competitive index analysis in an ileal loop coinfection experiment (Fig. 5A). 
Both the wild type and ΔbcsA PcL::pga strains showed reduced capacity to 
adhere and invade the intestinal epithelium compared with the control strain, 
ΔbcsA. Secondly, we assessed the level of organ colonization following oral 
co-inoculation of the control strain, ΔbcsA, and either the wild type or ΔbcsA 
PcL::pga strain. In the case of mice co-infected with the wild type and ΔbcsA 
strains, the bacterial burden of the wild type was slightly higher than that of 
ΔbcsA in all organs analyzed (livers, spleens and gallbladders). Conversely, 
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the PGA producing strain showed to be extremely attenuated, since no 
ΔbcsA PcL::pga bacteria were recovered from the organs examined after 
co-infection with the control strain (Fig. 5B). To exclude the possibility that 
the control strain outcompetes the PGA producing strain when coinfection 
experiments are performed, we next compared the virulence of ΔbcsA and 
ΔbcsA PcL::pga strains by carrying out single infection experiments. Results 
confirmed that the PGA producing strain was highly attenuated, since mice 
inoculated with ΔbcsA PcL::pga did not show any disease symptom and 
most of them presented bacterial counts under the detection limit in livers, 
spleens and gallbladders (Fig. 5C). It is important to note that in the case of 
gallbladders, the entire organ was plated and that six out of seven 
gallbladders from mice inoculated with ΔbcsA PcL::pga were free from 
infection. Thus, these findings reflected the PGA impact on Salmonella 
intramacrophage survival and supported the view that heterologous PGA 
production impairs Salmonella survival in orally infected mice.  
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Fig. 5. PGA production leads to a complete Salmonella attenuation in a mouse model of 
infection. (A) Competitive index analysis of the wild type strain and ΔbcsA PcL::pga coinoculated 
with the control strain, ΔbcsA, after performing an ileal loop coinfection experiment. Five ileal loops 
were coinfected with 2x107 cfu containing equal numbers of the control and either the cellulose or 
PGA producing strains. A CI > 0 indicates the exopolysaccharide producing strain with a colonization 
advantage compared to the control and a CI < 0 indicates the exopolysaccharide producing strain 
with a colonization disadvantage over the control.  (B) CI analysis following intragastric inoculation of 
four BALBc mice with a 1:1 mixture of the control strain, ΔbcsA, and either the wild type or ΔbcsA 
PcL::pga strain (total inoculum administered was 2 x 108 cfu). Mice were sacrificed when evident 
signs of disease (score 2 to 3) were observed, and bacteria were enumerated from livers, spleens 
and gallbladders. No ΔbcsA PcL::pga bacteria were recovered from any of the organs analyzed; 
detection limit was 133 cfu/g in livers and spleens and 2 cfu/organ in the gallbladder. This detection 
limit was used to calculate the output corresponding to mice coinoculated with ΔbcsA and ΔbcsA 
PcL::pga. The plots display values obtained from individual samples and the mean CI is represented 
by horizontal bars. P-values were determined by a Student t test. ns = no significant difference; *P < 
0.05; ** P < 0.01. (C) Virulence of ΔbcsA and ΔbcsA PcL::pga in mice inoculated intragastrically. 
Seven mice were infected with 1 x 108 cfu of the indicated strain. Mice inoculated with ΔbcsA were 
sacrificed when evident signs of disease (score 2 to 3) were observed, whilst mice inoculated with 
ΔbcsA PcL::pga were sacrificed at the end of the experiment. Bacterial loads in livers, spleens and 
gallbladders were analyzed. The dashed line indicates detection limit (133 cfu/g in livers and 
spleens).  The plots display values obtained from individual samples and the median is represented 
by horizontal bars. Differences in colonization were statistically analyzed by using the Mann-Whitney 
U test. ** P < 0.01; *** P < 0.001.  
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PGA production makes Salmonella sensitive to bile salts  
Bile resistance is indispensable for Salmonella to colonize the 
hepatobiliary tract during systemic infection and persist in the gall bladder 
during chronic infection (Andrews-Polymenis et al., 2010; Gonzalez-
Escobedo et al., 2010) and again, this characteristic represents a major 
difference between Enterobacteriaceae species. Thus, to further examine 
the consequences of PGA production in the Salmonella infection process, 
we analyzed the ability of Salmonella PGA producing cells to cope with the 
presence of bile. Dilutions from cultures of the wild type, the PGA producing 
strain, ΔbcsA PcL::pga, and their corresponding exopolysaccharide minus 
strain, ΔbcsA, were spread on LB plates supplemented with 24% bile 
bovine. Exposure to bile caused a decrease of ~3 logs in the number of cfu 
of both the wild type and ΔbcsA strain, whereas it provoked a reduction of 
~5 logs in the case of the PGA producing strain (Fig. 6A). Remarkably, PGA 
production in E. coli was also very detrimental for bile survival, since an E. 
coli strain producing PGA showed a ~2.5 logs reduction in bile sensitivity 
compared either with the wild type or with a pgaC mutant (Fig. 6B and Fig. 
S6). In order to analyze whether PGA production somehow alters 
membrane integrity, we tested the sensitivity of Salmonella and E. coli PGA 
producing strains to the ionic detergent SDS. The minimal inhibitory 
concentration (MIC) of SDS for the Salmonella wild type and ΔbcsA strains 
was 17%, whilst it decreased to 15% in the case of ΔbcsA PcL::pga. On the 
other hand, the MIC for E. coli MG1655 and ΔpgaC strains was found to be 
15%, compared with 7% for the PGA producing strain MG1655 PcL::pga. 
Altogether, these results indicate that PGA causes a significant reduction in 
bile resistance both in Salmonella and E. coli, perhaps through 
modifications of membrane permeability. 
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Fig. 6. Production of PGA in Salmonella and E. coli greatly increases bile 
sensitivity. (A) Bile sensitivity assay for the wild type, the PGA producing strain, ΔbcsA 
PcL::pga, and their corresponding exopolysaccharide minus strain, ΔbcsA. Two microliter 
portions of the appropriate dilutions of each culture were incubated for 24 h at 37°C in an 
LB Cb plate (left) or an LB Cb plate containing 24% bile bovine (right). (B) Bile sensitivity 
assay for E. coli MG1655, a MG1655 pgaC mutant and MG1655 PcL::pga strain that 
overproduces PGA. Two microliter portions of the appropriate dilutions of each culture were 
incubated for 24 h at 37°C in an LB plate (left) or an LB plate containing 13% bile bovine 
(right).  
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Acquisition of new genes is considered to be a mechanism to enhance 
an organism’s ability to colonize a new environment, resist a specific 
antimicrobial or evade the immune system (Wiedenbeck and Cohan, 2011; 
Soucy et al., 2015). However, genomic data reveal that gene loss is also a 
widespread strategy to enhance bacterial fitness (Maurelli et al., 1998; 
Sokurenko et al., 1999; Koskiniemi et al., 2012; Hottes et al., 2013; Bolotin 
and Hershberg, 2015; Albalat and Cañestro, 2016). There are at least two 
reasons why bacteria may loss genes during evolution. A gene product or 
pathway may become superfluous in the new environment. In the absence 
of purifying selection, the gene accumulates neutral mutations, generating 
pseudogenes that may be finally removed from the bacterial genome. 
Alternatively, the product of the gene may be detrimental, triggering 
selection to optimize bacterial fitness in the new environment. It is well 
established that Salmonella evolution towards virulence has, at least, 
involved the acquisition by horizontal gene transfer (HGT) of a virulence 
plasmid and several pathogenicity islands that contain the genes necessary 
for invasion of intestinal epithelial cells and the systemic phase of infection 
(Gulig et al., 1993; Baumler et al., 1998). However, the possibility that 
adaptation of Salmonella to the intracellular environment has occurred 
through gene loss has rarely been considered (Eswarappa et al., 2009; 
Koskiniemi et al., 2012). This work provides evidence that acquisition by 
Salmonella of an arsenal of virulence factors might have been useless in a 
strain producing PGA.  
All bacterial species adapted to the mammalian intestine are resistant 
to the antibacterial activity of bile salts. However, the resistance of 
Salmonella enterica is especially remarkable. During systemic infection, 
Salmonella is able to transit from the liver into the gallbladder, where it can 
either induce inflammation and acute infection or persist chronically, 
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creating a carrier state (Crawford et al., 2010; Bäumler et al., 2011; 
Gonzalez-Escobedo and Gunn, 2013) . Several cell components and 
mechanisms have been related with Salmonella resistance to bile (Gunn, 
2000; Sistrunk et al., 2016). On one hand, different efflux pumps transport 
bile salts outside the cell decreasing their intracellular concentration 
(Piddock, 2006; Nikaido et al., 2008). On the other, diverse strategies that 
involve membrane reorganization and provide barriers to reduce bile salts 
uptake have been described, such as remodeling the lipopolysaccharide 
(both lipid A and O-antigen), changing the length of the enterobacterial 
common antigen and reducing the content of the Braun lipoprotein bound to 
the peptidoglycan, the levels of muropeptides cross-linked by 3-3 peptide 
bridges and the amount of porins sensitive to bile (Van Velkinburgh and 
Gunn, 1999; Ramos-Morales et al., 2003; Hernández et al., 2012; Crawford 
et al., 2012; May and Groisman, 2013; Hernández et al., 2015). Our finding 
that constitutive production of PGA causes bile sensitivity in S. Enteritidis 
suggests an alternative strategy: the removal of compounds (PGA) that 
render the bacteria susceptible to bile. How PGA causes this effect is 
presently unclear. PGA represents an unusual bacterial exopolysaccharide, 
as some GlcNAc residues become deacetylated by the PgaB protein during 
secretion, providing a positive net charge to the polymer (Wang et al., 2004; 
Itoh et al., 2008). Thus, the presence of PGA may favor the accumulation of 
anionic bile salts on the bacterial surface and/or alter membrane 
permeability. The finding that PGA increased the susceptibility not only to 
bile bovine but also to the anionic detergent SDS support the hypothesis 
that PGA induces changes in membrane permeability.  
We showed that constitutive expression of PGA also causes bile 
sensitivity in E. coli. These results raise the broader question of why E. coli, 
which displays a fair level of bile resistance necessary to grow in the small 
intestine, still produces PGA. Bile salts are maintained at high 
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concentrations in the duodenum, jejunum, and proximal ileum. In the distal 
ileum, bile salts are absorbed into the blood-stream, and the majority of bile 
is recycled back into the small intestine and does not enter the colon 
(Sistrunk et al., 2016). E. coli resides in the microbiota found in the cecum 
and colon of humans. Thus, the presence of PGA might be compatible with 
the bile concentration in the small intestine and not with the concentration in 
the gallbladder. Alternatively, it is also possible that E. coli has developed 
regulatory systems to prevent PGA expression in the small intestine. 
The second step of the infection process that is negatively affected 
by the presence of PGA is the survival and replication in the vacuole within 
host phagocytic cells. During systemic infection, Salmonella survives and 
replicates in vacuoles within host phagocytic cells where it must overcome 
the reactive oxygen species produced by macrophages (Fang, 2011). It has 
been reported that Salmonella needs to repress cellulose production inside 
the vacuole through the activation of MgtC, which prevents a rise in c-di-
GMP (Pontes et al., 2015). Increased levels of cellulose interfere with 
replication inside the vacuole and impair virulence in mice. The mechanisms 
underlying the antivirulence trait of cellulose has not been determined. We 
have now found that PGA production also hinders Salmonella division inside 
macrophages. Regarding this phenotype, we showed that production of 
PGA increases the susceptibility to H2O2 treatment, thus providing a 
potential mechanism for this attenuation. The notion that PGA is detrimental 
during infection of mammal cells is supported by studies with Y. pestis 
(Bobrov et al., 2010). Y. pestis forms PGA mediated biofilms below 30ºC in 
the blood-feeding fleas favoring the transmission and invasiveness of the 
bacteria from fleas to mammals (Sun et al., 2014). However, PGA 
production has to be inhibited in the mammal host over 30ºC to allow the 
development of a lethal infection. This temperature dependent regulation of 
PGA depends on the tight regulation of the c-di-GMP secondary 
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messenger.  
Salmonella is an ubiquitous bacterium with a dual 
intracellular/extracellular lifestyle. Its extracellular life involves survival in the 
environment, a scenario in which exopolysaccharide-mediated biofilms play 
an important role, protecting bacteria against environmental threats. Our 
results indicate that PGA loss provides a fitness advantage when 
Salmonella colonizes the liver, gallbladder or resides inside the 
macrophages. However, loss of PGA might have negative consequences 
for survival in the environment unless another compound of the cell wall was 
able to compensate for PGA absence. Comparative phenotypic analysis 
between the protection conferred by PGA and cellulose against 
environmental threats revealed that PGA confers at the most similar 
benefits than cellulose, indicating that cellulose is sufficient to provide 
Salmonella with protection against environmental stresses and compensate 
for the loss of PGA function. 
Our findings provide a plausible explanation for PGA loss from the 
Salmonella genome during evolution. They also enhance our understanding 
of the benefits and burdens of a widely used exopolysaccharide to form the 
bacterial biofilm matrix, highlighting the necessity of additional studies to 
depict the exact role of PGA at each step of the life cycle. Finally, our study 
may also encourage microbiologists to turn more attention towards gene 
loss research as an approach to obtain information about how pathogenic 
bacteria have adapted to the host. 
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Fig. S1. Gene neighborhood analysis for pgaA, as provided in the STRING 
database (Szklarczyk et al., 2015). Results for Enterobacteriaceae genomes are fully 
displayed, while those from other groups are presented in a collapsed mode.  
Chapter III 
236 
 
 
 
 
Fig. S2. Analysis of PGA synthesis dependence on c-di-GMP. Quantification of 
PGA exopolysaccharide production by dot blot. Serial dilutions (1/10) of the samples were 
spotted onto nitrocellulose membranes and PGA production was detected with specific anti 
PIA/PNAG antibodies. UD; undiluted sample. (A) Dot blot analysis of the PGA accumulated 
by S. Enteritidis wild type, WT PcL::adrA and their corresponding transformed strains with 
plasmid pJET::pga throughout 72 hours of incubation under Salmonella biofilm forming 
conditions, that is incubation in LB or LB Cb broth, at room temperature, under static 
conditions. (B) Dot blot analysis of the PGA accumulated by ΔXII and its twelve derivative 
strains, in which c-di-GMP synthesis is provided by a unique GGDEF domain protein. The 
wild type strain is shown as a control. All strains carried plasmid pJET::pga and were grown 
for 72 hours in LB Cb broth, at room temperature, under static conditions. Seven genes that 
are shown in a black box encode predicted or demonstrated c-di-GMP synthases. Five of 
them, namely AdrA, YedQ, YegE, YfiN and SEN4316, were able to induce PGA synthesis. 
The rest of the proteins, namely YciR, YfeA, YhdA, YhjK and SEN2484, although harboring 
a GGDEF domain, are predicted or demonstrated phosphodiesterases (c-di-GMP 
degrading enzymes) or proteins with no c-di-GMP metabolic activity, and therefore, do not 
elicit PGA synthesis. 
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Fig. S3. Hydrophobicity analysis of macrocolony biofilms formed by WT 
PcL::adrA and ΔbcsA PcL::adrA pJET::pga. (A) The cellulose overproducing strain, WT 
PcL::adrA, the PGA overproducing strain, ΔbcsA PcL::adrA pJET::pga and the control 
strain,  ΔbcsA PcL::adrA, were incubated on LB agar or LB agar Cb media for 48h at 28ºC. 
A bent tip was used to visualize the macrocolony appearance. The cellulose mediated 
macrocolony looked like a pellicle that was very difficult to disrupt whilst the PGA mediated 
macrocolony appeared much more mucoid. (B) Macrocolony biofilms were generated and a 
10 µl water droplet stained with red food coloring was placed on each macrocolony, 
showing the hydrophobicity exhibited by the structure. 
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Fig. S4. Strains WT PphoP::adrA and ΔbcsA PphoP::adrA PcL::pga produce 
cellulose and PGA, respectively, in a phoP dependent fashion. A cellulose based 
biofilm is produced by WT PphoP::adrA after overnight growth in low-Mg2+ liquid medium (top 
panel). An aggregate of ΔbcsA PphoP::adrA PcL::pga bacteria can be observed at the 
bottom of the tube as Mg2+ concentrations decrease, indicative of PGA synthesis (low 
panel). Such aggregation correlates with increased PGA production detected by dot blot, 
using specific anti PIA/PNAG antibodies. Strain ΔbcsA PphoP::adrA that produces neither 
cellulose nor PGA shows a planktonic phenotype. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. S5. Synthesis of PGA by a Salmonella strain that constitutively expresses 
the pgaABCD operon from the chromosome. Comparison of the PGA accumulated by 
WT PcL::pga and  WT pJET::pga, expressing the pgaABCD operon from the chromosome 
or from a plasmid, respectively, after 24 hours of growth at 37°C in LB or LB Cb media. 
Serial dilutions (1/10) of the samples were spotted onto nitrocellulose membranes and PGA 
production was detected with specific anti PIA/PNAG antibodies. UD; undiluted sample.  
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Fig. S6. Fitness of ΔbcsA versus the wild type or ΔbcsA PcL::pga strains. The 
competitive fitness of ΔbcsA in co-culture with either the wild type or ΔbcsA PcL::pga was 
determined by combining the two strains in LB broth, incubating at 37°C and enumerating 
each strain over time. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. S7. PGA is overproduced by E. coli MG1655 when the pgaABCD operon is 
expressed from a constitutive promoter. Dot blot analysis of the PGA accumulated by E. 
coli MG1655, a pgaC mutant and a derivative of E. coli MG1655 in which the pgaABCD 
operon was placed under the control of the constitutive promoter PcL, after 24 hours of 
growth at 37°C in LB media. Serial dilutions (1/10) of the samples were spotted onto 
nitrocellulose membranes and PGA production was detected with specific anti PIA/PNAG 
antibodies. UD; undiluted sample. Note that, as it has already been described (7), the 
parental E. coli MG1655 strain exhibited an extremely weak reaction with the antibody 
because of the posttransciptional repression of PGA production by the CsrA protein (8). 
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FUTURE PROSPECTS 
Salmonella follows a cyclic lifestyle in which host colonization is followed 
by periods outside the host, where biofilm formation capacity plays a key role. 
Once inside the biofilm matrix, bacterial cells are up to 1000 times less 
susceptible to environmental stresses and disinfection treatments than 
planktonic cells (Costerton et al., 1987). Protected by the biofilm matrix and 
probably also due to some physiological adaptations that occur during 
multicellular lifestyle, Salmonella biofilms in food processing plants, farms and 
fresh food constitute a source of contamination very difficult to eradicate. In this 
thesis, I have tried to expand our understanding of how biofilm related 
compounds have affected the evolution and pathogenicity of Salmonella, in the 
conviction that a deeper knowledge of the factors governing Salmonella 
multicellularity is essential to implement measures to control the infections 
caused by this pathogen. In this section, several questions raised by the results 
of this thesis as well as strategies that might be used to answer such questions 
are discussed. 
 
1) Involvement of c-di-GMP in Salmonella virulence 
The results obtained in the first chapter showed that c-di-GMP signaling is 
almost dispensable for Salmonella infection of BALB/c mice. The lack of c-di-
GMP signaling only results in a slight but constant reduction of virulence in 
acute mice infection models. These results were somewhat unexpected 
because a signal transduction network that serves to connect environmental 
conditions with bacterial physiology was thought to be more relevant during 
adaptation to the conditions encountered inside the host. The finding that 
virulence capacity is slightly attenuated in the ΔXII mutant most likely reflects 
that a GGDEF domain containing protein is necessary during the infection 
process. To identify such protein, we are planning to perform virulence studies 
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with the collection of derivatives of ΔXII, each containing a single GGDEF-
domain containing protein to evaluate if any diguanylate cyclase (DGC) is able 
to restore a virulent phenotype. Needless to say, this strategy would fail if more 
than one protein is necessary in the process. In the hypothetical case that a 
single DGC restored virulence, we would repeat similar virulence studies with a 
derivative strain producing a mutant version of the DGC without diguanylate 
cyclase activity. Intuitively, one would expect that the identified DGC affected 
virulence through its diguanylate cyclase activity. However, it cannot be 
excluded that DGCs might play additional roles independently of their capacity 
to produce c-di-GMP. Another strategy to evaluate whether c-di-GMP plays a 
role during infection would be to monitor c-di-GMP production inside the host. 
Recently, attempts to develop c-di-GMP reporters based on riboswitches (cis 
acting regulatory elements found in the 5’ untranslated region (UTR) of some 
mRNAs) have been described (Bastet et al., 2011). Riboswitches with the 
capacity to bind c-di-GMP have been described in Bacillus spp., Vibrio cholerae 
or Clostridium difficile species (Sudarsan et al., 2008; Lee et al., 2010; 
Bordeleau and Burrus, 2015). A reporter containing the c-di-GMP responsive 
riboswitch, under the control of a constitutive promoter and fused to the 
luxABCDE genes encoding luminescence proteins represents a conceivable 
tool for measuring c-di-GMP levels during mice infection (Hutchens and Luker, 
2007). One possible limitation of this approach might be the affinity of the 
riboswitch for c-di-GMP. If the amount of c-di-GMP accumulated during infection 
is low, the sensitivity of the reporter might not be sufficient to detect its 
presence. Different strategies such as tandem fusion of riboswitches have been 
suggested to increase sensitivity  (Zhou et al., 2016).  
A final aspect that is necessary to consider regarding c-di-GMP and 
Salmonella virulence is the role of c-di-GMP during chronic infections. Our 
results were obtained using acute mice infection models and therefore it cannot 
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be excluded that c-di-GMP may be important for establishing chronic infections 
where biofilm formation plays a key role. Thus, additional virulence studies 
using chronic models of infection are necessary to answer this question 
(Monack et al., 2004). 
 
2) ΔXIII strain as a carrier for the heterologous expression of 
antigens. 
The results of chapter I established that the attenuated Salmonella ΔXIII 
strain is a safe and effective mean for inducing humoral and cellular immune 
responses in mice. Based on these two characteristics, attenuation and efficient 
activation of the immune response, strain ΔXIII appears to be a good vaccine 
candidate for the expression of heterologous antigens. The use of live 
attenuated Salmonella strains to deliver recombinant antigens to the immune 
system has been proposed for the development of multivalent vaccines 
(Hegazy and Hensel, 2012). Examples of heterologous antigens for expression 
in Salmonella ΔXIII, in order to develop a multivalent vaccine, are fimbrial 
adhesins and toxins from Enterotoxigenic Escherichia coli (ETEC). ETEC 
infections are the major cause of neonatal and post-weaning diarrhea in piglets, 
producing significant economic losses in pig farming and hundreds of millions of 
cases of diarrheal disease in humans every year. Another therapeutic use of 
Salmonella ΔXIII would be the treatment of solid tumors. The use of bacteria as 
cancer therapeutic agents has been followed for more than a century. Bacterial 
colonization of tumors may result in retardation of growth or even complete 
clearance of the tumor. In this regard, Salmonella has been intensively 
investigated for its potential to treat tumors (Cheng-Zhi Wang et al., 2016) 
because it has the capacity to specifically migrate to the tumor region, infect 
tumoral cells and promote antitumor immunity as potent natural adjuvants, by 
activating innate immune cells followed by secretion of cytokines that can 
recruit and activate other immune cells at the tumor site (Henderson et al., 
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1996). Although some Salmonella strains possess sufficient cytotoxicity against 
tumors, heterologous expression of toxins in Salmonella ΔXIII would allow the 
accumulation at high concentrations of chemotherapeutics, enhancing their 
antitumor effects.  
One problem that we can envision for the use of Salmonella ΔXIII for 
heterologous expression of antigens is the unclear capacity of this strain for 
secreting proteins. We ignore how the simultaneous absence of c-di-GMP and 
RpoS might affect the functionality of the bacterial secretion machinery. Thus, it 
would be necessary to clarify this issue before considering the use of 
Salmonella ΔXIII for heterologous expression of antigens. 
 
3) Specificity of c-di-GMP signaling 
The presence of numerous proteins involved in c-di-GMP metabolism as 
well as c-di-GMP receptors in the same bacteria raises questions about the 
mechanisms that establish specificity of the c-di-GMP signaling pathways. In 
this respect, several possibilities have been proposed: i) colocalization of DGCs 
and their targets: c-di-GMP produced by a specific DGC affects the targets 
present in the near vicinity; ii) regulation of expression of c-di-GMP-related 
genes: there is a differential transcriptional regulation of c-di-GMP metabolizing 
enzymes for each particular environment or growth phase; and Iii) binding 
affinity of c-di-GMP receptors: specificity of c-di-GMP signaling is simply 
regulated through the binding affinity of c-di-GMP receptors. This last 
hypothesis implies the existence of a general pool of c-di-GMP whose level will 
depend on the number of GGDEF/EAL proteins present and active under each 
specific environmental condition. Using the collection of ΔXII derivatives, each 
of which contains the chromosomal copy of a single gene encoding a GGDEF 
domain protein, we have determined that five out of the eight DGCs from 
Salmonella have the ability to activate PGA synthesis. The finding that the PGA 
machinery is activated by c-di-GMP produced by many different DGCs, 
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including one that is unique to Salmonella (sen4316), disagrees with the 
hypothesis that regulation through c-di-GMP depends on the colocalization of 
the DGC with a receptor, in this particular case the PGA machinery. 
Furthermore, our results are in good agreement with previous studies showing 
that heterologous expression of HmsT, a diguanylate cyclase from Yersinia 
pestis, in ΔXII strain results in cellulose production (Solano et al., 2009). Again, 
the localization of a DGC from Yersinia in the vicinity of the cellulose-synthase 
machinery in Salmonella, to locally activate cellulose production is 
counterintuitive. 
Overall, these results support the hypothesis of the existence of a common pool 
of c-di-GMP that when reaching a higher level than the dissociation constant of 
PgaD, would have the capacity to activate PGA synthesis.  
 
4) Involvement of bacterial polysaccharides in infection.  
A striking characteristic shared by cellulose and PGA is that they are 
chosen by many phylogenetically unrelated bacteria, including gram negative 
and gram positive bacteria, to build the biofilm matrix. Furthermore, some 
bacterial species such as Klebsiella pneumoniae, E. coli or Burkholderia spp. 
produce both types of exopolysaccharides, indicating that there should not be 
any metabolic or functional incompatibility between both exopolysaccharides. 
Despite the fact that E. coli and Salmonella are closely related, E. coli maintains 
the capacity to produce both exopolysaccharides, whereas Salmonella only 
produces cellulose. In this study, we have identified some specific 
environmental niches (gallbladder and macrophages) where the presence of 
PGA is detrimental for Salmonella colonization. Based on these findings, we 
propose that Salmonella has favored the capacity to colonize these locations 
over the advantages that the presence of PGA might confer on bacteria. 
However, there are several questions related with the presence of these two 
exopolysaccharides that would require further investigation. For instance, are 
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both exopolysaccharides simultaneously present in E. coli? The finding that the 
synthesis of both exopolysaccharides is activated by c-di-GMP suggests that 
indeed, this should be the case. Otherwise, it would be difficult to understand 
how the synthesis of one exopolysaccharide might be inhibited when levels of 
c-di-GMP reach the dissociation constant of the receptor with lower affinity. We 
have tried to establish which of the exopolysaccharides is firstly synthesized in 
LB media, but unfortunately, the antibodies against cellulose were very 
inefficient at detecting cellulose in dot blot experiments and we could not obtain 
conclusive results. Alternatively, we are planning to use immunogold labeling 
and electron microscopy to determine whether both exopolysaccharides are 
simultaneously present on the bacterial surface. We know that the antibodies 
against PGA (kindly provided by G. Pier) are functional in this technique but we 
do not know whether the commercial antibodies against cellulose recognize 
cellulose under these conditions. 
Another unsolved question relates with the properties that PGA confers to 
E. coli and whether these properties are different from the ones conferred by 
cellulose. Intuitively, the fact that several bacteria produce both 
exopolysaccharides strongly suggests that they are complementary and 
consequently that they do no confer similar properties. Alternatively, it is 
possible that both exopolysaccharides confer similar properties but due to their 
different biochemical nature, each one would assume its role under different 
environmental conditions. The phenotypic comparisons performed in this study 
have not unraveled any significant difference between cellulose and PGA but it 
would obviously be necessary to analyze other stresses and also, the same 
stress under different environmental conditions.  
Finally, evidence is accumulating that production of exopolysaccharides 
are detrimental in some specific locations during infection of a mammalian host. 
Pontes et al (Pontes et al., 2015) defined cellulose as an antivirulence factor, 
because stimulation of cellulose synthesis inside macrophages causes a 
Future prospects 
249 
decrease in bacterial virulence. Salmonella solves the toxicity of cellulose in 
certain locations by tightly regulating cellulose levels through MgtC, a protein 
that inhibits the ATP synthase and consequently reduces ATP levels, 
preventing the rise of c-di-GMP. Similarly, the finding that PGA production is 
detrimental during Salmonella infection suggests that E. coli should also tightly 
regulate PGA production. In fact, E. coli regulates PGA production at a 
posttranscriptional level through CsrA, a small RNA binding protein that 
recognizes the leader sequence of the pga 5’ UTR and blocks ribosome binding 
(Xin Wang et al., 2005). In addition, PGA production is also regulated at a 
posttranslational level through the allosteric binding of c-di-GMP to PgaAD 
proteins (Steiner et al., 2013). Consequently, loss of CsrA or increased levels of 
c-di-GMP augment PGA production. Therefore, PGA deregulation by any of 
these two approaches might be an interesting method to analyze PGA 
consequences during E. coli intestinal colonization. However, considering that 
CsrA and c-di-GMP regulate many other genes, the strategy of PGA 
derepression by modifying the levels of these regulators might probably be 
accompanied by many pleitropic effects. In this regard, it is very important to 
note that we have constructed a novel strain, MG1655 PcL::pga, described in 
Chapter III, in which the pga operon is expressed under the control of the PcL 
constitutive promoter and the consensus 5’ UTR of λ T0 phage. Thus, in this 
strain, PGA expression is insensitive to CsrA activity and PGA production is 
perfectly detectable by Dot Blot. MG1655 PcL::pga can therefore be considered 
as a promising strain to evaluate the effects of PGA synthesis in E. coli host 
colonization.    
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Table 1: Comparative analysis of GGDEF domain containing proteins in E.coli and 
Salmonella genomes. The first column associated to each organism shows the genome 
position of all genes encoding a putative diguanylate cyclase protein (GGDEF domain 
containing protein). The second column shows the names of currently described genes. The 
aminoacid sequence of the catalytic A site of the GGDEF domain is then shown and conserved 
motifs are written in blue. Cells shaded in grey indicate an absence of the homologous protein 
in the corresponding organism. The last column associated to Salmonella shows the ability of 
each diguanylate cyclase to activate PGA production. 
 
 
 Salmonella Enteritidis P125109  E. coli K-12 MG1655 
G
G
D
E
F 
Gene Name Motif PGA  Synthesis Gene Name motif 
sen0368 adrA  GGDEF ✓ b0385 yaic GGDEF 
sen1769 yeaJ  GGDEF X b1786 yeaJ GGDEF 
sen1023 yedQ  GGEEF ✓ b1956 yedQ GGEEF 
sen2593 yfiN  GGDEF ✓ b2604 yfiN GGDEF 
sen4316  GGEEF ✓    
    b1025 ycdT GGEEF 
    b1535 ydeH GGDEF 
    b1341 ydaM GGDEF 
    b1522 yneF GGEEF 
    b1785 yeaI GEVFG 
    b0834 yliF GGDEF 
    b1490 dosC (yddV) GGDEF 
    b1794 yeaP GGDEF 
G
G
D
E
F-
 E
A
L 
sen1329 yciR  GGDEF-EAL X b1285 gmR/yciR GGDEF-EAL 
sen2119 yegE  GGDEF-EAL ✓ b2067 yegE GGDEF-EAL 
sen2396 yfeA  PGSEL-LEKE X b2395 yfeA PGSEL 
sen3209 yhdA  HRSDF-ELM X b3252 csrD (yhdA) HRSDF-ELM 
sen3222  GGDEF-EAL X    
sen3438 yhjK  SGYDF-EAL X    
sen2484  SGHDL-EAL X    
    b1489 dosP GGNGW-EAL 
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CONCLUSIONS 
 
1. Removal of all GGDEF domain containing proteins and thus c-di-
GMP in S. Enteritidis causes a moderate loss of virulence in a 
murine model of infection, indicating that either a specific GGDEF-
domain containing protein or c-di-GMP itself is required during 
infection.  
 
2. A S. Enteritidis strain deficient in the c-di-GMP signaling network and 
rpoS (ΔXIII strain) is highly attenuated but capable of eliciting a 
cellular/humoral immune response against a lethal oral-challenge 
with a S. Typhimurium virulent strain. 
 
3. The ability of S. Enteritidis ΔXIII strain to survive under desiccation 
conditions and to form a biofilm is seriously compromised, 
suggesting that its environmental survival and transmission to new 
hosts may probably be undermined. Also, ΔXIII shows DIVA features 
that allow differentiation of infected and vaccinated animals.  
 
4. There is a Sting dependent IFN-β response in Salmonella infected 
macrophages, that is independent of the presence of c-di-GMP 
 
5. STING deficient mice do not show any special susceptibility to a 
Salmonella infection, indicating that STING-mediated IFN-β does not 
play any detectable function during a Salmonella infection in mice.  
 
6. Phylogenetic analyses suggest that the pgaABCD cluster was lost 
somewhere after the divergence of Salmonella and Citrobacter 
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clades, and previous to the diversification of the currently sequenced 
Salmonella strains 
 
7. Heterologous pgaABCD expression is sufficient to restore 
Salmonella capacity to synthesize PGA in a c-di-GMP dependent 
manner. PGA production makes Salmonella able to a build biofilm 
that differs at a structural and functional point of view from the 
cellulose-mediated biofilm.  
 
8. PGA production reduces Salmonella resistance against bile and its 
capacity to survive inside macrophages, rendering Salmonella 
avirulent in the mouse oral infection model.  
 
9. PGA is an antivirulence factor whose loss may have been a 
necessary event during Salmonella speciation to permit survival 
inside the host. 
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1. La mutación de todos los genes que codifican proteínas que contienen 
un dominio GGDEF y, por lo tanto, la ausencia de c-di-GMP en S. 
Enteritidis da lugar a una atenuación moderada de la virulencia en un 
modelo de infección murino, indicando que bien una proteína GGDEF 
específica o bien el propio c-di-GMP son necesarios durante la infección.  
 
2. Una cepa de S. Enteritidis deficiente en la ruta de señalización del c-di-
GMP y además mutante en rpoS (cepa ΔXIII) presenta una gran 
atenuación y es capaz de generar una respuesta inmune celular y 
humoral frente a un desafío, vía oral, con una cepa virulenta de S. 
Typhimurium.  
 
3.  La capacidad de la cepa S. Enteritidis ΔXIII de sobrevivir en condiciones 
de desecación y de formar un biofilm se encuentra seriamente 
comprometida, lo cual sugiere que su supervivencia en el ambiente y 
transmisión a nuevos huéspedes esté probablemente afectada. Además, 
la cepa ΔXIII posee características DIVA que podrían permitir la 
diferenciación de animales infectados y vacunados.  
 
4. En macrófagos infectados con Salmonella se activa la producción de 
IFN-β dependiente de STING e independiente de la presencia de c-di-
GMP.  
 
5. Ratones deficientes en STING no muestran una susceptibilidad especial 
a la infección por Salmonella, lo cual indica que la producción de IFN-β 
mediada por STING no juega un papel significativo durante la infección 
por Salmonella.  
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6. Análisis filogenéticos sugieren que el operón pgaABCD se perdió en 
Salmonella después de la divergencia entre los géneros Salmonella y 
Citrobacter y previamente a la diversificación de las cepas de 
Salmonella que están actualmente secuenciadas.  
 
7. La expresión heteróloga del operon pgaABCD es suficiente para 
restaurar la capacidad de Salmonella de sintetizar PGA, en una manera 
dependiente del c-di-GMP. La producción de PGA permite a Salmonella 
formar un biofilm que es diferente desde el punto de vista estructural y 
funcional al biofilm mediado por celulosa.  
 
8. La producción de PGA disminuye la supervivencia de Salmonella tanto 
en presencia de sales biliares como en el interior del macrófago, lo cual 
da lugar a una atenuación total de la virulencia en un modelo de 
infección oral en ratón.  
 
9. El PGA es un factor de antivirulencia cuya pérdida pudo haber supuesto 
un evento necesario durante la especiación de Salmonella para permitir 
su supervivencia en el interior del huésped.  
 
